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Abstract 
 
Erythropoietin (Epo) modulates red blood cell production (erythropoiesis) by 
binding to its receptor and activating STAT5, a Signal Transducer and Activator of 
Transcription (STAT) protein implicated in both basal and stress erythropoiesis. Epo 
concentration in serum changes over three orders of magnitude, as it regulates basal 
erythropoiesis and its acceleration during hypoxic stress. However, it is not known how 
STAT5 translates the changes in Epo concentration into the required erythropoietic rates. 
We addressed this question by studying STAT5 phosphorylation, at the single cell level, 
in developing erythroblasts.  
We divided erythroid progenitors in tissue into several flow-cytometric subsets 
and found that each of them exhibited distinct modes of Stat5 activation, based on their 
developmental stage. STAT5 activation is bistable in mature erythroblasts, resulting in a 
binary (or digital), low-intensity STAT5 phosphorylation signal (p-Stat5). In early 
erythroblasts, and in response to stress levels of Epo, the low intensity bistable p-Stat5 
signal is superseded by a high-intensity graded, or analog, signal.  
The gradual shift from high-intensity graded signaling in early erythroblasts to 
low intensity binary signaling in mature erythroblasts is due to a decline in STAT5 
expression with maturation. We were able to convert mature, digital transducing 
erythroblasts into analog transducers simply by expressing high levels of exogenous 
STAT5. We found that EpoR-HM mice, expressing a mutant EpoR that lacks STAT5 
docking sites, generate the binary, but not the analog, STAT5 signal. Unlike Stat5-null 
??
mice, which die perinatally, the EpoR-HM mice are viable but deficient in their response 
to stress, demonstrating that while binary STAT5 signaling is sufficient to support basal 
erythropoiesis, analog signaling is required for the stress response. Bistable systems 
contain a positive loop, which is important for flipping the switch between the two stable 
‘on’ or ‘off’ states. We show that bistable activation is the result of an autocatalytic loop 
in which active STAT5 promotes further STAT5 activation. The isolated STAT5 N-
terminal domain, which is not required for STAT5 phosphorylation, enhanced 
autocatalysis, converting a high intensity graded signal into a high intensity binary 
response. The N-terminal domain is known to participate in a radical conformational 
reorientation of STAT5 dimers inherent in STAT5 activation. We propose that the N-
terminal domains of active STAT5 dimers facilitate the conformational reorientation of 
inactive dimers, in a prion-like autocatalytic interaction that underlies bistability and 
binary signaling. Together, bistable STAT5 activation, combined with a graded response 
allow erythropoietic rate to faithfully reflect a wide Epo concentration range, while 
preventing aberrant signaling.  
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?CHAPTER I: Introduction 
1. Erythropoiesis 
Erythropoiesis, the production of red blood cells, is regulated by the glycoprotein 
hormone erythropoietin (Epo), whose production is modulated by tissue oxygen tension. 
Given the central role of red blood cells in oxygen transport, erythropoiesis is a tightly 
regulated process aimed at maintaining homeostasis as well as responding to changes in 
oxygen demand. Definitive erythropoiesis in mice occurs in the fetal liver, whereas basal 
adult erythropoiesis occurs primarily in the bone marrow and at low levels in the spleen. 
However, in conditions that cause hypoxic stress, such as moving to high altitude, blood 
loss or anemia, the spleen becomes the main erythropoietic organ and erythropoiesis can 
increase up to 10-fold its basal rate, in a process known as stress erythropoiesis.  
Tissue oxygen tension modulates Epo secretion by the kidney peritubular cells 
through the Hypoxia-Inducible Factor (HIF) [1]. The transcription factor HIF-2, 
composed of an oxygen sensitive α subunit, HIF-2α, and a constitutively expressed β 
subunit, HIF-β, regulates Epo induction by binding to hypoxia-response elements (HREs) 
in the promoter of the Epo gene [2, 3]. Under normal oxygen conditions, the HIF-2α 
subunit is hydroxylated by oxygen- and iron-dependent prolyl-hydroxylases, allowing 
binding of the von Hippel-Lindau tumor suppressor (pVHL) and subsequent targeting of 
the HIF-2α subunit for proteasomal degradation [4, 5]. Under conditions of hypoxia the 
α subunit is stabilized leading to the formation of an active HIF-2αβ heterodimer.  
Epo levels can increase up to 1000 fold during severe tissue hypoxia [6]. High 
Epo, in combination with other factors, such as stem cell factor (SCF) [7], 
?glucocorticoids [8, 9] and bone morphogenetic protein 4 (BMP4) [10], promotes an 
increased erythropoietic rate. However, the details of Epo receptor (EpoR) signaling 
during basal and stress erythropoiesis are not yet known.  
2. Identification of erythroid progenitors 
Erythroid progenitors are generated from hematopoietic stem cells present in the 
fetal liver or in the bone marrow, via multipotential progenitors, such as the common 
myeloid progenitor (CMP) and the megakaryocytic/erythrocytic progenitor (MEP). 
Erythroid progenitors have been identified in the past using colony-forming assays in 
semisolid medium (Figure 1.1A). The earliest committed erythroid progenitor identified 
ex vivo by this method is the Burst Forming Unit-erythroid (BFU-e), that generates, in the 
presence of Epo, Stem Cell Factor (SCF) and Interleukin-3 (IL-3), about 500 cells in 6-10 
days [11]. A more mature progenitor is the Colony Forming Unit-erythroid (CFU-e), that 
forms, in the presence of Epo, colonies of 8-32 cells in 2-3 days [12]. CFU-e gives rise to 
increasingly mature erythroblasts that are identified by their morphology and are 
classified into proerythroblasts, basophilic, polychromic and orthochromic erythroblasts. 
Our laboratory has developed a flow-cytometric assay that allows identification 
and analysis of erythroblasts in freshly isolated hematopoietic tissue. By staining total 
fetal liver (Figure 1.1C), bone marrow or spleen cells (Figure 1.1B) with antibodies 
against the cell surface markers CD71, the transferrin receptor, and Ter119, an erythroid 
specific marker, we can identify erythroid subsets that form a developmental sequence 
[13, 14]. In the fetal liver we identify six subsets, S0 to S5 (Figures 1.1C and 3.4). As 
they progress in differentiation, they decrease in size, compact their chromatin and start 
?expressing hemoglobin (Figure 1.1C). Subsets S1 to S5 are Epo dependent in vitro and in 
vivo and entirely erythroid. The S0 subset, on the other hand, though still largely 
composed of early erythroid progenitors, also contains non-erythroid cells (30% of S0), 
which comprise cells of other hematopoietic lineages and earlier uncommitted 
progenitors. In the adult tissue, by combining the CD71/Ter119 staining with the forward 
scatter parameter (FSC), we resolve 4 subsets, ProE (Ter119med CD71high FSChigh), EryA 
(Ter119high CD71high FSChigh), EryB (Ter119high CD71high FSClow), and EryC (Ter119high 
CD71low FSClow) (Figure 1.1B). These subsets, which morphologically represent 
progressively mature erythroblasts, approximately correspond to proerythroblasts, 
basophilic erythroblasts, basophilic and polychromic erythroblast, polychromic and 
orthochromic erythroblasts, respectively. 
EpoR is expressed in long term HSCs, cells with BFU-e potential [15, 16], as well 
as early erythroblasts (Figure 1.1A). In fetal liver cells, it is expressed in subsets S0 to S3. 
Mice that lack either Epo or EpoR die at embryonic day 13 (E13), due to severe anemia. 
The fetal liver of these knock-out mice can generate normal numbers of BFU-e and CFU-
e progenitors but cannot produce mature red blood cells [17], indicating an essential role 
for EpoR signaling in erythropoiesis. Janus Kinase 2 (Jak2)-/- mice die one day earlier 
than the EpoR-/- mice and exhibit a decreased number of total fetal liver cells as well as 
erythroid progenitors, suggesting that JAK2 is required at earlier stages of erythroid 
development than the EpoR [18]. 
?Figure 1.1 Identification of erythroid progenitors by traditional methods and flow 
cytometry.
(A) Hematopoietic stem cells in the fetal liver or bone marrow generate the common 
myeloid progenitor (CMP), which gives rise to the megakaryocytic/erythrocytic 
progenitor (MEP) that commits to the erythroid lineage. Cells in the same vertical 
position indicate the same differentiation stage. (Top panel) Traditional methods of 
identifying erythroid progenitors comprise: colony forming assays, used to identify the 
Burst Forming Unit-erythroid (BFU-e) and Colony Forming Unit-erythroid (CFU-e) 
(left); morphological assays (cytospins), used to identify erythroblasts (right). A recently 
developed flow cytometric assay (bottom panel), based on simultaneous staining for 
CD71 and Ter119, allows the identification of erythroblasts that form a developmental 
sequence (ProE, EryA, EryB, EryC) directly within adult hematopoietic tissue.  
(B) Gating strategy for freshly explanted spleen erythroid subsets. Dead cells are 
excluded by staining with LIVE/DEAD fixable viability staining and gating on the 
negative population. CD71/Ter119 staining combined with forward scatter (FSC) 
analysis, resolves 4 subsets: ProE (Ter119med CD71high FSChigh), EryA (Ter119high 
CD71high FSChigh), EryB (Ter119high CD71high FSClow), and EryC (Ter119high CD71low 
FSClow). Same data as in figure A1.4. 
(C) (Top) Gating strategy for freshly isolated fetal liver cells processed for intracellular 
staining. The gate drawn in the side scatter (SSC)/FSC dot plot serves to exclude small 
events like nuclei and debris. The diagonal gate identifies single cells, while excluding 
doublets or aggregates. The CD71/Ter119 staining in total fetal liver cells identifies 
?subsets S0-S4. S3 cells are subdivided, based on the FSC parameter in S3 large and S3 
small. (Bottom) A cytospin preparation of cells from individual subsets is shown. 
Decrease in cell size and hemoglobin expression is observed with maturation.  
?Figure 1.1 
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Reproduced with permission of LIPPINCOTT WILLIAMS & WILKINS, INC. Socolovsky M, Molecular insights into stress 
erythropoiesis, Curr Opin Hematol, 14: 215-24 [19], Copyright (2007). 
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?3. Erythropoietin receptor signaling  
The EpoR, first identified in 1989 [20], is a class I cytokine receptor characterized 
by the presence of conserved regions in the extracellular domain, a cysteine motif (a set 
of four conserved cysteine residues) and a WSXWS motif in proximity of the 
transmembrane segment.  The murine EpoR is a 507 amino acid protein that contains an 
extracellular domain, a transmembrane domain and a cytosolic domain lacking any 
kinase activity, but associated with JAK2 kinase. The inactive EpoR is present in the 
membrane as a homodimer [21, 22]. An EpoR mutant containing an intermolecular 
disulfide bond in proximity of the membrane, R129C, is constitutively active and is able 
to cause erythroleukemia in mice [23].  
Upon ligand binding, the receptor undergoes a conformational change that leads 
to activation of the pre-associated kinase, JAK2, and subsequent phosphorylation of the 
cytoplasmic domain of the receptor at eight tyrosine residues. The phosphorylated 
tyrosines serve as docking site for several signaling molecules that contain Src-
Homology 2 (SH2) domains, such as STAT5 (Signal Transducer and Activators of 
Transcription 5), PI-3 kinase, Mitogen Activated Protein Kinases (MAPKs) and several 
negative regulators. Upon binding to the phosphorylated receptor the signal transduction 
molecules are phosphorylated. They then dissociate from the receptor and deliver the 
signals directly to the nucleus, in the case of STAT5, or to downstream effectors. STAT5 
primarily binds to Y343 and Y401 of the EpoR [24-26], whereas Y479 recruits the p85 
subunit of PI-3 kinase [27, 28] and Y464 is bound directly by Grb2 [29]. Among the 
MAPKs, EpoR activates Erk1/2, SAP Kinase/Jun kinase and p38 [30-33].  
?Cytoplasmic negative regulators include tyrosine phosphatases and members of 
the Suppressor of Cytokine Signaling (SOCS) family, which bind to the phosphorylated 
tyrosines on the EpoR and prevent further signaling by competing with the signaling 
molecules for receptor binding (SOCS family members) or inactivating JAK2 or the 
receptor (Figure 1.2). Among the cytoplasmic phosphatases, SH-2 domain containing 
phosphatase-1 (SHP1) binds to Y429 and Y431 [34] and indirectly inactivates JAK2 
[35], CD45 and protein-tyrosine phosphatase 1B (PTP1B) directly inhibit JAK2 [36, 37], 
whereas SHP2 and SH-2 domain containing inositol-5-phosphatase (SHIP-1) are 
recruited to Y401 [38]. The SOCS family members, CIS, SOCS1 and SOCS3, are 
transcriptionally induced upon Epo-mediated STAT5 activation and act by different 
mechanisms. CIS and SOCS-3 bind to Y401 and therefore compete with STAT5 for 
receptor binding [39-41], while SOCS1 and SOCS3 exert their action by N-terminal 
inactivation of JAK2 [41, 42]. 
?Figure 1.2 Negative regulation of erythropoietin receptor signaling. Erythropoietin 
receptor cytoplasmic domain contains 8 tyrosines, which upon phosphorylation, serve as 
docking site for several signaling molecules, one of which is STAT5. STAT5 activation 
initiates a negative feedback loop, that leads to signal termination, by inducing the 
transcription of negative regulators of the SOCS family: CIS, SOCS1 and SOCS3. CIS 
and SOCS3 bind to Y401 on the EpoR, competing with STAT5 and therefore preventing 
further phosphorylation. SOCS1 and SOCS3 inhibit JAK2 by direct binding. Other 
negative regulators include the cytoplasmic tyrosine phosphatases SHP-1, PTP1-B and 
CD45, which negatively regulate JAK2.  
??
Figure 1.2 
 
Reprinted from [Trend in Cell Biology], Volume 15, Richmond TD et al., Turning cells red: signal transduction 
mediated by erythropoietin, Pages: 146-55 [43], Copyright (2005) with permission from Elsevier. 
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4. In vivo study of EpoR distal domain in erythropoiesis  
Naturally occurring mutations in the C-terminal domain of human EpoR, to which 
negative regulators are recruited, have been associated with familial erythrocytosis [44, 
45], a disorder of red blood cell production, characterized by an absolute increase in red 
cell mass, with elevated hematocrit and hemoglobin levels. These findings suggested that 
lack of negative regulation could be the cause of excessive red blood cell production. 
Moreover, studies in cell lines suggested a central role for Y343, a STAT5 docking site, 
in EpoR signaling and erythropoiesis (Chapter I-3 and I-10).  
In order to study the role of the EpoR distal domain in erythropoiesis, two knock-
in mice were generated, in which a C-terminally truncated EpoR was ‘knocked-in’ at the 
wild-type EpoR locus. EpoR-H mice retained Y343, whereas EpoR-HM mice contained, 
in addition to the truncation, a mutation of the residual tyrosine to phenylalanine (Y343F) 
(Figure 1.3). Both mice are viable and fertile. EpoR-H mice exhibit a slight increase in 
hematocrit levels, whereas the EpoR-HM mice show a slight decrease [46]. In addition, 
EpoR-HM mice showed increased renal Epo transcript levels, which were 1.9 fold higher 
than in wild type controls, while EpoR-H mice showed a decrease to levels that were 
about 60% of the wild type controls [47].  
Several studies showed that EpoR-HM mice, despite normal basal erythropoiesis, 
are unable to respond to anemic stress induced by hemolysis, 5-fluorouracil treatment or 
bone marrow transplantation. Conversely, efficient stress erythropoiesis is rescued in 
EpoR-H mice, which are also are hypersensitive to Epo [47, 48].  
??
These findings suggest that an EpoR lacking any tyrosines is sufficient to support 
basal erythropoiesis in vivo and that EpoR tyrosines are required for the erythropoietic 
stress response. 
??
Figure 1.3 Mouse models of EpoR distal domain truncation. EpoR-H and -HM mice 
are knock-in mice expressing a C-terminally truncated EpoR. The STAT5 docking site, 
Y343, is maintained in EpoR-H mice while is mutated to phenylalanine in EpoR-HM 
mice. JAK2 is activated upon Epo binding to the receptor, in both mouse models. 
??
Figure 1.3 
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5. STAT Biology 
The JAK-STAT pathway was first identified in the early 1990 during the study of 
interferon (IFN) signaling [49-51]. This new pathway could transduce signals from the 
cell surface directly to the nucleus, rapidly inducing new genes, through proteins with 
dual function in signal transduction and activation of transcription, STAT proteins.  
STAT proteins are latent cytoplasmic transcription factors that become activated 
by phosphorylation of a single carboxy-terminal tyrosine in response to a variety of 
extracellular signals, such as cytokines, growth factors and hormones.  
In the classical JAK/STAT pathway, ligand binding to the cytokine receptor, 
devoid of intrinsic tyrosine kinase activity, leads to receptor dimerization and activation 
of the pre-associated JAK kinase. The activated JAKs trans-phosphorylate the receptor 
cytoplasmic tyrosines generating docking site for the STAT proteins that then become 
substrates of the JAK. Upon tyrosine phosphorylation and nuclear translocation, STATs 
exert their function as transcriptional activators.  
STAT activation also occurs downstream of other receptor families, such as 
receptors with intrinsic tyrosine kinase activity (for example, the Epidermal Growth 
Factor (EGF) receptor) [52] as well as seven-transmembrane receptors, associated to 
tyrosine kinases like Src [53]. 
The importance of the JAK-STAT pathway is highlighted by its evolutionary 
conservation. STAT molecules first emerged with multicellularity, and therefore, with 
intercellular signaling. For example, a STAT molecule required in the induction of pre-
stalk cell differentiation, has been described in the slime mold, Dictyostelium discoideum 
??
[54]. The Drosophila melanogaster genome only encodes for one STAT molecule, 
STAT92E (or D-STAT), which is essential for development [55, 56] and is very similar 
to murine STAT5. The Drosophila JAK/STAT pathway regulates eye development [57], 
sex determination [58, 59], germ cells self renewal [60, 61] and hemocyte proliferation 
and differentiation [62]. STAT molecules have been found in the African Malaria 
mosquito (Anopheles gambiae) [63], in zebrafish (Danio rerio) [64], frog (Xenopus 
laevis) [65] and the round spotted puffer fish (Tetradon fluviatilis) [66].  
The identification of multiple mammalian STAT indicates that the genes encoding 
for STAT proteins have undergone duplication in the evolution of mammals. Seven 
mammalian STAT genes have been identified to date, Stat1, 2, 3, 4, 5A, 5B and 6. The 
generation of STAT knock out models has uncovered the essential function of individual 
STATs in vivo. Stat3-/- mice are embryonic lethal [67], whereas Stat5a, b-/- mice die 
perinatally [68]. The finding that not all STAT molecules are essential for life might 
reflect the specialized function of some of these proteins. While STAT3 is ubiquitously 
expressed and functions in a variety of biological processes, STAT5 role is more 
prominent in hematopoiesis, reproductive system development and mammary gland 
development (STAT5A) [69] as well as body growth (STAT5B) [70]. STAT1, 2, 4 and 6, 
on the other hand, have more specialized roles in the immune system. STAT1 plays a 
central role in IFN signaling (IFNα/β and IFNγ) [71, 72], STAT2 is important for IFNα/β 
signaling only [73], while STAT4 and 6 are involved in T cell signaling downstream of 
IL-12 and IL-4, respectively [71, 72, 74, 75]. 
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6. STAT structure and functional domains  
The mammalian STAT proteins exhibit a 28% to 40% sequence identity in their first 700 
amino acids. The sequence of the carboxyl-terminal region of the protein is the most 
divergent part among members of the STAT family. STAT2 and 6 are 850 amino acids 
long, while STAT1, 3, 4, 5A and 5B proteins contains between 750 and 795 amino acids. 
Sequence comparison and mutagenesis studies have revealed the presence of conserved 
functional domains within STAT proteins [76, 77]: N-terminal domain (ND), Coiled-coil 
domain (CCD), DNA binding domain (DBD), linker domain, SH2 domain and 
transactivation domain (Figure 1.4). 
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Figure 1.4 Structural and functional domains in STAT family members. (A) STAT 
family members share the following conserved domains: N terminal domain (N-term), 
Coiled-coil domain (CCD), DNA binding domain (DBD), Src homology 2 (SH2) domain 
and the transactivation domain (TAD). The C-terminal region of the protein is the most 
divergent among STAT family members. (B) Crystal structure of phosphorylated STAT1 
core bound to DNA. ND and TAD were not part of the crystal structure. (Top Panel) 
Colored representation of the identified domains in a ribbon diagram: CCD (green), DBD 
(red), linker domain (orange), and SH2 domain (blue). A stick representation of the 
phosphotyrosine is shown. The DNA double helix is shown in grey. (Bottom Panel) 
Molecular surface of the STAT1 dimer: the colors indicate the electrostatic potential, 
with red representing positive and blue representing negative potential. 
??
Figure 1.4  
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Reprinted by permission from Macmillan Publisher Ltd: [Nat Rev Cancer], Volume 4, Yu, H. and R. Jove, The STATs of 
cancer-new molecular targets come of age, Pages: 97-105 [78], Copyright (2004).  
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Reprinted from [Cell], Volume 93, Chen X et al., Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA, 
Pages: 827-39 [76], Copyright (1998), with permission from Elsevier. 
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 The crystal structure of tyrosine phosphorylated human STAT1 (Figure 1.4B) and 
mouse STAT3 dimers bound to DNA revealed a rigid hydrophobic core (residues 130-
712) formed by the CCD, the DBD, the linker domain and the SH2 domain [76, 77]. The 
region containing the tyrosine phosphorylation site appeared flexible. The tyrosine-
phosphorylated dimers were stabilized by interaction between the phospho-tyrosine of 
one monomer and the SH2 domain of the other.  
The structure of the ND (amino acids 1-130) has been determined separately for 
STAT1 and STAT4 [79, 80]. The domain consists of 8 helices that are organized in a 
hook-like structure. The ND is connected to the molecule core by a flexible tether of 
approximately 20 amino acids. Functionally, the ND plays a crucial role in STAT 
dimerization, in the activation/inactivation cycle and in the formation of higher order 
molecular complexes, such as tetramers that can bind to adjacent DNA consensus sites. 
The DBD, which consists of several beta sheets, interacts with the DNA both in the major 
and minor groove, at consensus oligonucleotide palindromic sequences, 5’-TT(N4-6)AA-
3’ [81]. The SH2 domain recognizes phospho-tyrosine residues specifically [82, 83] and 
is required for binding to activated receptors and for the formation of phosphorylated 
STAT dimers. All STAT molecules except STAT2 form homodimers upon tyrosine 
phosphorylation. Only a few heterodimeric complexes are formed, consisting of 
STAT1:3, STAT1:2 and STAT5A:5B [84]. In addition, the transactivation domain 
regulates transcription by interacting with several coactivators [85], undergoes serine 
phosphorylation and seems to regulate the stability of some STAT proteins [86]. 
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7. Negative regulation of STAT activation  
STAT activation is transient and tightly regulated since constitutive activation of 
several STAT molecules is oncogenic (Chapter I-13). Negative regulators of STAT 
signaling are present both in the nucleus and the cytoplasm.  
The nuclear regulators of STAT signaling include nuclear phosphatases and 
Proteins that Inhibit Activated STATs (PIAS). The nuclear tyrosine phosphatase TC45, 
has been implicated in dephosphorylation of STAT1 and 3 [87]. PIAS proteins have been 
shown to interact with STAT1 and 3 in mammalian cells and block DNA binding, in vitro 
[88]. Moreover, genetic studies in Drosophila suggest that PIAS could modulate STAT 
activity in vivo [57].  
The cytoplasmic regulators include phosphatases and SOCS family proteins. 
SHP1, SHP2, CD45 and PTP1B, promote tyrosine dephosphorylation of the receptor and 
the kinase, therefore preventing further STAT tyrosine phosphorylation [81, 89-91]. The 
SOCS family proteins, that include SOCS1-4 and CIS, are part of the negative feedback 
loop initiated by receptor signaling. They are transcriptionally induced upon STAT 
activation and act on the activated receptor, the JAK kinase and STATs [92]. The SOCS 
family proteins act through three different mechanisms: 1) N-terminal inactivation of 
JAKs by binding to their catalytic pocket [93, 94]; 2) Receptor association. By binding to 
tyrosine phosphorylated receptors they compete with STATs and therefore prevent 
further STAT activation [95, 96]; 3) SOCS-box mediated proteasomal degradation. 
SOCS proteins act as adaptors for E3 ubiquitin ligase complexes, mediating 
ubiquitination and degradation of JAKs [42, 97-99].  
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8. Conformational reorientation during STAT phosphorylation/ dephosphorylation 
cycle  
STAT molecules were originally reported to be monomeric in their inactive form 
[100]. However, several studies indicated the presence of unphopshorylated STAT 
dimers in the cytoplasm of unstimulated cells. Unphosphorylated STAT3 was shown to 
form stable homodimers [101], as well as higher order complexes called the statosomes 
[102], by size exclusion chromatography. Unphosphorylated STAT1 could be 
coimmunoprecipitated with STAT2 and STAT3, in absence of cytokine stimulation [103, 
104]. Moreover, studies using surface plasmon resonance and other methods 
demonstrated that inactive STAT1 was mainly dimeric [105].  
Yeast two-hybrid analysis showed the formation of unphopshorylated STAT4 
dimers in absence of cytokine stimulation [106]. Importantly, mutations in the ND 
dimerization interface of STAT4 impaired the formation of unphosphorylated STAT4 
dimers and prevented cytokine-mediated phosphorylation, suggesting a role for ND-ND 
interactions in the formation of unphosphorylated STAT dimers. ND-ND interactions 
were found to be homotypic for all STATs except STAT2 [106]. The interaction between 
NDs was also supported by the observation that isolated STAT NDs are present in 
solution as homodimers [107, 108].  
Comparison of the crystal structure of unphosphorylated STAT1 [80] and STAT5 
[109] with the previously available structures of phosphorylated STAT1 and 3 (Chapter I-
6), revealed that unphosphorylated dimers were rearranged differently in space than the 
phosphorylated ones, with the SH2 domains located at opposite ends of the dimer (Figure 
??
1.5A). Unphosphorylated dimers where stabilized by interaction between the CCD of one 
monomer and the DBD of the other, as well as by reciprocal interaction between the 
NDs. The phosphorylated dimers were referred to as “parallel”, because the SH2 domains 
are at the same end of the tyrosine-phosphorylated structure, while the unsphosphorylated 
dimers were referred to as “antiparallel” (Figure 1.5B). 
??
Figure 1.5 Phosphorylated and unphosphorylated STATs conformation and 
structure. (A) Crystal structure of phosphorylated (bottom left) and unphosphorylated 
STAT1 (right). (B) Three potential dimerization interfaces between the two monomers 
have been identified: the reciprocal pY-SH2 interaction in the parallel, phosphorylated 
dimer and the ND-ND interaction as well as the CCD-DBD interaction in the antiparallel, 
unphosphorylated dimer. The white circle represents the unphosphorylated tyrosine, 
while the red circle indicate the phosphorylated tyrosine (PY). 
??
Figure 1.5 
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Reprinted from [Molecular Cell], Volume 17, Mao X et al., Structural bases of unphosphorylated STAT1 association and 
receptor binding, Pages: 761-71 [80] Copyright (2005), with permission from Elsevier. 
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Reprinted from [Genes & Development], Volume 20, Mertens C et al., Dephosphorylation of phosphotyrosine on STAT1 
dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain, Pages 3372-81 [110], 
Copyright (2006), with permission from Cold Spring Harbor Laboratory Press.  
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Mutagenesis studies, performed to disrupt the interaction between the NDs (F77A and/or 
L78A) or the CCD and the DBD (F172W) in STAT1, showed absence of 
unphosphorylated dimers and a persistent STAT1 phosphorylation phenotype, 
characterized by prolonged phosphorylation in IFNγ-stimulated cells and resistance to 
TC45 phosphatase treatment in vitro [111]. A similar persistent phosphorylation 
phenotype was previously observed upon partial deletion of the ND of STAT1 [112] and 
following substitution of STAT1 ND with the ND of STAT2 or STAT5 in a STAT1 
chimera [113], suggesting that the STAT ND plays a central role in the 
phosphorylation/dephosphorylation cycle. These findings led to the hypothesis that, upon 
DNA dissociation, phosphorylated STAT dimers undergo a conformational change from 
parallel to antiparallel, to expose the phosphorylated tyrosines to phosphatases for 
dephosphorylation.  
Experiments with differentially tagged monomers showed that there is no 
exchange of partners in a dimer during the phosphorylation/dephosphorylation cycle, 
suggesting that the conversion from parallel to antiparallel dimers must occur through 
reorientation, without dissociation of the monomers [110]. Moreover, shortening of the 
flexible tether that connects the ND to the core caused a persistent phosphorylation 
phenotype, indicating that the tether was required for the conformational reorientation. 
These findings led to the development of a mechanistic model for the conformational 
reorientation of the dimer in which following DNA dissociation, interacting NDs could 
disrupt the pY-SH2 interaction, possibly by binding to the body of the phosphorylated 
molecule. Subsequent rotation of the dimer, stabilized by the ND-ND interface, could 
??
facilitate the interaction between the CCD of one monomer and the DBD of the other, 
stabilizing the antiparallel dimer and providing an accessible substrate for phosphatases 
(Figure 1.6). 
??
Figure 1.6 Model of STAT dephosphorylation by conformational reorientation. 
Three dimerization interfaces between the two monomers have been proposed: 1) 
reciprocal PY-SH2 interaction in the phosphorylated parallel dimer; 2) ND-ND 
interaction and 3) CCD-DBD interaction in the unphosphorylated antiparallel dimer. 
Upon dissociation from the DNA (surrounded by the nuclear membrane) phosphorylated 
(the red circle represents the phosphorylated tyrosine (PY)) parallel STAT dimers 
undergo a conformational reorientation, involving the contact between interacting NDs 
and the body of the molecule (aimed at disrupting the PY-SH2 interaction) followed by 
rotation. The reorientation leads to the formation of an antiparallel dimer that is 
accessible to phosphatase (P’ase) and can be dephosphorylated and exported to the 
cytoplasm. 
??
Figure 1.6 
 
 
Reprinted from [Genes & Development], Volume 20, Mertens C et al., Dephosphorylation of phosphotyrosine on STAT1 
dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain, Pages 3372-81 [110], 
Copyright (2006), with permission from Cold Spring Harbor Laboratory Press.  
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9. STAT5 and erythropoiesis 
STAT5 was first identified in mammary tissue from lactating sheeps as Mammary Gland 
Factor (MGF), a transcription factor activated by the prolactin receptor and responsible 
for the expression of milk protein genes in mammary epithelium [114]. The search for the 
mouse homolog led to the discovery of STAT5A and a closely related protein, STAT5B 
[115-117]. STAT5A and STAT5B are encoded by two genes, located next to each other 
in opposite orientation on chromosome 11 (in mice) and chromosome 17 (in humans), in 
the same locus as the Stat3 gene. STAT5A and STAT5B are highly homologous with 
96% identity at the protein level. The three-dimensional structure of the 
unphosphorylated STAT5A core fragment showed similarity to other members of the 
STAT family [109]. STAT5 regulates hematopoiesis, reproductive system development 
and mammary gland development (STAT5A) as well as body growth (STAT5B) [68-70, 
118-121]. Moreover, STAT5 is constitutively activated in many leukemias and 
myeloproliferative syndromes, and its constitutive activation is sufficient for 
hematopoietic cell transformation [122-125].  
STAT5 is a central player in EpoR signaling and a critical regulator of 
erythropoiesis. Mice lacking STAT5 exhibit severe anemia and die perinatally [68], 
whereas mice hypomorphic for STAT5, in which the first exon of each STAT5 gene has 
been deleted (Stat5ΔN/ΔN), survive to adulthood but show a defective response to 
erythropoietic stress [119, 126-129]. In erythroblasts, STAT5 is a key mediator of cell 
survival through induction of B-cell lymphoma-extra large (BclXL) [130], an 
antiapoptotic molecule of the Bcl2 family.  BclXL-/- mice die at day E12.5 due to severe 
??
anemia and brain defects, despite the fact that the number of BFU-e, CFU-e and 
erythrolasts is normal [131]. On the other hand, exogenous expression of human BclXL in 
murine erythroblasts allows Epo-independent differentiation [132]. However, STAT5 is 
not the only transcription factor that mediates BclXL induction in erythropoiesis: GATA1 
also participates in the induction of BclXL expression [133]. Moreover, it has recently 
been shown that STAT5 controls the induction of erythroblast CD71 in fetal liver tissue 
[119, 134]. 
10. Erythropoietin-mediated STAT5 activation in cell lines.  
The current knowledge of STAT5 activation downstream of the EpoR is based on 
in vitro studies using cell culture systems. The ability of Epo to induce tyrosine 
phosphorylation of STAT5 via JAK2 was first shown in CTLL-2 cell lines transfected 
with EpoR [135]. The DNA binding activity of STAT5 in response to Epo has been 
reported in COS cells transfected with EpoR and STAT5 and in several hematopoietic 
cell lines [25, 136, 137]. Moreover, in vitro kinase assays and studies using EpoR 
mutants showed that Jak2 is required for STAT5 phosphorylation [138]. Transfection of 
several EpoR mutants in multiple cell lines demonstrated that STAT5 phosphorylation 
was mediated primarily through Y343, although other EpoR tyrosines could substitute for 
its absence [24-26]. Y401 of the EpoR was, in fact, sufficient to mediate maximal STAT5 
activation (both phosphorylation and DNA binding activity) upon Epo stimulation, while 
Y429 and Y431 were shown to activate STAT5 to an intermediate level [25, 26]. On the 
other hand, cells transfected with the EpoR F8 mutant, in which all tyrosines were 
mutated to phenylalanine, activated STAT5 at low levels in response to high Epo 
??
concentrations, suggesting that JAK2 could directly phosphorylate STAT5 in cells 
containing an EpoR without any tyrosine [24, 34].  
Despite the numerous studies in cell lines, STAT5 phosphorylation at the single 
cell level, in primary erythropoietic tissue, has not yet been analyzed, due to technical 
limitations. Based on previous studies (Chapter I-11), the importance of analyzing 
signaling at the single cell level has emerged. 
11. Signaling dynamics in biology  
Previous studies have shown that a signal transduction pathway can specify 
multiple biological functions, in different cell contexts or within the same cell. For 
example, the Raf/Mek/Erk cascade can cause proliferation in tissue culture cells, 
differentiation or proliferation in PC12 cells [139, 140], activation of Cdc2-cyclinB 
complexes in oocytes [141], and fate determination in developing embryos [142]. 
However, it is still unknown how signaling specificity for a given downstream outcome is 
determined.  
The dynamics of the signal, more precisely the way it varies with time and 
stimulus strength, could specify its function in situations where different stimuli that 
converge on the activation of an identical signaling molecule generate distinct functional 
outcomes within the same cell. For example, in PC12 cells EGF stimulation causes cell 
proliferation through transient Erk activation whereas NFG treatment leads to neurite 
outgrowth and differentiation through sustained Erk signaling [143-145]. Therefore, 
understanding signal dynamics could help us gain insights in the determinants of 
signaling specificity.  
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Signal characteristics can change with time (sustained versus transient signaling) 
and dose (graded versus switch-like response). For example, a 
phosphorylation/dephosphorylation reaction can exhibit a graded, switch-like or bistable 
response (Figure 1.7). The various types of signaling responses are described in more 
detail below. 
A graded response is characterized by a hyperbolic stimulus response curve, 
described by the Michaelis-Menten equation: at low stimulus concentration the response 
increases linearly with the stimulus and then it levels off (Figure 1.7b). A switch-like 
response, on the other hand, is characterized by a sigmoidal stimulus response curve, 
described by the Hill equation, in which the Hill coefficient (nH), that is bigger than 1, is 
an indicator of how switch-like the response is (Figure 1.7c).  
A switch-like type of response has a built-in threshold: at low stimulus 
concentration there is almost no response, but once the threshold is reached the system 
flips from “off” to “on” over a very narrow range of doses (Figure 1.7d) [146]. In 1982, 
Goldbeter and Koshland proposed the term “ultrasensitivity” to describe systems that are 
characterized by a sigmoidal stimulus response curve [147]. Cooperative enzymes are the 
best example of an ultrasensitive system.  
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Figure 1.7 Summary of different types of signaling responses. (a) Scheme of the 
phosphorylation/dephosphorylation reaction. (b) Graded response: characterized by a 
hyperbolic stimulus response curve, described by the Michaelis-Menten equation. (c) 
Switch like response: characterized by a sigmoidal stimulus response curve, described by 
the Hill equation, with a Hill coefficient (nH) bigger than one. It has a built-in threshold 
that determines the ultrasensitivity. Systems described by a sigmoidal response curves are 
defined as ultrasensitive. (d) Bistable response: characterized by ultrasensitivity and 
positive feedback. 
??
Figure 1.7  
 
 
Reprinted from [Trends in Biochemical Sciences], Volume 23, Ferrell JE, How regulated protein translocation can produce 
switch-like responses, Pages: 461-5 [148], Copyright (1998), with permission from Elsevier. 
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Similarly to a switch-like response, a bistable response exhibits ultrasensitivity. In 
addition, bistable systems are characterized by the presence of two stable states, 
hysteresis and a positive feedback loop [148]. Hysteresis is the memory for a transient 
stimulus (Figure 1.8A). When a system exhibits hysteresis, the stimulus history 
influences the response. In particular, the stimulus response curve varies based on 
whether the system was previously exposed to the stimulus or never stimulated before. In 
an hysteretic system it is easier to maintain the system in its stable state than to flip it 
from one state to the other [149]. A non-biological example of hysteresis is a light switch: 
once the switch is ‘on’ it is not going to switch itself ‘off’. By contrast, a non-hysteretic 
system, such as a doorbell, needs somebody to be continuously pushing at it, in order to 
be active. The positive feedback loop, which can be generated by multiple mechanisms, 
ensures that the system does not rest in intermediate states, and therefore contributes to 
the generation of two stable states.  
Xenopus laevis oocyte maturation is an example of a bistable system. In Xenopus 
oocytes, Erk2 activation converts a continuously variable stimulus, progesterone 
concentration, into an “all or none” biological response, oocyte maturation [150]. 
Intracellularly, Erk2 activation is bistable as a result of intrinsic ultrasensitivity and 
positive feedback [150-157]. Erk2 participate in the positive feedback by regulating the 
protein stability of its activator, Mos [158-161]. The ultrasensitivity of the cascade helps 
setting the threshold for the activation of the positive feedback, whose role is to ensure 
the oocyte does not dwell in intermediate states of Erk2 phosphorylation. A combination 
of ultrasensitivity and the presence of a positive feedback loop, often observed in bistable 
??
systems, helps to filter out “noise” while allowing a decisive response (Figure 1.8B). 
Similar mechanisms underlie several ‘all or none’ phenomena, such the generation of 
action potential in neurons and the lysis-lysogeny switch in E. Coli infection by phage 
lambda [162]. 
??
Figure 1.8. Components of bistatble systems. (A) Hysteresis: memory for a transient 
stimulus. Representation of the activity as a function of stimulus concentration: if the 
system has been stimulated before, it will stay on until the stimulus is decreased to a 
concentration that is well below (dotted line on the “coming down” curve) the one that 
set the system on initially (dotted line on the “going up” curve). (B) The combination of 
ultrasensitivity and positive feedback allows for a bistable response. The graph represents 
calculated stimulus response curves for MAPK phosphorylation assuming one of the two 
components is present, none is present or both are present. The x-axis represents the 
concentration of Mos, the progesterone-activated MAP kinase, which is upstream of 
Erk2. The y-axis represents the phosphorylation of Erk2. When none of the two 
components is present the response looks graded. When only ultrasensitivity is present 
the response is not decisive. When only positive feedback is present the system is 
activated by noise (lack of a threshold). When both components are present the response 
is decisive above a threshold of activation (set by the ultrasensitivity). The combination 
of the two characteristics leads to a true switch.  
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Figure 1.8 
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Reprinted from [Current Opinion in Cell Biology], Volume 14, Ferrell JE, Self-perpetuating states in signal transduction: 
positive feedback, double-negative feedback and bistability, Pages: 140-8 [148], Copyright (2002), with permission from 
Elsevier. 
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From Ferrell JE et al., The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes, Science, 280: 895-8 [150], 
Copyright (1998). Reprinted with permission from AAAS. 
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The advantage of the Xenopus laevis oocyte system is the ability to study signal 
transduction at the single cell level. The response of a population of cells does not always 
reflect the response of individual cells, especially when the cells differ, for example, with 
respect to the threshold of activation. In the case of Xenopus oocyte maturation, at the 
level of the population the response to progesterone is graded, with the number of 
oocytes that undergo maturation being proportionally related to the amount of 
progesterone. However, within each oocyte the response is “all or none” [150, 163, 164].  
Recent advances in flow cytometry led to the development of a new method to 
perform quantitative studies of cellular signaling within rare cell populations of primary 
cells, facilitating the study of signaling dynamics in biological systems (Chapter I.12).  
12. Development of a new flow-cytometric method to study protein phosphorylation 
at the single cell level  
The most commonly used methods to study protein phosphorylation are western 
blot and immunoprecipitation. However, these biochemical techniques suffer several 
limitations, such as requirement of a large number of cells, the inability to analyze 
heterogenous cell populations, and lack of single cell resolution.  
The recent development of phospho-flow cytometry, a flow cytometric method 
used to study the phosphorylation status of signaling molecules in single cells, has 
revolutionized the study of cellular signaling [165-170]. This method offers several 
advantages compared to traditional biochemical approaches, such as 1) requirement of a 
small number of cells; 2) ability to discriminate cell subsets by simultaneous staining for 
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the cell surface markers and the phospho-protein of interest; 3) single cell resolution, 
which allows quantitative analysis of protein phosphorylation. 
Cells are stimulated with the growth factor of interest, fixed to freeze the 
phosphorylation status of the signaling molecule, permeabilized to allow access of the 
phospho-antibody within the cell, and simultaneously stained with the phospho-antibody 
and antibodies against the cell surface markers of interest. One of the biggest challenges 
of this technique is to preserve the integrity of the cell surface markers during the fixation 
and permeabilization step. However, the benefits that this method offers definitely 
outweigh the efforts required for its optimization. 
We adapted this technique to the flow cytometric method developed in our 
laboratory (Chapter I-2 and Chapter IV) to study STAT5 activation, at the single cell 
level, in freshly isolated erythropoietic tissue. 
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13. STAT5 and cancer 
Among all the STAT molecules, STAT3 and STAT5 are frequently over-
activated in cancer. STAT5 is consitutively activated in a variety of human solid tumors 
such as breast cancer [171, 172], head and neck cancer [173, 174]; in blood malignancies, 
such as chronic myeloid leukemia (CML) [175-177], acute myeloid leukemia (AML) 
[175, 178], acute lymphoblastic leukemia (ALL) [175, 178]; as well as in 
myeloproliferative disorders (MPD) [179-181]. The V617F mutation in JAK2, found in 
many patients with polycytemia vera (PV), has been associated with constitutive STAT5 
activation [182-186].  
Naturally occurring mutations in the Stat5 gene have not been identified. 
Constitutive STAT5 activation usually occurs downstream of over-active kinases that are 
the result of genetic or epigenetic abnormalities. In the Drosophila larvae, mutations 
responsible for constitutive activation of the JAK kinase hopscotch (hopTum-l and hop742) 
allow the formation of melanotic tumors and cause a leukemia-like excessive 
proliferation of hemocytes [187, 188]. D-STAT, which is very similar to STAT5, is 
hyperactivated in hopTum-l larvae and is required for tumor formation [189, 190]. In 
mammals, an example of constitutively active kinase of which STAT5 is a target [122, 
177, 191, 192], is the BCR-ABL kinase, a fusion protein consisting of Ableson leukaemia 
protein (ABL) kinase and the breakpoint-cluster region (BCR), that has been shown to 
cause CML [193]. The TEL-JAK fusion protein, that causes a myelo- and lympho- 
proliferative disease, also leads to constitutive STAT5 activation [194]. Moreover, 
STAT5 is constitutively activated by the FMS-like tyrosine kinase 3 (FLT3) receptor 
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tyrosine kinase in AML [195] and its activation is blocked by a FLT-3 specific inhibitor 
[196]. STAT5 is required for the BCR-ABL [197-200] and TEL-JAK mediated 
leukemogenesis [179]. Furthermore, a constitutively active STAT5 mutant is sufficient to 
cause leukemia in a bone marrow transplantation model [125, 179]. These findings 
suggest that STAT5 plays a very important role in leukemogenesis.  
Therefore, understanding STAT5 signaling in a physiological context can help us 
gain insights into the regulation of its activity during malignant transformation and design 
targeted therapies. The currently available drugs aimed to inhibit STAT5 in leukemia are 
small molecule inhibitors of the upstream kinases [196, 201]. Targeting STAT proteins 
directly, ideally through small molecule inhibitors, will increase the treatment specificity, 
minimize the off-target effects and increase the efficacy. 
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 Aims of the study  
Epo concentration in serum spans three orders of magnitude from 10 
milliunits/mL in the basal state, to 10 units/mL during hypoxic stress, when it drives a 
sharp increase in the rate of red blood cells formation (Chapter I-1). However, the 
mechanisms responsible for modulating the erythropoietic rate are largely unknown. Epo 
acts on erythroid progenitors by binding to the EpoR and initiating intracellular signaling. 
Among the several signaling molecules activated downstream of EpoR, STAT5 plays a 
central role in both basal and stress erythropoiesis (Chapter I-3 and I-9). Therefore, we 
hypothesized that dynamic changes in Stat5 signaling are responsible for modulating the 
erythropoietic rate within a broad range of Epo concentrations.  
Our knowledge of STAT5 activation downstream of the EpoR, is mainly based on 
in vitro studies using cell culture systems (Chapter I-10). Previous studies exploring the 
dynamics of signaling in Xenopus laevis oocytes highlighted the importance of 
investigating signaling at the single cell level (Chapter I-11). However, due to technical 
limitations of the traditional biochemical approaches to study signal transduction 
(Chapter I-12) STAT5 phosphorylation at the single cell level, in primary erythropoietic 
tissue, has not yet been analyzed.  
To understand how intracellular STAT5 signaling translates the wide range of 
Epo concentrations into the correct erythropoietic rate, we combined a flow-cytometric 
assay that allows identification of stage-specific erythroblasts in primary erythropoeitic 
tissue (Chapter I-2 and Chapter III) with flow-cytometric measurements of STAT5 
phosphorylation with single cell resolution (Chapter I-12). We aimed to define the 
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identity and spectrum of erythroblasts in which STAT5 is phosphorylated downstream of 
EpoR and to study the dynamics of STAT5 signaling during basal and stress 
erythropoiesis.  
The significance of our study extends beyond erythropoiesis.  STAT5 has been 
shown to play a central role in leukemogenesis (Chapter I-13). Therefore, studying the 
dynamics of STAT5 signaling in primary tissue could help us gain insights in the 
regulation of erythropoiesis as well as understand the mechanisms of malignant 
transformation.  
The next chapter, Chapter II, represents the main body of work in this thesis. It 
describes the identification of two modes of STAT5 signaling in erythroblasts, digital and 
analog signaling, which are required for basal and stress erythropoiesis, respectively. 
Moreover, it investigates in detail the molecular mechanisms underlying the generation of 
these two modes of STAT5 signaling. The subsequent chapter, Chapter III, describes the 
flow cytometric method developed in our laboratory to identify erythroblasts within 
freshly isolated erythropoietic tissue. The last chapter summarizes the main findings and 
discusses future directions. 
Appendix I describes the in vivo study of the dynamic responses of two survival 
pathways, the Bcl-xL and Bim pathways, during erythropoietic stress. Moreover, it 
investigates the molecular mechanisms responsible for these dynamic behaviors. Bcl-xL 
is a STAT5 target gene. In order to understand the molecular mechanism of Bcl-xL 
response to erythropoietic stress, I investigated STAT5 signaling in vivo using models of 
acute and chronic erythropoietic stress, as well as two knock-in mice, EpoR-HM and 
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EpoR-H mice, which lack the cytoplasmic regulatory domain of the EpoR but differ by 
one essential tyrosine residue, Y343 (Chapter I-4). We found that the dynamics of 
STAT5 activation paralleled the one of Bcl-xL response, although on two different time 
scales, indicating that STAT5 signaling behavior during erythropoietic stress dictates 
Bcl-xL dynamics.  
??
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CHAPTER II: Autocatalytic activation of Stat5 underlies   
bistability and binary signaling 
Introduction 
Healthy individuals at sea level continuously generate red blood cells at a rate of 
2.5 million per second, in a process known as ‘basal erythropoiesis’ that is essential to 
life. Erythropoiesis increases by up to 10 fold its basal rate in response to hypoxic stress, 
as may occur at high altitude, or in response to anemia or hemorrhage. The wide dynamic 
range of erythropoietic rates is regulated by the hormone Erythropoietin (Epo), whose 
concentration in blood spans a remarkable, three-orders of magnitude range, from ≈0.01 
U/ml in the basal state to 10 U/ml in extreme stress. Epo exerts its effects by binding to 
its receptor, EpoR, a transmembrane homodimer of the cytokine receptor superfamily 
expressed by erythroid progenitors [20]. Epo binding to EpoR results in activation of 
Jak2, a cytoplasmic tyrosine kinase closely associated with the EpoR, and in 
phosphorylation of EpoR cytoplasmic-domain tyrosines that act as docking sites for Stat5 
and other signaling molecules [202]. 
A key challenge lies in understanding how EpoR signaling encodes extracellular 
Epo concentration, specifying a given erythropoietic rate from within the wide range of 
rates spanning basal and stress erythropoiesis. Here we addressed this question by 
studying Stat5, which, as suggested by mouse genetic models, is a key mediator of both 
basal and stress erythropoiesis. Stat5-null mice die perinatally due to anemia, suggesting 
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an inability to sustain basal erythropoiesis; while mice hypomorphic for Stat5 are 
deficient in their response to erythropoietic stress [119, 126-128].  
Stat5 functions are due to two highly homologous proteins, Stat5a and Stat5b, of 
the Signal Transducers and Activators of Transcription (STAT) family. STAT proteins 
are latent cytoplasmic transcription factors that become activated by phosphorylation of a 
C-terminal tyrosine in response to a variety of extracellular signals [84, 203]. Stat5 is a 
key mediator of cell survival in erythroblasts and other hematopoietic progenitors; it is 
also implicated in the regulation of the cell cycle and in leukemogenesis [119, 126-128].  
Stat5 shares the conserved STAT protein domain structure. An N-terminal 
domain (ND) is connected via a flexible ‘tether’ to the molecule’s core containing the 
DNA-binding (DBD) and a coiled-coil (CC) domains. A C-terminal SH2 domain binds to 
phosphorylated YXXL motifs on the activated EpoR, facilitating phosphorylation of 
Stat5’s C-terminal tyrosine. The newly phosphorylated Stat5 (p-Stat5) dissociates from 
the EpoR, homodimerizes via reciprocal interactions between the C-terminal tyrosines 
and the C-terminal SH2 domains, and relocalizes to the nucleus where it activates 
transcription.  
Although it has long been known that active STATs form ‘parallel’ homodimers, 
with both SH2 domains and both C-terminal tyrosines at the same end of the dimeric 
complex, recent crystallographic and functional studies show that inactive STATs also 
form dimers. However, inactive dimers are in an ‘anti-parallel’ conformation, with the 
two SH2 domains at opposite ends of the dimeric complex. The inactive anti-parallel 
dimers are held by reciprocal CCD and DBD interactions and by ND dimerization [80, 
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109]. STAT dimers do not dissociate during the phosphorylation/dephosphorylation 
cycle, which must therefore entail radical reorientations between the anti-parallel and 
parallel dimer conformations [110]. The functional implications of these conformational 
reorientations to the dynamics of STAT activation are not clear.  
Here we set out to investigate whether the dynamic properties of the Stat5 signal, 
namely, the manner with which it varies with stimulus strength or with time, might 
somehow specify erythropoietic rate. Previously, distinct dynamic forms of both the ERK 
and the Ras signals have been shown to specify distinct cellular responses [204] [205]. 
The dynamic form of a signal, however, is often masked when measured in large 
populations of cells with inherently variable responses. Analysis of a signal’s dynamic 
properties therefore requires measurement in single cells. 
Here we combined a flow-cytometric assay that allows identification of 
differentiation-stage-specific erythroblasts in primary tissue [14, 127, 206] with single-
cell flow-cytometric measurement of Stat5 phosphorylation in wild-type and mutant mice 
[207]. We found that Stat5 activation is bistable, a consequence of an autocatalytic 
interaction between active and inactive Stat5 that promotes Stat5 activation and that is 
mediated via the Stat5 N-terminal domain (ND). Bistable activation gives rise to a low-
intensity binary Stat5 signal in mature erythroblasts, that is both necessary and sufficient 
for mediating Stat5 functions in basal erythropoiesis. By contrast, stress levels of Epo 
generate a much higher, graded Stat5 signal unique to early erythroblasts. We show that 
higher Stat5 expression is the key factor that allows p-Stat5 to increase beyond its low-
intensity bistable activation level in early progenitors during stress. The combination of a 
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low-intensity but decisive, bistable signal in response to basal Epo, together with a 
further graded increase in p-Stat5 in response to stress, ensures high fidelity Stat5 
signaling throughout the wide basal and stress range of Epo concentrations. Further, 
based on our results, we expand the previously proposed hypothesis suggesting STAT 
conformational reorientation during its phosphorylation/dephosphorylation cycle [110]. 
We propose that the ND of active Stat5 molecules facilitates this conformational 
reorientation in trans, underlying autocatalysis and bistability.  
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Results 
Flow cytometric measurement of phosphorylated-Stat5 (p-Stat5) in primary 
erythroblasts 
Murine erythropoiesis takes place in fetal liver between embryonic days 12 (E12) and 15, 
and in adult bone marrow and spleen. We used cell-surface markers CD71 and Ter119 to 
identify stage-specific erythroid progenitors directly within primary tissue [14, 206, 208]. 
The CD71/Ter119 epitopes are preserved following cell fixation and permeabilization, 
which are required in order to measure intracellular p-Stat5 (Figure 2.1A). This allowed 
us to sub-divide fetal liver into several erythroid differentiation subsets, labeled S0 to S3 
(Figure 2.1A left panel). The earliest erythroid progenitors are found in the S0 subset, 
where they form ≈70% of all S0 cells. Subsets S1 to S3 are composed entirely of Epo-
dependent erythroblasts, with the least mature in S1 and the most mature in S3; the S3 
subset is further divided into earlier, large cells and later, small cells (Figure 2.1A). 
Intracellular Stat5 activation was measured following cell fixation and permeabilization 
with an AlexaFluor 647-conjugated antibody directed against the tyrosine-phosphorylated 
Stat5.  An Epo-dependent p-Stat5 signal was obtained in wild-type, but not in Stat5-/-, 
fetal liver (Figure 2.1B, upper panels). Further, the p-Stat5 signal was lost if, following 
Epo stimulation, fixed cells were incubated with λ phosphatase (Figure 2.1B, lower 
panels). Therefore, the p-Stat5 signal is specific to the active, phosphorylated-Stat5. 
Work below (Figure 2.9A) also confirmed, with the use of a Stat5 mutant, that the signal 
is specific to the phosphorylated, C-terminal Y694 residue.  
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Erythroid maturation determines the p-Stat5 response 
We stimulated freshly isolated fetal liver cells with Epo and examined the resulting p-
Stat5 response (Figures 2.1C-E, 2.2A). Specifically, we measured three aspects of the p-
Stat5 fluorescence signal (Figure 2.1C). First, ‘total p-Stat5’ corresponds to the p-Stat5 
median fluorescence intensity (MFI) of the entire cell population in a subset; the total p-
Stat5 MFI of all the S3 cells in the red histogram, upper panel of Figure 2.1C, is 1200 
fluorescence units. This measure includes both signaling and non-signaling cells in the 
subset. Second, we measured the number of ‘p-Stat5 positive’ (p-Stat5+) cells, or the 
fraction within the p-Stat5+ gate (Figure 2.1C, lower panel), as an estimate of the number 
of signaling cells within the subset. The placement of the p-Stat5+ gate was determined 
by reference to the baseline, pre-stimulation histogram (black histogram, Figure 2.1C 
lower panel), which was closely similar to that of cells stained with an AlexaFluor 647-
conjugated isotype-control antibody in place of the anti-p-Stat5 antibody. Last, we 
measured the ‘p-Stat5 in p-Stat5+ cells’, which estimates the p-Stat5 MFI in signaling 
cells only (Figure 2.1C lower panel, where p-Stat5 in p-Stat5+ cells is 1700 fluorescence 
units).  
We examined the p-Stat5 response to Epo at 15 minutes post stimulation, when a peak 
response is attained and persists for 15-30 minutes (see time course of activation, Figure 
2.2B). The p-Stat5 signal intensity was clearly dependent on erythroblast maturation 
stage, being highest in S1, and decreasing with erythroid maturation through subsets S2 
and S3. In the earliest, S0 subset, only ∼25% of cells responded to Epo, suggesting that 
the p-Stat5 response to Epo is enabled with the onset of Epo dependence at the transition 
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from S0 to S1 (Figures 2.2A, 2.2C; [208]). We contrasted the detailed responses of 
earlier, S1 cells with those of more mature, S3 cells. Figure 2.1D shows the p-Stat5 
response, measured as delineated in Figure 2.1C, to Epo concentrations spanning the 
physiological (<0.05 U/ml) and hypoxic-stress range (0.05 to 10 U/ml). S1 cells 
generated a graded increase in total p-Stat5 (Figure 2.1D, upper panel), which reflected a 
graded increase in both the number of signaling cells (p-Stat5+ cells, Figure 2.1D middle 
right panel) as well as in the MFI of signaling S1 cells (Figure 2.1D, lower right panel). 
By contrast, the highest total p-Stat5 MFI attained by ‘S3 large’ (=‘S3’) cells was ≈4 fold 
lower than in S1. Although S3 cells also showed a graded increase in total p-Stat5 MFI 
with Epo stimulation, this was principally a result of a graded increase in the number of 
p-Stat5+ cells, while the p-Stat5 MFI of signaling p-Stat5+ cells showed relatively little 
variation (Figure 2.1D lower panel). A summary of five independent experiments for all 
erythroid subsets shows that these dose/response characteristics are reproducible, and that 
the decrease in total p-Stat5 signal intensity from S1 to S3 occurs gradually as cells 
mature (Figure 2.1E).  
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Figure 2.1 The p-Stat5 response in fetal liver.  
(A) Flow cytometric method of identifying differentiation-stage-specific erythroblasts 
directly in freshly isolated fetal liver. Fetal livers from E13.5 embryos were fixed and 
permeabilized in preparation for intracellular p-Stat5 measurements, and labeled with 
antibodies directed at cell-surface CD71 and Ter119. Subsets S0 to S4 (left histogram) 
contain erythroblasts of increasing maturation, as seen from the morphological 
appearance of cytospin cell preparations from each subset (stained with Giemsa and 
diaminobenzidine). The right histogram shows the further division of S3 cells into small 
and large subsets based on the flow-cytometric ‘forward scatter’ parameter.  
(B) Specificity of the Alexa 647-conjugated  anti-p-Stat5 antibody (BD Biosciences # 
612599). Upper panels: response of S1 cells from either wild-type or Stat5-/- fetal livers to 
Epo stimulation (2 U/ml) for 15 minutes (red histograms). Blue histograms are baseline 
fluorescence in the absence of Epo. Lower panels: Epo-stimulated (2 U/m; 15 minutes, 
red histograms) or unstimulated (blue histograms) S1 cells in wild-type fetal liver, either 
treated or untreated with λ-phosphatase prior to p-Stat5 staining. Numbers in all panels 
indicate the fraction (%) of p-Stat5+ cells within the indicated horizontal gates.  
(C) Illustration of the three measures used to analyze the p-Stat5 response to Epo 
stimulation (9 U/ml, 15 minutes, red histogram) in S3-subset erythroblasts. The black 
histogram corresponds to pre-stimulation cells of the same subset.   
(i) ‘total p-Stat5 median fluorescence intensity (MFI)’ (upper panel): the p-Stat5 MFI of 
the entire S3-subset population, represented by the shaded red histogram. This measure 
does not distinguish between signaling and non-signaling cells. The black histogram 
corresponds to the unstimulated S3 subset population.  
(ii) ‘p-Stat5+ cells(%)’ (lower panel): cells within the p-Stat5+ gate, shaded in red, 
expressed as a fraction (percent) of all cells in the Epo-stimulated S3 subset. This is an 
estimate of the number of signaling cells. The placement of the p-Stat5+ gate was 
determined by reference to the baseline, pre-stimulation histogram (in black), so that no 
more than 1% of the unstimulated population is included within the p-Stat5+ gate.   
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(iii) ‘p-Stat5 in p-Stat5+ cells’ (lower panel): estimates the p-Stat5 MFI in signaling cells 
only.  
(D)  Response of cells in subsets S1 and S3 to stimulation with Epo. Freshly isolated 
fetal liver cells were deprived of Epo for 90 minutes and were then stimulated with a 
range of Epo concentrations as indicated, from 0.004 to 9 U/ml, for 15 minutes. Colored 
flow-cytometry histograms correspond to Epo-stimulated cells, black histograms in each 
panel correspond to unstimulated cells (Epo=0). An overlay of the responses is shown in 
the two lowest panels.  
For each Epo concentration, three measures of the p-Stat5 response, as illustrated in ‘C’, 
are noted next to each flow-cytometry histogram in blue, black and green, corresponding 
to the total p-Stat5 MFI, to the p-Stat5+ cells (%), and to the p-Stat5 in p-Stat5+ cells, 
respectively. Each of these measures is then plotted as a function of Epo concentration 
(right panels); the color of each symbol in these plots corresponds to the color of the 
respective flow-cytometry histogram for the same Epo concentration.   
(E) The p-Stat5 reponse to a range of Epo concentrations at 15 minutes post 
stimulation. Summary of five independent experiments similar to 1D. Data (mean ± SE) 
for each experiment were normalized by expressing each p-Stat5 MFI reading as a ratio 
to the p-Stat5 MFI in p-Stat5+ cells of the ‘S3 large’ subset following stimulation with 1 
U/ml Epo for 15 minutes. Data in the upper two panels were fitted with Hill curves.  
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Figure 2.1 
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Figure 2.2: The p-Stat5 response in fetal liver and in adult tissue. 
(A) The p-Stat5 response of fetal liver subsets S0 to S3 to Epo (2 U/ml, 15 minutes). 
Freshly isolated fetal liver cells were deprived of Epo for 90 minutes and were then 
stimulated. Cells were labeled for CD71, Ter119 and p-Stat5.  
(B)  Time-course of the p-Stat5 response to Epo (2 U/ml for up to 6 hours). Each of 
the three measures used to assess the p-Stat5 response (Figure 2.1C) is plotted versus 
time. Representative of 5 similar experiments.  
(C) Representative responses of S0 cells to stimulation with a range of Epo 
concentrations for 15 minutes. Flow-cytometry histogram overlay is shown. Even at the 
highest Epo concentrations, only 20 to 30% of S0 cells are responsive to Epo. For 
responding cells, the p-Stat5 MFI increases with Epo concentration, in the manner seen 
for S1 cells. 
(D-I) Time course of the p-Stat5 response to Epo stimulation in vivo, in adult mouse 
bone-marrow and spleen. Mice were injected with Epo (300U/25g mouse 
subcutaneously). Bone marrow and spleen were harvested at the indicated time points for 
up to 16 hours following injection, and cells were immediately fixed, permeabilized and 
labeled for CD71, Ter119 and p-Stat5. Erythroid subsets in adult mouse bone-marrow or 
spleen may be defined by flow cytometry using cell surface Ter119 and CD71 (Figures 
1.1B, 3.2A; [14]). Cells in subsets ProE→EryA→EryB→EryC contain cells of increasing 
maturity. The maturation stage of ProE resembles that of S2 in fetal liver and the 
maturation stage of EryA resembles that of S3.  
(D-F) Bone-marrow subsets; (G-I) Spleen subsets; (D), (G) total p-Stat5 response; (E), 
(H) p-Stat5+ cells; (F), (I) p-Stat5 in p-Stat5+ cells (solid lines). For comparison, the 
dashed lines show the total p-Stat5 response data from (D), (G), respectively.   
Data is pooled from four independent experiments. Each time point is the mean ± sem of 
data from two to four mice. MFI data is normalized as follows: background MFI in the 
absence of Epo is subtracted, and the remainder MFI is expressed as a ratio to MFI of p-
Stat5+ cells in bone-marrow EryA at time=1 hour for each experiment. 
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Figure 2.2 
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Binary and Graded Stat5 signaling coexist in developing erythroblasts 
The intensity of the p-Stat5 signal within signaling S3 cells (p-Stat5 MFI in p-
Stat5+ cells) remained relatively constant in spite of wide variation in the number of 
responding cells (Figure 2.1E, lower panel). We found similar behavior in maturation-
stage equivalent cells in adult tissue (Figure 2.2 D-I). These observations raised the 
possibility that S3 cells may be generating a binary p-Stat5 response. Under this 
hypothesis, individual S3 cells would either express their maximal p-Stat5 levels 
regardless of Epo concentration (and be ‘on’), or fail to respond and remain ‘off’; they 
would not assume intermediate levels of p-Stat5 stably. A binary p-Stat5 response in 
single cells may nevertheless result in a graded response at the population level. This is 
illustrated in Figure 2.3A, which contrasts three hypothetical cases of signaling cells. In 
the first case (Figure 2.3A left panels), there is a graded increase in signal within 
individual cells in response to increasing Epo concentration, resulting in a graded 
increase in the total p-Stat5 MFI at the population level.  The two hypothetical cases of 
binary signaling (Figure 2.3A, middle and right panels) differ only in the Epo threshold at 
which cells respond with a p-Stat5 signal. In the ‘variable threshold’ example, individual 
cells vary substantially with respect to the Epo concentration at which they switch from 
‘off’ to ‘on’. At the population level, this results in a graded p-Stat5 response to 
increasing Epo concentration. The corresponding flow-cytometry histograms at each Epo 
dose (in color) are a composite of two underlying histograms, of non-signaling cells (in 
grey) and signaling cells (in black). Only the amplitudes of the black and grey histograms 
change with Epo concentration, while their MFI remains constant. However, the MFI of 
??
the composite, color histogram, representing the total p-Stat5 response for all subset cells, 
increases gradually with Epo dose. In the second binary signaling example (Figure 2.3A, 
right panels), cells have a similar threshold to Epo stimulation, so that the entire cell 
population switches from ‘off’ to ‘on’ within a narrow range of Epo concentrations. This 
results in the population response resembling the binary responses of individual cells, 
with a much steeper Epo dose/p-Stat5 response curve that is characterized by a high Hill 
coefficient (nH>1).  
The graded p-Stat5 response of the S3 population does not therefore preclude the 
possibility that individual S3 cells have binary responses that are masked by variable 
response thresholds (as in Figure 2.3A, middle panel). We found, however, that binary p-
Stat5 signaling became apparent at the population level, in a manner resembling the 
‘similar threshold’ example, when we examined p-Stat5 signaling in the EpoR-HM 
mutant mouse (Figure 2.3 B-E). 
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Figure 2.3. Binary p-Sta5 signaling in EpoR-HM erythroblasts. 
(A) Contrasting graded and binary signaling responses: three hypothetical examples.  
In a graded signaling response (left panels), increasing Epo concentration results 
in a graded increase in p-Stat5 in individual cells, represented by increasingly darker 
shades of grey. Simulations of the corresponding flow-cytometric profiles show that 
increasing Epo concentration causes a gradual shift of the p-Stat5 fluorescence histogram 
to the right. A plot of the total p-Stat5 median fluorescence intensity (MFI) vs. Epo 
concentration has Michaelian kinetics with a Hill coefficient (nH) of 1 (lower left panel, 
please note a log scale was used for the x-axis).   
In binary signaling (middle and right panels), the p-Stat5 signal in individual cells 
can only assume two states, either ‘off’ (white) or ‘on’ (black), but intermediate states 
(shades of grey) are unstable. Two distinct cases of binary signaling are illustrated, that 
differ in their threshold responses.  
In ‘variable threshold’ (middle panels), the threshold at which Epo causes a cell to 
switch from ‘off’ to ‘on’ varies substantially between cells of the population. 
Consequently, increasing Epo concentration causes a gradual increase in the number of 
cells that are p-Stat5+ (‘on’). The simulated flow-cytometric histograms at each Epo 
concentration (in color) are each the sum of two histograms, corresponding to cells that 
are ‘off’ (light grey histograms) and cells that are ‘on’ (black histograms). The median 
fluorescence of the ‘on’ and ‘off’ histograms remain unaffected by Epo concentration, 
but as Epo increases, the number of cells in the ‘on’ histogram, reflected by its height, 
increases, with a corresponding decrease in the height of the ‘off’ histogram.  Although 
individual cells have binary responses, there is a graded increase in the MFI of colored 
histogram representing the whole population. Therefore, a plot of total p-Stat5 MFI vs. 
Epo concentration shows a graded response and has a low Hill coefficient (here, nH=1).  
In the case of cells with binary responses and similar threshold (right panels), 
cells switch from ‘off’ to ‘on’ within a much narrower Epo concentration range. 
Consequently, the response of the whole population reflects the response of individual 
cells more closely. Flow-cytometric histograms representing the population tend to be in 
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one of two principal positions, corresponding to the ‘on’ or to the ‘off’ states. A plot of 
total p-Stat5 MFI vs. Epo concentration is steep, reflected by a high Hill coefficient (nH, 
> 1). 
(B) Representation of the cytoplasmic domains of wild-type EpoR, or its truncated 
mutants, EpoR-H and EpoR-HM. Tyrosine residues are represented by red lines. 
Tyrosine 343 is the only remaining tyrosine in EpoR-H, and is mutated in EpoR-HM.  
(C)  The p-Stat5 response to Epo (2 U/ml, 30 minutes) in S1 cells from wild-type 
(WT), EpoR-H (H) or EpoR-HM (HM) fetal livers on E13.5. Percentage of cells in the p-
Stat5+ gate is indicated. 
(D) Fluorescence p-Stat5 histogram overlay of S1 cells from E13.5 wild-type (top) or 
EpoR-HM (bottom), stimulated with a range of Epo concentrations for 30 minutes. 
Representative of 3 similar experiments. S1 cells in each case are pooled from several 
fetal livers of the same genotype. 
(E) Top left panel: plots of ‘p-Stat5 MFI vs. Epo concentration’, in wild-type or 
EpoR-HM S1 cells; the p-Stat5 MFI data corresponds to the histograms shown in ‘D’. 
Data is fitted with Hill curves.  
Top right panel: Hill curves that were fitted to the data in ‘D’ as in the top left 
panel, but shown as a fraction of the maximal p-Stat5 response (p-Stat5max). The p-
Stat5max was calculated from fitting the Hill equation to the experimental ‘total p-Stat5’ 
data. Hill coefficients (nH) are indicated.  
Lower panel: table summarizing the Hill coefficients (nH) obtained by fitting the 
Hill curve to plots of ‘total p-Stat5 vs Epo concentration’, for each of subsets S1 to S3, in 
each of three independent experiments. Fetal liver cells were pooled from 3 or 4 embryos 
of each genotype in each experiment. Differences between nH for EpoR-HM and WT are 
significant at p=0.01, paired t test. ‘r2’ is Pearson’s product moment correlation 
coefficient, correlating experimental data with values predicted by the Hill equation for  
the corresponding Epo concentrations. 
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Figure 2.3 
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Figure 2.4: Binary p-Stat5 signaling in EpoR-HM erythroblasts. 
(A)  Representative plots of ‘total p-Stat5 versus Epo concentration’ for subsets S1 to 
S3 in wild-type (left panel) and EpoR-HM (right panel) fetal liver. This experiment was 
also illustrated in Figure 2.3D. 
(B) Values for p-Stat5max and apparent Km obtained by fitting Hill curves to plots of 
‘total p-Stat5 MFI vs. Epo concentration’ of the type illustrated in ‘A’.  The Hill equation 
was used as follows:  
 p-Stat5=
(p-Stat5max )S
n
(Km )
n +Sn
 
Where S= Epo concentration in U/ml, and ‘p-Stat5’ is the total p-Stat5 fluorescence; best 
fit was obtained by varying n (= Hill coefficient), Km (=the apparent Km) and p-Stat5max 
(=the maximal p-Stat5 response to high Epo), using the solver function of Microsoft 
Excel. ‘r2’ is Pearson’s product moment correlation coefficient, correlating experimental 
data with values predicted by the Hill equation for  the corresponding Epo concentrations. 
The Hill coefficients and r2 values for this analysis are shown in Figure 2.3E.  
Differences between Km and p-Stat5max were all significant (paired t-test, p=0.003 and 
0.023, respectively).  
??
Figure 2.4 
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EpoR-HM erythroblasts generate only binary low-intensity p-Stat5 signal 
We studied p-Stat5 signaling in the EpoR-H and EpoR-HM mouse strains, in 
which the respective EpoR truncation mutants are ‘knocked-in’ at the wild-type EpoR 
locus, replacing wild-type EpoR (Figure 2.3B, [46]). EpoR-H lacks seven of the eight 
cytoplasmic domain tyrosines. The remaining tyrosine, Y343, a Stat5 docking site, is 
mutated to phenylalanine in EpoR-HM, which therefore lacks tyrosine docking sites for 
Stat5.  
S1 cells from EpoR-H fetal livers generated a p-Stat5 signal equivalent to that of 
wild-type cells, but had a high background of p-Stat5 in the absence of Epo stimulation, 
consistent with a previously-identified negative regulatory function for the carboxy-
terminal domain (Figure 2.3C, lower panel; [209]). S1 cells from EpoR-HM fetal liver, 
by contrast, generated only a low intensity p-Stat5 response to Epo, consistent with 
previous studies (Figure 2.3C, upper panel; [25]). A full Epo dose/p-Stat5 response 
analysis revealed that the maximal p-Stat5 signal generated by S1 cells in EpoR-HM was 
≈3-4 fold lower than in wild-type S1, resembling in intensity p-Stat5 signals generated by 
more mature, wild-type S3 cells (Figures 2.3D, 2.3E upper left panel, 2.4A).  Strikingly, 
in addition to their lower p-Stat5 intensity, the EpoR-HM S1 response was binary, 
resembling the hypothetical example of binary signaling in a population of cells with 
similar Epo thresholds (Figure 2.3A, right panels). Thus, unlike wild-type S1, the p-Stat5 
fluorescence histograms in EpoR-HM S1 are in one of two clusters, either ‘off’ or ‘on’ 
(Figure 2.3D, lower panel). This binary behavior was reflected in the steep Epo dose/ p-
Stat5 response curve for EpoR-HM S1 cells (Figure 2.3E upper panels). In each of 3 
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independent experiments, the Hill coefficients found for each of the EpoR-HM subsets 
were consistently higher than in wild-type controls (Figure 2.3E, lower panel), with nH 
for S1 cells ranging between 2 and 3.5. Taken together, S1 cells in EpoR-HM have lost 
the high intensity graded signaling mode characteristic of this subset. The residual signal 
is of low intensity, similar to that of S3 cells, and is binary in nature. 
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The maximal p-Stat5 response (p-Stat5max) is linearly correlated with Stat5 
expression levels 
We investigated factors that might account for the gradual decrease in the p-Stat5 
response as cells mature (Figure 2.1E). The transition from subset S1 to ‘S3 small’ takes 
24 to 48 hours in vivo [206, 208] and entails large changes in gene expression. We 
examined the potential role of established Stat5 regulators, and found that neither SOCS3 
(Figure 2.5) nor SHP1 [210] (Figure 2.6) regulate the peak intensity of the p-Stat5 
response. We also examined the potential role of changes in EpoR or Stat5 expression 
during erythroblast maturation. To this end we investigated embryos heterozygous for 
either Stat5 or EpoR (Figure 2.7). An Epo dose/ p-Stat5 response analysis in fetal liver 
cells from Stat5+/- embryos showed a clear decrease in the p-Stat5 signal across the entire 
Epo concentration range compared with wild-type controls (see representative example in 
Figure 2.7A; data from the entire dataset of 7 Stat5+/- and 6 wild-type littermates embryos 
is summarized in Figure 2.7B). Fitting Hill curves to the dose/ response data yielded the 
apparent Km, the maximal p-Stat5 signal at high Epo concentrations, defined as ‘p-
Stat5max’, and the Hill coefficient, nH (Figure 2.8A). In addition to the clear decrease in p-
Stat5max in all subsets of the Stat5+/- fetal liver (Figures 2.7A and B, 2.8A), the p-Stat5 
response curve was steeper, reflected in a higher Hill coefficient (Figure 2.7B).  
We also examined the Epo dose/p-Stat5 response in fetal livers derived from 
EpoR+/- embryos and their littermate controls (Figure 2.7C). We found an approximately 
2-fold decrease in EpoR mRNA in EpoR+/- fetal livers (Figure 2.8B). Unlike the Stat5+/- 
embryos, there was no change in p-Stat5max in EpoR+/- fetal liver, suggesting that cell-
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surface EpoR is not limiting for the maximal p-Stat5 response. Instead, the EpoR+/- 
dose/response curves were shifted to the right, with a 2-fold increase in the apparent Km 
(Figures 2.7C, 2.8C), suggesting that a doubling in Epo concentration compensated for 
the reduced expression of EpoR.  
To assess the relation between Stat5 expression and the maximal p-Stat5 response 
more precisely, we measured total Stat5 protein levels in individual cells within each of 
the Stat5+/- and wild-type embryos, using anti-Stat5 antibodies and flow cytometry 
(Figures 2.7D, 2.8D). Stat5 expression decreased with maturation, being highest in S1 
and 4 fold lower in ‘S3 large’ cells (Figure 2.7D, closed symbols). A similar pattern was 
observed in Stat5+/- embryos, but for each corresponding subset, Stat5 expression was 
approximately halved compared with wild-type cells (Figure 2.7D open symbols). There 
was a linear correlation (R2=0.85) between Stat5 expression levels and the maximal p-
Stat5 response (p-Stat5max) across all subsets in both wild-type and Stat5+/- embryos 
(Figure 2.7E; p-Stat5max was determined by fitting a Hill curve to data from each 
embryo). These findings suggested that decreased Stat5 expression caused the decrease in 
the p-Stat5 response with cell maturation, as well as the reduced p-Stat5max in Stat5+/- 
embryos. 
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Figure 2.5 SOCS3 regulation of Stat5 signaling. 
(A) Real time PCR for SOCS3 in sorted S0-S3 subsets from wild type embryos (E13-
E14.5). The left graph shows SOCS3 mRNA relative to β actin (mean±SE), calculated 
from 3 independent experiments. The right graph shows the ΔCt ± SE for each individual 
experiment. 
(B) Fetal liver cells were electroporated with SOCS3 siRNA or with ‘scrambled’ 
control siRNA. Four hours later the cells were stimulated with Epo and collected at 
different time points. The time course of the p-Stat5 response is shown (two independent 
experiments (top and bottom)). 
(C) Fetal liver cells were treated as in ‘B’. Real time PCR for SOCS3 mRNA at the 
indicated times is shown (mean ± SE). 
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Figure 2.6 Stat5 signaling in Shp1-/- fetal liver. 
(A) Real time PCR for Shp1 in sorted S0-S3 subsets from wild type embryos (E12.5-
E13.5). The left graph shows Shp1 mRNA relative to β actin (mean ± SE), calculated 
from 3 independent experiments. The right graph shows the ΔCt ± SE for each individual 
experiment. 
(B) Epo dose/p-Stat5 response analysis in Shp1-/- fetal liver fitted with Hill curves. 
Data (mean) from 2 independent experiments each with one embryo of each genotype.  
(C) Time course of p-Stat5 response to Epo stimulation with 0.2U/ml, in Shp1-/- 
embryos (n=5) and in matched controls (n=3). Data points are measurements in 
individual embryos. 
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Figure 2.7 The maximal p-Stat5 response (p-Stat5max) is linearly correlated with 
Stat5 expression levels.  
(A) The p-Stat5 response of S1 cells from Stat5+/- fetal liver and from littermate wild-
type controls. Representative p-Stat5 fluorescence histograms are shown for the indicated 
Epo concentrations. 
(B) Plots of ‘total p-Stat5 vs. Epo concentration’ in Stat5+/- and in wild-type littermate 
fetal livers in experiments similar to ‘A’, fitted with Hill curves. Data (mean ± SE) from 
n= 7 Stat5+/- embryos and 6 littermate controls, each analyzed separately. p-Stat5 MFI 
was normalized as in Figure 2.1E. Parameter values used for fitting the Hill curves and 
goodness of fit information are in Figure 2.8A.  
(C) Plots of ‘total p-Stat5 vs. Epo concentration’ in EpoR+/- and in wild-type littermate 
fetal livers, fitted with Hill curves. Data (mean ± SE) from n=4 EpoR+/- embryos and 3 
littermate controls, each analyzed separately. p-Stat5 MFI was normalized as in Figure 
2.1E. Parameters values used for fitting the Hill curves and goodness of fit information 
are in Figure 2.8C. 
(D) Stat5 protein expression in subsets S1, S2 and S3 in wild-type or Stat5+/- embryos. 
Individual data points correspond to data from individual embryos. Stat5 protein was 
measured by flow-cytometry, and is expressed as a ratio to the average fluorescence 
signal for S1 cells in all wild-type embryos. The assay was verified using Stat5-/- 
embryos, see Figure 2.8D. 
(E) Linear correlation between Stat5 protein expression and p-Stat5max, across all 
subsets in Stat5+/- and wild-type embryos (R2=0.85). Data points correspond to individual 
embryos. Stat5 protein expression as in ‘D’. p-Stat5max was determined by fitting Hill 
curves to individual embryo ‘total p-Stat5 vs. Epo concentration’ analyses, with p-Stat5 
normalized as in Figure 2.1E.  
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Figure 2.8 Analysis of Stat5 phosphorylation in Stat5+/- and EpoR+/- embryos. 
(A) Values for the Hill coefficients, p-Stat5max, and apparent Km, obtained by fitting 
Hill curves (see legend to Figure 2.4B) to the plots of ‘total p-Stat5 MFI vs. Epo 
concentration’ shown in Figure 2.7B. Note a substantially lower p-Stat5max in Stat5+/- 
embryos. Data is derived by fitting the Hill curve through the mean values obtained from 
the means of a total of 7 Stat5+/- and 6 control embryos, analyzed independently. ‘r2’ is 
Pearson’s product moment correlation coefficient, correlating experimental data with 
values predicted by the Hill equation for  the corresponding Epo concentrations. 
(B) EpoR mRNA was measured using quantitative RT-PCR in fetal livers of wild 
type (red circles) or EpoR+/- (pink squares) embryos (E13.5). Data points represent 
measurements in individual embryos, and are expressed relative to β actin mRNA. Mean 
values for each genotype are denoted with a black line. 
(C) Values for the Hill coefficients, p-Stat5max, and apparent Km, obtained by fitting 
Hill curves (see legend to Figure 2.4B) to the plots of ‘total p-Stat5 MFI vs. Epo 
concentration’ shown in Figure 2.7C. Note doubling of the apparent Km in EpoR+/- 
embryos. Data is derived by fitting the Hill curve through the mean values obtained from 
the means of a total of 4 EpoR+/- and 3 control embryos, analyzed independently. ‘r2’ is 
Pearson’s product moment correlation coefficient, correlating experimental data with 
values predicted by the Hill equation for  the corresponding Epo concentrations. 
(D) Measurements of Stat5 protein using flow-cytometry. Fixed and permeabilized 
fetal liver cells were labeled with CD71, Ter119, and with a rabbit polyclonal antibody 
which recognizes Stat5 regardless of its state of activation, and with a secondary anti-
rabbit IgG antibody conjugated to APC. Flow cytometry histograms reflecting total Stat5 
protein expression (as APC fluorescence) are shown for two Stat5-/- embryos (these 
provide the non-specific background fluorescence); and for one wild-type and one Stat5+/- 
embryo. Stat5 expression in Figure 2.7D, E was determined as Stat5 MFI, with 
background fluorescence subtracted, and expressed as a ratio to the average Stat5 MFI of 
S1 cells. 
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Exogenous Stat5 expression rescues graded high intensity p-Stat5 signaling in 
EpoR-HM erythroblasts and wild-type S3 cells  
To test whether the loss of the high-intensity p-Stat5 response in mature, S3 cells 
is indeed due to their decreased Stat5 expression (Figure 2.7E), we asked whether we 
could rescue high-intensity Stat5 signaling in these cells by exogenously expressing 
Stat5.  In parallel, we also examined the effect of exogenous Stat5 expression in EpoR-
HM erythroblasts, which signal exclusively via the low-intensity binary signaling mode 
(Figure 2.3 D-E). We electroporated FLAG-tagged Stat5a constructs (‘FLAG-Stat5’), 
control FLAG-tagged Stat5aY694F (‘FLAG-Stat5Y694F’) lacking the C-terminal 
tyrosine, or ‘empty vector’ control (‘pcDNA3’), into freshly isolated wild-type or EpoR-
HM fetal liver. Cells were incubated overnight in the presence of Epo (0.2 U/ml), to 
allow expression of the transduced constructs. Cells were deprived of Epo for 3 hours 
prior to their stimulation with a range of Epo concentrations (0.004 to 9 U/ml). Cells 
were then fixed and labeled with both anti-FLAG and anti-p-Stat5 antibodies. A single 
electroporation contained cells with a spectrum of FLAG expression levels, allowing us 
to determine how FLAG-Stat5 expression affected the p-Stat5 response (Figures 2.9, 
2.10). We noted that in the absence of Epo stimulation, cells expressing the highest levels 
of FLAG-Stat5 nevertheless contained p-Stat5 (Figure 2.9A, top left panel, double-
headed arrows). This constitutive p-Stat5 signal was specific, since it was absent in cells 
expressing equivalent levels of FLAG-tagged Stat5Y694F, which cannot be tyrosine 
phosphorylated (Figure 2.9A, middle left panel). This phenomenon is further addressed 
below (Figure 2.12). In response to stimulation with Epo, there was an increase in p-
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Stat5, with the highest response in cells expressing the highest levels of FLAG-Stat5 
(Figure 2.9A, top middle panel). To analyze the p-Stat5 response quantitatively for each 
FLAG-Stat5 expression level, we sub-divided the ‘p-Stat5 vs. FLAG-Stat5’ dot plots for 
EpoR-HM into narrow vertical gates, each of which contained cells with similar FLAG-
Stat5 expression (Figure 2.9B, left panels). Three of these vertical gates, numbered 10 to 
12, are color coded in red, green and blue respectively, in three examples of cells 
stimulated with Epo concentrations of 0 U/ml (top left panel), 0.33 U/ml (middle left 
panel) or 9 U/ml (bottom left panel). Panels to the right show an overlay of responses to 
the three Epo concentrations in each of the red, green or blue vertical gates. The entire p-
Stat5 response data set to nine Epo concentrations in each of 4 vertical gates (9 to 12) for 
EpoR-HM is plotted in the lower panel of Figure 2.9B, fitted with Hill curves. A similar 
analysis for wild-type S3 cells is shown in Figure 2.10A.  
Inspection of the Epo dose/p-Stat5 response curves for wild-type (Figure 2.10A) 
and EpoR HM erythroblasts (Figure 2.9B) shows that they are altered by exogenous 
FLAG-Stat5 in two ways. First, the maximal response (p-Stat5max) in a given vertical gate 
was positively and linearly correlated with the level of FLAG-Stat5 expression in that 
gate (Figures 2.9C, 2.10B). Second, as FLAG-Stat5 expression increased, there was a 
decrease in the steepness of the p-Stat5 response curves, as reflected by decreasing Hill 
coefficients (Figures 2.9B, lower right panel for EpoR-HM, and 2.10A, lower right 
panels for wild-type S3 cells). As examples, the high FLAG-Stat5 expression 
(MFI=1700) in gate 12 gave rise to a higher p-Stat5max (MFI=1100) and a lower Hill 
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coefficient (nH=1.4) than in gate 9, where a lower FLAG-Stat5 expression (MFI=340) 
resulted in a lower p-Stat5max (MFI=120) and a high Hill coefficient (nH=2.5).  
Therefore, by varying the level of exogenous Stat5 expression in a single cell type 
(wild-type S3 cells, or EpoR-HM S3 cells), we were able to generate the entire spectrum 
of Stat5 signaling responses encountered in the erythroblast maturation series (Figure 
2.1E). Taken together, the data in Figures 2.7, 2.9 and 2.10 show that decreasing Stat5 
expression with erythroblast maturation is the cause of the gradual shift from high-
intensity, graded signaling in early erythroblasts to low intensity, binary signaling in 
mature erythroblasts.   
The loss of high-intensity Stat5 signaling in EpoR-HM shows that, in addition to 
high Stat5 expression, this mode of signaling also requires Stat5 docking sites on the 
EpoR. Exogenous expression of Stat5 successfully compensated for the EpoR-HM 
mutation, however, rescuing high-intensity graded signaling in these cells (Figure 2.9).  
The linear dependence of p-Stat5max on Stat5 expression levels, whether 
endogenous (Figure 2.7E) or exogenous (Figures 2.9C, 2.10B), indicates that Stat5 is 
limiting for Stat5 phosphorylation in erythroid cells. A theoretical analysis of this finding 
is provided below.  
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Figure 2.9 High exogenous Stat5 levels rescue high-intensity graded p-Stat5 
signaling in EpoR-HM cells. 
(A) The p-Stat5 response to Epo in S3 cells expressing exogenous FLAG-Stat5. Wild-
type fetal liver cells were electroporated with either FLAG-tagged Stat5a (=FLAG-Stat5, 
C-terminal tag, top panels), FLAG-tagged Stat5Y694F (middle panels) or ‘empty vector’ 
(pcDNA3, lower panels). Following overnight incubation in the presence of Epo (0.2 
U/ml), cells were deprived of Epo for 3 hours, and then either left unstimulated (left 
panels) or were stimulated with Epo for 30 minutes (response to 9 U/ml is shown here, 
middle panels; altogether 9 different Epo concentrations were examined, ranging from 
0.04 to 9 U/ml, and are shown in panel B and in Figure 2.10). Double-headed arrows 
indicate Epo-independent p-Stat5, seen only in cells expressing high levels of FLAG-
Stat5.    
(B) Analysis strategy for the experiment described in panel ‘A’; results for EpoR-HM 
S3 erythroblasts are shown here; results for wild-type S3 are in shown Figure 2.10. Dot 
plots of the p-Stat5 response vs. FLAG-Stat5 expression are shown for 3 of the nine Epo 
concentrations examined (left panels; Epo= 0, 0.33 or 9 U/ml). For analysis, these dot 
plots were sub-divided into narrow vertical gates, each containing cells of similar FLAG-
Stat5 expression. Three of these gates, numbered 10 to 12, are highlighted in red, green 
and blue. Data from each of the three red gates (gate 10) were overlayed in a single 
histogram (top right histogram, highlighted in red). This histogram therefore contains the 
p-Stat5 responses to a range of Epo concentrations, of cells expressing similar FLAG-
Stat5 levels (580±13, MFI±SE). A similar analysis was carried out for each of the nine 
Epo concentrations for cells in gate 10, and the ‘total p-Stat5 response’ to each Epo 
concentrations were plotted and fitted with a Hill curve (red symbols and curve, lowest 
right panel). A similar analysis was carried out for each of the other vertical FLAG-Stat5 
gates; Hill coefficients are indicated next to the Hill curve for each gate. Data points in 
the ‘total p-Stat5 vs. FLAG-Stat5’ plots are mean ± sem for cells in each gate. Each of 
the ‘total p-Stat5’ MFI measurements was corrected by subtracting background 
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fluorescence, given by the ‘total p-Stat5’ MFI of cells expressing FLAG-Stat5Y694F in 
the same gate.  
(C) Linear correlation between FLAG-Stat5 expression and p-Stat5max in EpoR-HM 
S3 cells (R2=0.998); analysis is of data shown in ‘B’. p-Stat5max is the maximal p-Stat5 
response to Epo, defined by the Hill equation in Figure 2.4 and obtained by fitting Hill 
curves to data in ‘B’, lower right panel, for each of the indicated vertical FLAG 
expression gates. 
??
Figure 2.9
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Figure 2.10: High exogenous Stat5 levels rescue high-intensity graded p-Stat5 
signaling in wild-type S3 cells. 
Experiment as described in Figure 2.9A.  
(A) The p-Stat5 response of wild type S3 cells expressing exogenous FLAG-Stat5, to 
three Epo concentrations. Vertical gate analysis as described for EpoR-HM erythroblasts 
in Figure 2.9B. Hill plots for cells in vertical FLAG-Stat5 gates numbered 7 and 8 are 
shown twice, with different y-axis scales. Data points in Hill plots are mean ± sem for 
cells in each gate.  
(B) Linear correlation between FLAG-Stat5 expression and p-Stat5max in wild-type S3 
cells (R2=0.96); analysis is of data shown in ‘A’. p-Stat5max is the maximal p-Stat5 
response to Epo, defined by the Hill equation in Figure 2.4 and obtained by fitting Hill 
curves to data in ‘A’, lower right panel, for each of the indicated vertical FLAG 
expression gates. 
??
Figure 2.10  
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Cellular Stat5 is limiting during Stat5 phosphorylation in erythroid cells 
Our data shows that maximal p-Stat5 produced in response to Epo dosing  (=’p-Stat5max’) 
is linearly related to total cellular Stat5 (Figures 2.7E, 2.9C, 2.10B). This linear 
relationship is maintained across all erythroid progenitor stages and over a wide range of 
cellular Stat5 expression levels, whether endogenous, or exogenously introduced into 
cells.  By contrast, p-Stat5max is not affected by the reduced number of cell-surface EpoRs 
in EpoR+/- cells (Figure 2.7C). It is also apparently unaffected by the decrease in cell-
surface EpoRs known to occur with progenitor differentiation [13], since introduction of 
exogenous Stat5 into late erythroid progenitors increases p-Stat5max linearly with cellular 
Stat5.  
These findings suggest that the limiting parameter for p-Stat5max is cellular Stat5, rather 
than the number of cell-surface EpoRs. Therefore, conditions of substrate excess, 
required for Michaelis-Menten kinetics, do not apply to Stat5 phosphorylation in 
erythroid cells. Instead, the analysis below shows that our results are consistent with 
conditions of enzyme excess. Under such conditions, maximal product formation is 
linearly related to initial substrate concentration [211, 212].  
 Analysis: 
Epo binds a pre-formed complex of EpoR and Jak2, to form an active enzyme complex, 
or ‘E’: 
 
  Epo + (EpoR-Jak2)? ???? (Epo-EpoR-Jak2)  (1) 
and E = (Epo-EpoR-Jak2)  (2) 
??
The activated enzyme complex ‘E’ binds Stat5, to form an enzyme-substrate complex 
‘C’, which phosphorylates Stat5: 
 
 
E + Stat5
k1
k−1
? ?????? C k2⎯ →⎯ p-Stat5+E   (3) 
Let initial Stat5 concentration be denoted as ‘S0’  and the concentration of the product, p-
Stat5, as ‘P’. From reaction (3), the rate of  p-Stat5 formation, dP/dt, is  provided by  
 
dP
dt
= k2C  (4) 
If the active enzyme concentration is in great excess of ‘S0’, that is,  E ? S0 , then reaction 
(1) is essentially independent of reaction (3). Namely, the binding of Stat5 to E will not 
appreciably decrease E from its value as set by reaction: 
 E ≈ E0  (5) 
where E0  is the initial active enzyme concentration1. More generally, this assumption 
holds whenever the fraction of substrate-bound enzyme is negligible: 
 
C
E
?1 ; such 
conditions arise not only at pure enzyme excess,  E ? S0 , but also under the weaker 
requirement that,  E + K,m ? S0 , where Km =
k−1 + k2
k1
 is the Michaelis-Menten constant 
of reaction (3) [212]. 
Under these conditions, 
 C =
E0 (S0 − P)
Km + E0
 (6) 
1 Note that strictly speaking E0 is not the initial active enzyme concentration, but the equilibrium 
concentration implied by reaction (1). 
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From (4), (5) and (6), the rate of formation of p-Stat5 (=P) is given by 
 dP
dt
= k2
E0 (S0 − P)
Km + E0
 (7) 
If we let K =
k2E0
Km + E0
, equation (7) now becomes 
 
dP
dt
= K(S0 − P) . (8) 
From (8), and the initial condition P = 0, the concentration of the product, p-Stat5 
increases with time as 
 P = S0 (1− e−Kt )  (9) 
Equation (9) is in agreement with our observations in Figures 2.7E and 2.9C, that the 
maximal value for P, ‘p-Stat5max’, obtained by fitting the Hill equation to the Epo dose/p-
Stat5 response data (when a relative steady state is reached, ≈15 minutes after the onset 
of Epo stimulation), is independent of E0 and Km and is a linear function of the initial 
Stat5 substrate concentration, S0. Therefore, our observations are consistent with the 
initial assumption of this analysis that the active enzyme complex is in excess of cellular 
Stat5 concentration. 
Distinct biological functions of the binary and graded Stat5 signaling modes 
Mice lacking Stat5 die perinatally of severe anemia [68, 119, 126]. By contrast, 
EpoR-HM mice, which retain only the low-intensity binary p-Stat5 signal, are viable with 
near-normal basal erythropoiesis. Therefore, the low intensity binary p-Stat5 signal is 
sufficient to support essential Stat5 functions in basal erythropoiesis. EpoR-HM mice are, 
however, deficient in their response to erythropoietic stress, a deficit that, by comparison 
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with the normal stress phenotype of the EpoR-H mouse (Figure 2.3B), was attributed to 
the absence of the Y343 Stat5 docking site on the mutant EpoR-HM receptor [47]. 
Therefore, the high intensity Stat5 signal absent in EpoR-HM may be specifically 
required during stress. We examined these possibilities by studying two established Stat5 
functions: its anti-apoptotic effect in erythroblasts, required in both basal and stress 
erythropoiesis [126, 127, 213]; and its induction of the transferrin receptor (CD71), 
which transports iron for hemoglobin synthesis [134, 214].  
We first examined the role of Stat5 signaling in erythroblast survival, by 
incubating freshly isolated fetal liver cells from either EpoR-HM, Stat5-/-, or strain-
matched wild-type embryos, in the absence of Epo for 90 minutes. We then labeled the 
cells with Annexin V, to detect cells undergoing apoptosis. A large fraction (40%) of 
Stat5-/- S1 cells, but only 1-2% of wild-type controls, were Annexin V positive, 
confirming that Stat5 is essential to erythroblast survival. The level of apoptosis of EpoR-
HM cells, however, was low and similar to that of wild-type controls (Figure 2.11A, 
representative examples in left panels, summary of several experiments in right panels). 
Therefore, the low-intensity, binary Stat5 signal is sufficient for mediating Stat5’s anti-
apoptotic function in EpoR-HM erythroblasts, and for maintaining basal erythropoiesis.  
To examine the erythropoietic stress response, we administered adult EpoR-HM 
mice, or wild-type control mice, with a single subcutaneous injection of Epo (100U/ 25 g 
mouse) that generates stress-levels Epo concentrations in vivo. As previously reported 
[46], the EpoR-HM mice failed to increase their hematocrit (Figure 2.11B, left upper 
panel). The erythropoietic response to high Epo entails upregulation of erythroblast cell-
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surface CD71 [14], a Stat5 target [134, 214]. We found that Epo injection caused a 2 to 3 
-fold increase in cell surface CD71 of wild-type Ter119high CD71high spleen erythroblasts, 
but failed to generate an increase in erythroblasts from EpoR-HM mice (Figure 2.11B, 
duplicate experiments in upper right panel, flow-cytometry contour plots in lower 
panels). We have found above that the high intensity Stat5 signal, missing in EpoR-HM 
erythroblasts, can be rescued in these cells by high exogenous Stat5 expression (Figure 
2.9B). We therefore asked whether rescue of the high-intensity Stat5 signal might also 
restore high CD71 expression to EpoR-HM erythroblasts. EpoR-HM or wild-type fetal 
liver cells were electroporated with either FLAG-Stat5 or with control FLAG-
Stat5Y694F, as illustrated in Figure 2.9A. Cell-surface CD71 was measured by flow 
cytometry following overnight culture in the presence of stress Epo levels (0.2 U/ml). We 
found that rescue of high-intensity p-Stat5 signaling to EpoR-HM erythroblasts by 
exogenous FLAG-Stat5 (Figure 2.9B), also restored their high CD71 expression (Figure 
2.11C). There was no change in CD71 expression as a result of exogenous expression of 
the inactive, FLAG-Stat5Y694F mutant. These findings strongly suggest that CD71 
upregulation by Stat5 is a function specifically mediated by the high-intensity graded 
Stat5 signal during the erythropoietic response to stress.  
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Figure 2.11 Biological functions of binary and graded Stat5 signaling.  
(A) Increased erythroblast apoptosis in Stat5-/- but not in EpoR-HM fetal liver.  
Freshly harvested fetal livers from E13.5 Stat5-/- or from EpoR-HM embryos and from 
matched controls were incubated in the absence of Epo for 90 minutes. Cells were then 
labeled with 7-AAD to exclude dead cells, and with Annexin V, CD71 and Ter119 to 
assess apoptosis. Representative histograms are shown for S1 cells in EpoR-HM (top left 
panel) or Stat5-/- (bottom left panel) fetal liver: cells shown have preserved membrane 
impermeability to the DNA dye 7-AAD. Summary of Annexin-V+ cells in 3 independent 
experiments is shown in right panels; each data point corresponds to an individual 
embryo, black line represents the mean for all embryos of a given genotype. Number of 
embryos analyzed: EpoR-HM=15, strain and age matched controls= 20; Stat5-/-=5, 
littermate controls=5. No statistically significant difference was detected between EpoR-
HM and control embryos; the difference between Stat5-/- and control embryos is 
significant (p=0.0007, 2 tailed t test, unequal variance). 
(B)  Adult EpoR-HM mice fail to generate an erythropoietic stress response. Adult 
EpoR-HM mice or strain-matched wild-type mice were injected with Epo (100 U/ 25g 
mouse). Hematocrit measurements are shown in top left panel. Expression level of CD71 
(expressed as MFI) in CD71highTer119high splenocytes are summarized in the top right 
panel. Each data point represents an individual mouse. A representative example of flow-
cytometric CD71 measurement one day post-injection is shown in the contour plots in the 
lower panel. Numbers in lower panel are the CD71 MFI of cells in the indicated 
CD71highTer119high gate.  
(C)  Rescue of stress-induced CD71 upregulation in EpoR-HM fetal liver cells after 
rescue of high-intensity graded p-Stat5 signaling by transduction with high levels of 
FLAG-Stat5. EpoR-HM or wild-type fetal liver erythroblasts were transduced with either 
FLAG-Stat5 or FLAG-Stat5Y694, as described in Figure 2.9A. Cells were incubated 
overnight in the presence of stress-levels of Epo (0.2 U/ml; this is 6 to 10 fold the Epo 
basal levels), and were then labeled and analyzed for CD71, Ter119 and FLAG 
expression by flow-cytometry. CD71 (MFI) is compared in cells negative for FLAG 
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expression (FLAG gate 6 or lower, Figure 2.9B) with cells expressing high levels of 
FLAG (FLAG gate 10 or higher, Fig 2.9B), in the same electroporation sample. Data 
points are mean ± sem of 9 replicates; differences in CD71 expression between EpoR-
HM cells expressing high or low levels of FLAG-Stat5 are significant at p=0.020 (two- 
tailed t-test, unequal variance).
??
Figure 2.11 
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The low-intensity p-Stat5 signal shows hysteresis  
The binary nature of the low-intensity p-Stat5 signal, reflected in its steep Epo 
dose/p-Stat5 response relationship, may arise from either a monostable or a bistable 
system [149, 215]. A monostable binary system is analogous to a doorbell: its response 
reflects the current stimulus. It is described by a single, continuous stimulus/response 
curve, where a given stimulus always elicits a similar response regardless of stimulus 
history. By contrast, a bistable system is analogous to a toggle-switch. Its stimulus/ 
response curve is discontinuous, since the response is either ‘off’ or ‘on’, but 
intermediate states are unstable. The response of bistable systems is dependent on both 
the current stimulus and on stimulus history, namely, whether the system was previously 
‘on’ or ‘off’. This phenomenon, known as hysteresis, endows the system with memory 
[149, 215, 216]. Thus, a stimulus that is insufficient to generate a response in resting cells 
may nevertheless be sufficient for maintaining the ‘on’ response in cells that are already 
‘on’ as a result of a previous, stronger stimulus.  
To determine whether the p-Stat5 response in fetal liver cells was bistable or 
monostable we stimulated cells with Epo at either 0.2 U/ml, or a ten-fold lower 
concentration (0.02 U/ml) (Figure 2.12A). At 30 minutes, when p-Stat5 reached a relative 
steady state, cells that were initially stimulated at the higher Epo concentration (0.2 U/ml) 
were switched to a ten-fold lower concentration (0.02 U/ml). The consequent changes in 
p-Stat5 were followed for several hours, and compared with those of cells that were 
subject to either high (0.2 U/ml) or low (0.02 U/ml) Epo throughout. 
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In S3 (Figure 2.12 A upper panels), a ten-fold reduction in Epo did not alter total 
p-Stat5 for the first 90 minutes, compared with cells remaining in high Epo. By 6 hours 
after the switch to lower Epo, total p-Stat5, though lower than in cells remaining in high 
Epo, was higher than in cells confined to low Epo throughout. Therefore, S3 cells had 
‘memory’ for the initial 30-minute period of high Epo, 6 hours previously.  By contrast, 
the high-intensity signal in S1 declined rapidly after the switch to low Epo, with kinetics 
that were the reverse of the onset of response at t=0 (Figure 2.12A, lower panels).  By 15 
minutes, p-Stat5 in S1 declined to a low intensity, stable signal that resembled the 
intensity of the hysteretic signal in S3. Hysteresis was also observed in a second 
experimental strategy, where Epo was completely withdrawn from the culture medium 
(Figure 2.13A, B). We therefore concluded that the low-intensity, binary signal in S3 was 
generated by a bistable system.  
A steep relationship between FLAG-Stat5 expression and Epo-independent, 
constitutive p-Stat5 
A bistable response suggests the presence of a positive feedback interaction or its 
equivalent. Such an interaction is responsible for the steep stimulus/response curve, 
amplifying low but supra-threshold signals to their full ‘on’ state and making 
intermediate states unstable [149, 215]. The hysteresis in the p-Stat5 response of S3 cells 
indicated bistability, and therefore raised the possibility that a positive feedback 
interaction, or its equivalent, may be promoting p-Stat5 formation. There were two broad 
possibilities regarding such an interaction. First, p-Stat5 might itself participate in a 
positive feedback interaction that contributes to further Stat5 phosphorylation. 
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Alternatively, a positive feedback interaction may be present at any of the upstream steps 
that are required for, and precede, the Stat5 phosphorylation step. These included the 
binding of Epo to EpoR, Jak2 activation and/or EpoR phosphorylation. Several lines of 
evidence discussed below, while not discounting other steps as possible contributors to 
the bistable p-Stat5 response, nevertheless suggest that p-Stat5 itself is responsible for a 
positive feedback interaction that contributes to bistable Stat5 activation.  
The first line of evidence comes from analysis of Epo-independent p-Stat5 
activation in cells expressing high FLAG-Stat5 (constitutive p-Stat5; Figures 2.9A upper 
left panel, 2.12B upper panel, double-headed arrows). We also found constitutively active 
p-Stat5 in non-erythroid cells that express high Stat5 levels, including Stat5-null mouse 
embryonic fibroblasts (MEFs) infected with high-titer retrovirus encoding Stat5 (Figure 
2.13C).  To analyze this finding quantitatively, we measured total p-Stat5 in a series of 
vertical gates containing cells of increasing FLAG fluorescence, as illustrated in Figure 
2.9B.  This analysis showed that the appearance of p-Stat5 occurs reproducibly above an 
abrupt FLAG-Stat5 expression threshold (Figure 2.12B, lower panel). The level of p-
Stat5 then rises steeply with increasing FLAG-Stat5 expression, delineating a steep, non-
Michaelian sigmoidal curve with a Hill coefficient of 2.4. This high Hill coefficient 
suggests that inactive, FLAG-Stat5 participates in a cooperative or positive feedback 
interaction during its phosphorylation reaction. Since this reaction occurs in the absence 
of Epo stimulation, cooperativity or positive feedback must involve FLAG-Stat5 directly, 
rather than be due solely to upstream components of EpoR signaling.  
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We hypothesized that the FLAG-Stat5 threshold at which constitutive p-Stat5 first 
appears is determined by the balance between the background levels of kinase and 
phosphatase activities within resting (unstimulated) erythroblasts. This was supported by 
the response of unstimulated erythroblasts to treatment with pervanadate, a broad-
spectrum phosphatase inhibitor. We found a time-dependent decrease in the FLAG-Stat5 
threshold for constitutive p-Stat5, with the curves describing the dependence of p-Stat5 
on FLAG-Stat5 shifting to the left (Figure 2.13D).  
p-Stat5 promotes Stat5 phosphorylation in trans 
The second line of evidence suggesting that p-Stat5 promotes phosphorylation of 
as yet inactive Stat5 comes from biochemical experiments in which we asked whether 
two populations of Stat5 molecules, distinguished by a tag, might affect each other’s 
phosphorylation state. Specifically, we asked whether a population of activated, 
untagged, p-Stat5 molecules could alter the phosphorylation level of a second, FLAG- 
tagged population of Stat5 molecules. In the absence of an interaction between active and 
inactive Stat5, phosphorylation of the FLAG-tagged Stat5 molecules should be 
unaffected by the presence of the untagged p-Stat5. Figure 2.12C illustrates the expected 
result of such an experiment if, however, p-Stat5 promotes the phosphorylation of as yet 
unphosphorylated Stat5 in trans. In the latter case, the phosphorylation level of the 
FLAG-tagged Stat5 molecules might increase as a result of the presence of untagged, p-
Stat5 molecules in the same cell.  
We transfected 293T cells with FLAG-tagged Stat5, in the presence or absence of 
untagged Stat5 constructs that give rise to constitutive p-Stat5 in vivo. As untagged 
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constructs, we used either the constitutively phosphorylated Stat5 mutant, Stat5 1*6 
[217], or alternatively, the untagged wild-type Stat5, since we found it to be 
constitutively active when expressed at high levels (Figure 2.12B). We assessed the 
phosphorylation level of the FLAG-tagged Stat5 by specifically immunoprecipitating 
FLAG-tagged protein under denaturing conditions, followed by quantitative blotting 
using infra-red imaging, for p-Stat5 (Figure 2.12D, E). Control cells were transfected 
with FLAG-Stat5Y694F, in the presence or absence of Stat5 1*6. Similar levels of 
FLAG-tagged protein were immunoprecipitated from these cells as from cells expressing 
FLAG-Stat5, but immunoblotting showed no p-Stat5 signal (Figure 2.12D, E), 
confirming that Stat5 1*6 was not co-immunoprecipitated with the FLAG-tagged protein.  
In five independent immunopreciptation experiments, we found that the presence 
of untagged, phosphorylated Stat5 in cells caused a 2 to 4 fold increase (mean ± SE =2.7 
±0.4, p<0.020) in the phosphorylation level of FLAG-Stat5, compared with its baseline 
phosphorylation level when present in cells not containing the untagged constructs. 
FLAG-Stat5 expression in both groups of cells was similar (mean ± SE =1.2 ±0.1, Figure 
2.12D, E).  
These results suggest that p-Stat5 promotes the phosphorylation of as yet inactive, 
unphosphorylated Stat5. 
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Figure 2.12 Hysteresis and positive feedback in Stat5 activation. 
(A) Stat5 signaling in freshly isolated fetal liver S3 cells shows hysteresis. Fetal liver 
cells were stimulated with Epo at 0.2 U/ml (dark blue or red symbols) or at 0.02 U/ml 
(grey symbols). At 30 minutes post stimulation (marked with arrows), Epo concentration 
was diluted ten fold from 0.2 to to 0.02 U/ml for some of the cells (light blue or orange). 
The time course of the total p-Stat5 response is shown for S3 (upper panel) and S1 (lower 
panel) cells. Left panels show a magnified x-axis for the first 60 minutes. Representative 
of 3 similar experiments. See also Figure 2.13A, B. 
(B) Constitutive (Epo-independent) p-Stat5 in cells expressing high levels of FLAG-
Stat5. Cells were electroporated with FLAG-Stat5 or with control, non-phosphorylatable 
FLAG-Stat5Y694F, incubated overnight in Epo (0.2U/ml) and then deprived of Epo for 
three hours, as described in Fig 2.9A. Upper panels: p-Stat5 may be seen in cells with 
high FLAG-Stat5, indicated by the double arrow; no p-Stat5 is seen in cells expressing 
equivalent levels of FLAG-Y694F. Lower panel: analysis of 5 independent 
electroporations in 3 independent experiments similar to that shown in the upper panels. 
Each symbol corresponds to the FLAG and p-Stat5 MFIs of cells in one vertical gate in a 
p-Stat5 vs FLAG dot plot from one electroporation. The background p-Stat5 MFI for 
cells expressing FLAG-Stat5Y694F is also shown. Data was fitted with a Hill curve, 
nH=2.4. 
(C)  Design of an experiment to examine whether p-Stat5 promotes Stat5 
phosphorylation in trans. Cells were electroporated with FLAG-tagged Stat5 (top), or 
with a combination of both FLAG-tagged Stat5 and a non-tagged Stat5 construct that 
would give rise to constitutive p-Stat5 in vivo. The level of phosphorylation of the 
FLAG-tagged Stat5 in both these cell populations is examined using denaturing FLAG 
immunoprecipitation to dissociate Stat5 dimers, followed by quantitative western blotting 
for both p-Stat5 and FLAG. The illustrated outcome corresponds to the case when p-Stat5 
promotes Stat5 phosphorylation, so that an increased proportion of the FLAG-Stat5 
molecules is phosphorylated when the cells also contained non-tagged p-Stat5; the 
alternative outcome would have been that the FLAG-Stat5 phosphorylation is similar 
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whether or not cells also express non-tagged p-Stat5. The FLAG tag is represented by the 
green letter ‘F’; phosphorylation is indicated in red and by the letter ’P’.  
(D), (E) Constitutively-active non-tagged p-Stat5 facilitates phosphorylation of 
FLAG-Stat5 in trans. Experimental design as in panel ‘C’. 293T cells were transfected 
with either FLAG-Stat5 or with control, FLAG-Stat5Y694F. Some cells were also 
electroporated with a non-tagged Stat5 construct that would give rise to constitutive 
(Epo-independent) p-Stat5 in vivo: either non-tagged wild Stat5, or non-tagged Stat5 1*6. 
FLAG-tagged protein was immunoprecipitated 48 hours post transfection, under 
denaturing conditions, followed by quantitative blotting using infrared imaging for p-
Stat5 and for FLAG. Panel ‘D’ shows a representative western blot; the numbers below 
each lane correspond to the infra-red fluorescence reading from each band, corrected for 
background. Panel ‘E’ shows a summary of 5 independent experiments (only two 
experiments also had samples of cells with non-tagged wild type Stat5; all experiments 
had samples of cells expressing non-tagged Stat5 1*6). Data points in ‘E’ refer to 
fluorescence readings for each lane in individual experiments, normalized to the 
fluorescence reading in cells expressing FLAG-Stat5 only in the same experiment. Mean 
for all 5 experiments is shown (black line). Increase in p-Stat5 relative to FLAG-Stat5, in 
FLAG-Stat5 cells that also express non-tagged Stat5 1*6, was significant (mean ± sem: 
2.7 ±0.4, p<0.020, paired t test). There was no significant difference in FLAG-Stat5 
expression in both groups of cells (mean ± sem: 1.2 ±0.1).
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Figure 2.12 
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The time course of p-Stat5 activation is consistent with autocatalysis 
Our findings suggested that p-Stat5 is a product of a reaction it promotes. We 
therefore asked whether Stat5 phosphorylation obeys autocatalytic reaction kinetics. 
Autocatalytic reactions are characterized by an initial latent period or slow phase, 
accelerating into a rapid phase when the accumulating product feeds back to accelerate 
the reaction. The reaction may eventually slow down as the reactants become limiting, 
giving rise to a sigmoidal time course [218, 219].  
We examined a detailed time course of p-Stat5 formation in response to 
stimulation with a low Epo concentration, or alternatively, in response to pervanadate, a 
non-specific phosphatase inhibitor (Figure 2.13E, F). In both cases, the time course for p-
Stat5 formation was in good agreement with an autocatalytic time course. Phosphatase 
inhibition was performed on cells expressing FLAG-Stat5. This showed the lag phase 
that precedes the accelerated phase of p-Stat5 accumulation to be shorter in cells 
expressing higher FLAG-Stat5 (Figure 2.13E).   
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Figure 2.13: Hysteresis and positive feedback in Stat5 activation. 
(A), (B) Stat5 signaling in S3 cells shows hysteresis. Freshly isolated fetal liver 
cells were stimulated with Epo (0.2U/ml; dark blue or red symbols). At 30 minutes post 
stimulation, Epo was removed from some of the cells (light blue or orange) by washing 
them three times in non-Epo containing medium; the time of wash is indicated with 
arrows. The time course of the total p-Stat5 response to S3 (upper panels) and S1 (lower 
panels) is shown in panel ‘A’; a magnified x-axis is shown for the first 60 minutes in the 
left panel.  The number of p-Stat5+ cells, and the p-Stat5 MFI in p-Stat5+ cells over the 
same time period in the same experiment are shown in panel ‘B’. Dashed lines mark the 
pre-stimulation level of total p-Stat5. Representative of 3 similar experiments. 
(C) Constitutive p-Stat5 in non-erythroid cells expressing high levels of Stat5. Stat5-/- 
mouse embryonic fibroblasts (MEFs) were infected with retrovirus (MSCV) encoding 
wild-type Stat5 (upper panel), or alternatively were infected with retrovirus encoding 
FLAG-tagged Stat5 or FLAG-Stat5Y694F (lower panel); control cells were infected with 
MSCV only. The dilution of the retroviral supernatant for each construct are indicated 
above each lane. Western blotting for p-Stat5, FLAG or Stat5 protein is shown. 
(D) The FLAG-Stat5 threshold for constitutive p-Stat5 is sensitive to phosphatase 
inhibition. Fetal liver cells were electroporated with FLAG-Stat5 as described in Figure 
2.9A and incubated overnight in 0.2 U/ml Epo. Cells were then incubated in the absence 
of Epo for over 3 hours prior to the addition of pervanadate. p-Stat5 was measured at the 
indicated time points following pervanadate addition; control cells were incubated for 
similar time periods in the absence of pervanadate. Individual symbols correspond to the 
total p-Stat5 in individual vertical FLAG gates as illustrated in Figures 2.9B and 2.10A.  
Representative of 3 similar experiments.  
(E) The time course of p-Stat5 formation following phosphatase inhibition by 
pervanadate is consistent with autocatalysis. Data is from the experiment presented in 
panel ‘D’. Each curve corresponds to the time course of total p-Stat5 formation in a 
specific FLAG- gate (the FLAG MFI for each gate is indicated in the legend). An initial 
slow phase of p-Stat5 accumulation is followed by a faster phase, consistent with an 
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autocatalytic reaction. The slow phase is shorter in gates with higher FLAG-Stat5 levels. 
Each data point is the mean of duplicate samples.  
(F) The time course of p-Stat5 activation by Epo is consistent with autocatalysis. 
Fresh fetal liver cells were stimulated with a low concentration of Epo (0.02 U/ml). The 
time course of the total p-Stat5 response is shown for S1 and S3 cells; two independent 
experiments are shown, colored blue and red, respectively. Data was fitted by the curve 
corresponding to a second order autocatalysis [Equation (11) below].  
The second order autocatalysis reaction is defined as (1) [218]: 
 A +B
? ??? 2B  (10) 
Here, A= Stat5, and B=p-Stat5 
 
The concentration of the product B at time t, Bt, is given by:  
 
Bt =
A0 +B0
1+
A0
B0
e−k (A0 +B0 )t
  `(11) 
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Figure 2.13 
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The isolated Stat5 N-terminal domain (ND) amplifies the binary p-Stat5 signal 
  The ND is connected to the core of the Stat5 molecule by a flexible tether (Figure 
2.14A) and is not essential for phosphorylation of the Stat5 C-terminal tyrosine. It is 
thought to play a role in the formation of Stat5 tetramers [125, 220]. In addition, intra-
dimer ND dimerization was recently suggested to stabilize the anti-parallel, inactive Stat5 
dimer, dissociating upon Stat5 phosphorylation [80, 109].  
We examined the effect of exogenous expression of the isolated Stat5 ND on the 
dynamics of Stat5 phosphorylation. We electroporated fetal liver cells with a construct 
encoding the full-length FLAG-Stat5 molecule, either alone, or together with a construct 
encoding the isolated Myc-tagged ND (Figure 2.14A-D). Following overnight incubation 
to allow expression of the transduced contructs, we assessed the effect of the isolated ND 
on the phosphorylation of the co-expressed FLAG-Stat5 in response to Epo stimulation. 
To analyze the effect of Myc-ND on FLAG-Stat5 phosphorylation quantitatively, we 
used a two-dimensional gate matrix where the position of each rectangular gate is 
denoted by (x,y) coordinates  (Figure 2.14B). All gates with the same ‘x’ coordinate 
contain cells with similar FLAG fluorescence, and therefore, with similar FLAG-Stat5 
expression. Similarly, all gates with the same ‘y’ coordinate have similar Myc 
fluorescence and contain cells with similar Myc-ND expression. In samples that were 
electroporated with a FLAG-Stat5 but not with a Myc-ND construct, coordinates are 
indicated as (x,-). Control cells were electroporated with either empty vector (pcDNA3, 
response as shown in Fig 2.9A), FLAG-Stat5 alone or Myc-ND alone (Figure 2.14B).  
???
 As shown previously (Figures 2.9, 2.10) in the absence of the Myc-ND, an 
increase in FLAG-Stat5 expression, from gate (8,-) to gate (11,-), results in increased p-
Stat5 MFI (Fig 2.14C, compare green and blue histograms). The p-Stat5 signal intensity 
in FLAG-gate 11, however, increased further in cells that also expressed Myc-ND 
(Figure 2.14C, compare red and blue histograms). A similar amplification of the Epo 
response as a result of Myc-ND expression was found for other FLAG expression gates 
(Figure 2.15A). Similar amplification was also seen when non-tagged ND was expressed.  
 An inspection of the p-Stat5 histograms (Figures 2.14C, 2.15A) showed a 
qualitative difference in the pattern of p-Stat5 signal amplification by FLAG-Stat5 and by 
Myc-ND. An increase in FLAG-Stat5 expression from FLAG gate (8,-) to (11,-) 
increased both the fraction of p-Stat5+ cells within the population, as well as their range 
of p-Stat5 signal intensities, in agreement with our previous results, in which the level of 
FLAG-Stat5 expression determined maximal p-Stat5 signal intensity (Figures 2.9B, 
2.10A). However, addition of Myc-ND to cells resulted principally in an increased 
number of p-Stat5+ cells, without increasing maximal p-Stat5 (compare flow cytometric 
histograms for cells in gate (11,3) with cells in gate (11,-) and see overlay of blue and red 
histograms, Figure 2.14C; see also Figure 2.15A).  
 We therefore examined the effect of Myc-ND on the entire Epo dose/p-Stat5 
response curve (Figure 2.14D). As found previously (Figure 2.10A) S3 cells expressing 
very low levels of FLAG-Stat5, in gate (6,-), responded to Epo stimulation with a low-
intensity, steep (binary) p-Stat5 signal, characterized by a high Hill coefficient (nH=3). 
Cells expressing higher levels of FLAG-Stat5, in gate (10,-), responded in a graded 
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fashion to increasing Epo concentrations, evident from the low Hill coefficient (nH= 0.6), 
but the response reached high p-Stat5 signal intensities. By contrast, cells in gate (10,3), 
expressing the same high level of FLAG-Stat5, but that in addition also expressing Myc-
ND, responded with a steep (binary) high-intensity p-Stat5 signal, reflected in a high Hill 
coefficient (nH=4.8). 
 The precise change in p-Stat5 was dependent on the expression level of Myc-ND 
relative to FLAG-Stat5. For a given level of FLAG-Stat5, low levels of Myc-ND (gates 
with coordinates (x,3) or (x,4)) amplified the p-Stat5 response (Figure 2.15B, red 
histograms), whereas higher levels of Myc-ND (gates with coordinates (x,5) or (x,6)) 
resulted in lower amplification, and potentially in inhibition, of the p-Stat5 response 
(Figure 2.15B, blue histograms).  
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Figure 2.14 The Stat5 ND enhances bistable Stat5 activation. 
(A) Representation of the Stat5 structural domains and of tagged Stat5 constructs (not 
to scale). ND: N-terminal domain; CC: coiled-coil domain; DBD: DNA binding domain; 
SH2: SH2 domain; Y694: C-terminal tyrosine targeted in the activating phosphorylation 
reaction. Stat5Y694F is a non-phosphorylatable mutant. Stat5ΔND is missing the first 
129 N-terminal amino acids. Stat5, Stat5ΔND and Stat5Y694F are FLAG-tagged at the 
C-terminal end. The isolated ND was expressed with a C-terminal Myc tag.  
(B) Gating strategy for the analysis of fetal liver cells transduced with both FLAG-
Stat5 and Myc-ND constructs. Fluorescence measurements were made simultaneously for 
FLAG, Myc, p-Stat5, CD71 and Ter119 expression. FLAG and Myc fluorescence are 
shown for S3 cells transduced with either Myc-ND only, FLAG-Stat5 only, or both 
constructs (left, middle and right histograms respectively). To analyze the effects of Myc-
ND and FLAG-Stat5 expression on the p-Stat5 response, we sub-divided the Myc vs. 
FLAG dot plots using a two-dimensional gate matrix. Each rectangular gate has 
coordinates (x, y). The ‘x’ coordinate denotes the horizontal position of the gate, which 
increases with increasing FLAG expression. Gates with the same ‘x’ coordinates contain 
cells with similar levels of FLAG expression. The ‘y’ coordinate denotes the vertical 
position of the gate and increases with increasing Myc expression; all gates with the same 
‘y’ coordinate contain cells with similar ‘Myc’ expression.  
(C) Effect of the isolated Stat5 ND on the p-Stat5 response to Epo. Fetal liver cells 
were transduced with FLAG-Stat5 only, or with both FLAG-Stat5 and Myc-ND, as in 
panel ‘B’.  After overnight incubation, cells were stimulated with Epo (2 U/ml) for 30 
minutes. The p-Stat5 response is shown for cells in three FLAG and Myc expression 
gates (see panel ‘B’): cells transduced with FLAG-Stat5 only, expressing low levels of 
FLAG-Stat5, in gate (8,-) (green histogram); cells transduced with FLAG-Stat5 only, 
expressing high levels of FLAG-Stat5, in gate (11,-) (blue histogram); and cells 
transduced with both constructs, expressing the same high levels of FLAG-Stat5, but in 
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the presence Myc-ND, in gate (11,4) (red histogram). Black histograms show the pre-
stimulation p-Stat5 signal for each corresponding gate. 
(D) Low levels of the isolated Myc-ND increase the steepness of the p-Stat5 response 
to Epo. Cells were transduced with FLAG-Stat5 alone or with both FLAG-Stat5 and 
Myc-ND. Following overnight incubation, cells were stimulated with a range of Epo 
concentrations, as described in Figures 2.9A, B and 2.10. The ‘total p-Stat5 vs. Epo 
concentration’ plot is shown for the indicated expression gates (see panel ‘B’): cells 
transduced with FLAG-Stat5 only, expressing low levels of FLAG-Stat5, in gate (6,-) 
(green); cells transduced with FLAG-Stat5 only, expressing higher levels of FLAG-Stat5, 
in gate (10,-) (blue); and cells transduced with both constructs, expressing the same high 
levels of FLAG-Stat5, but in the presence Myc-ND, in gate (10, 3) (red). An overlay of 
all three responses is shown. Data points are MFI ± sem of the p-Stat5 response for all 
cells within a gate. Data is fitted with Hill curves.  
(E) Low levels of the isolated Myc-ND increase the p-Stat5 response of fetal liver S3 
cells electroporated with FLAG-Stat5ΔND. Fetal liver cells were electroporated with 
FLAG-Stat5ΔND in the presence or absence of Myc-ND; responses of cells transduced 
with control FLAG-Stat5 in the same experiment are also shown.  Responses are shown 
for gates with FLAG coordinate 9, and where applicable, Myc coordinate 3. 
Representative of 2 experiments.  
(F) Epo dose/p-Stat5 response curves for fetal liver cells expressing FLAG-Stat5ΔND 
in the presence or absence of Myc-ND; responses of cells transduced with control FLAG-
Stat5. Response of FLAG-Stat5 constructs in the presence of absence of Myc-ND 
correspond to expression gates (11,3) or (11-), respectively. Hill coefficients are 
indicated. Data are MFI ± sem. Representative of two experiments.  
(G) Co-immunoprecipitation of the Myc-ND with wild-type Stat5. 293T cells were 
electroporated with either vector alone (pcDNA3, lane 1), FLAG-Stat5 (lane 2), Myc-ND 
(lane 3), or with both FLAG-Stat5 and Myc-ND (lane 4). Whole cell lysate was 
immunoprecipitated with FLAG-specific antibody and western blotting of the same 
membrane was carried out with either an anti-FLAG antibody (upper gel) or with an anti-
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Myc antibody (lower gel). The position of Stat5, the isolated ND, and IgG heavy and 
light chains (HC and LC respectively) is shown.  
(H) Pictorial representation of the current model (top left panel) and the proposed 
positive feedback model (top right panel) for the Stat5 phosphorylation/ 
dephosphorylation cycle. The Stat5 domains correspond to the key in panel ‘A’. 
Hypothetical intermediates are based on [110]. The positive feedback model is based on a 
second-order autocatalytic reaction. See ‘Discussion’ section, ‘Hypothesis: an 
autocatalytic conformational switch’ for details. 
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Figure 2.14  
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The isolated Stat5 ND enhances hysteresis and constitutive p-Stat5 activation  
The finding that the isolated Stat5 ND amplified the p-Stat5 response and 
generated a steep dose/response curve suggested that p-Stat5-mediated positive feedback 
is mediated via the Stat5 ND. We hypothesized above that the hysteresis in p-Stat5 
signaling (Figures 2.12A, 2.13A,B), as well as the Epo-independent (constitutive) p-Stat5 
in cells expressing high levels of FLAG-Stat5 (Figure 2.12B), are both outcomes of the p-
Stat5-mediated positive feedback. We therefore examined the effects of the isolated Stat5 
ND on these phenomena. We found that constitutive p-Stat5 was enhanced in cells that, 
in addition to expressing high FLAG-Stat5, also expressed Myc-ND (Figure 2.15C). 
Further, co-expression of Myc-ND with FLAG-Stat5 enhanced the hysteresis of the p-
Stat5 response to Epo (Figure 2.15D). At a given level of FLAG-Stat5 expression, 
following a ten-fold Epo dilution, cells expressing Myc-ND had a p-Stat5 response 
similar to that of cells lacking Myc-ND, from which Epo was not removed (Figure 
2.15D; compare orange and black curves and histograms, respectively). 
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Figure 2.15 The isolated Stat5 ND enhances hysteresis and constitutive Stat5 
activation. 
(A) The isolated Stat5 ND enhances the p-Stat5 response to Epo. Experiment as 
described in Figure 2.14B, C. The p-Stat5 response of cells expressing FLAG-Stat5 only 
is shown in blue, and of cells expressing both FLAG-Stat5 and Myc-ND is shown in red; 
each histogram corresponds to cells in the indicated gate; histograms on the same 
horizontal row have the same level of FLAG-Stat5 expression. Black histogram show the 
p-Stat5 signal pre-stimulation for the corresponding gate. The percentages indicate the 
number of p-Stat5+ cells.  
(B) Effect of different levels of Myc-ND expression on the p-Stat5 response to Epo. 
Experiment as described in Figure 2.14B. Cells expressing FLAG-Stat5 at two different 
levels, corresponding to gate 9 (left histograms) and gate 11 (right histograms) are shown 
as examples. Response in the absence of Myc-ND is shown in black; response in cells 
that also express, in addition to FLAG-Stat5, low levels of Myc-ND (Myc-ND gate 3), is 
shown in red; response in cells that express high levels of Myc-ND (Myc-ND gate 6) is 
shown in blue. The coordinates for each gate are indicated; percentages correspond to the 
number of p-Stat5+ cells; MFI values are for total p-Stat5 (for all cells in the gate). 
(C) Effect of Myc-ND expression on constitutive p-Stat5, in cells expressing FLAG-
Stat5. Fetal liver cells were electroporated with either FLAG-Stat5 alone or with both 
FLAG-Stat5 and Myc-ND, as described in Figure 2.14B. After overnight incubation, 
cells were deprived of Epo for 3 hours. Cells expressing high levels of FLAG-Stat5 
contain p-Stat5 in the absence of Epo stimulation, as shown in Figure 2.12B. Data was 
analyzed as in Figure 2.12B; cells in FLAG-gates 12 and 13 contain p-Stat5, which 
reaches higher levels if the cells also express Myc-ND. Data is mean ± sem for cells in 
each gate; the flow-cytometry histograms for gates 12 and 13 is shown on the right.  
(D) Effect of Myc-ND expression on the hysteresis of the p-Stat5 response to Epo. 
Fetal liver cells expressing either FLAG-Stat5 alone, or both FLAG-Stat5 and Myc-ND, 
were prepared as described in Figure 2.12B. Cells were stimulated with 2 U/ml Epo. At 
30 minutes, Epo concentration in the medium of some cells was diluted ten-fold to 0.2 
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U/ml. The p-Stat5 response was followed for an additional 2 hours. At t= 90 min (60 min 
after Epo dilution), cells in the diluted Epo medium expressing both FLAG-Stat5 and 
Myc-ND (orange curve and histograms) had p-Stat5 levels equivalent to cells in the non-
diluted medium that expressed FLAG-Stat5 alone (black curve and histogram). Thus, the 
expression of the Myc-ND was sufficient to compensate for a ten-fold dilution in Epo, 
over extended periods of time. Time course is shown for cells in FLAG gates 13 (data 
points are mean ± sem for cells in each gate), histograms are shown for t= 90 minutes for 
cells in FLAG gates 12 and 13. 
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Figure 2.15  
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Phosphorylation of an ND-truncated Stat5 molecule is amplified by co-expression of 
the isolated ND 
We investigated the properties of a Stat5 mutant in which the ND is absent, 
Stat5ΔND, and the effect of exogenous ND on this mutant. As previously reported [125], 
the Stat5ΔND has a higher level of constitutive activity than wild-type Stat5 (Figure 
2.16A, upper panels). In addition we found that at equivalent FLAG expression levels, 
the Stat5ΔND p-Stat5 response to Epo was higher than that of wild-type Stat5 (Figures 
2.14E, compare green and blue histograms; 2.16A, lower panels). Co-expression of 
relatively low levels of Myc-ND with the FLAG-Stat5ΔND resulted in further 
amplification of the p-Stat5 signal, beyond the already higher signal generated by this 
mutant (Figure 2.14E, compare blue and red histograms). Co-expression of the Myc-ND 
also rendered the Epo dose/p-Stat5 response relationship of FLAG-Stat5ΔND steeper, as 
reflected by a higher Hill coefficient (Figure 2.14F, compare red and blue Hill curves). In 
contrast to the effect of low Myc-ND expression, high expression of the Myc-ND either 
failed to amplify, or had a suppressive effect on the p-Stat5 signal (Figure 2.16B, black 
Hill curve). Taken together, these findings are similar to the effects exerted by the 
isolated ND on wild-type Stat5, suggesting that amplification of the p-Stat5 signal by the 
isolated ND, and the steeper dose/response curve it generates, do not require an 
interaction between the isolated ND and the Stat5 ND domain.  
The isolated Myc-ND co-immunoprecipitates with full-length FLAG-Stat5 
 We examined whether the isolated Myc-ND interacts with the full-length 
unphosphorylated Stat5 dimers. We transfected 293T cells with either FLAG-Stat5 or 
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with Myc-ND, or co-transfected the cells with both constructs. Whole cell lysates were 
subjected to immunoprecipitation with a FLAG-specific antibody, and 
immunoprecipitates were examined by western blotting (Figure 2.14G). The same 
membrane was first blotted for the Myc epitope, and then stripped and blotted for the 
FLAG epitope. In cells co-transfected with both Myc-ND and FLAG-Stat5, the FLAG 
antibody immunoprecipitated both FLAG and Myc epitopes, indicating an interaction 
between Myc-ND and FLAG-Stat5. No Myc-ND was seen in immunoblots of cells 
transfected with either construct alone.   
ND dimerization surface mutations are deficient in p-Stat5 amplification but retain 
p-Stat5 suppressive effect 
Mutations of L78 in STAT4, or the homologous F77 and/or L78 in STAT1, 
disrupt the homodimerization of their respective ND domains [106, 111]. An alignment 
of STAT1, STAT4 and STAT5a suggests that these residues are conserved in the 
STAT5a ND (Figure 2.16C). We mutated the equivalent residues in the STAT5 ND 
domain, to generate several isolated ND domain mutants, with mutations NDL82S or 
NDF81A/L82A. We also generated a full length Stat5 molecule bearing the F81A/L82A 
mutations, and found that it was similar in its behavior to the Stat5ΔND mutant, showing 
increased constitutive activity and an amplified response to Epo.  
Co-expression of the mutant Myc-ND molecules with FLAG-Stat5 suggested that 
they were deficient in amplifying the p-Stat5 response when expressed at lower levels, 
though they were still able to suppress the p-Stat5 response when expressed at high levels 
(Figure 2.16D, E). Thus, expression of the Myc-NDL82S failed to amplify the p-Stat5 
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response of FLAG-Stat5 (Figure 2.16D, compare blue and green histograms), while 
within the same FLAG/Myc expression gates, the wild-type Myc-ND generated 
substantial amplification (Figure 2.16D, compare blue and red histograms; equivalent 
levels of Myc-ND and Myc-NDL82S are expressed within the (10,4) gates, see Figure 
2.16D lower panels). Similar results were obtained with the Myc-NDF81A/L82A mutant 
(Figure 2.16E, F), which failed to amplify the p-Stat5 signal. Of note, high expression 
levels of the mutant Myc-NDF81A/L82A, like high expression of Myc-ND, suppressed 
the p-Stat5 response (Figures 2.16E, 2.15B). Therefore, mutations at the F81/L82 
residues of the ND uncouple its amplifying activity, exerted at low expression levels, 
from its suppressive activity, exerted at high expression levels. 
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Figure 2.16  Mutations of the Stat5 ND domain. 
(A) Constitutive activity (upper panels) and Epo responsiveness (lower panels) of a 
Stat5 molecule missing its N-terminal 129 amino acids, ‘Stat5ΔND’. Wild-type fetal liver 
cells were electroporated with FLAG-tagged Stat5ΔND, or control FLAG-Stat5 or 
FLAG-Stat5Y694F, and examined 18 hours later. The response of S3 cells is shown. 
Representative of 3 experiments 
(B) Epo dose/p-Stat5 response of fetal liver S3 cells electroporated with FLAG-
Stat5ΔND in the presence or absence of Myc-ND; responses of cells transduced with 
control FLAG-Stat5 in the same experiment are also shown.  Responses are shown for 
gates with FLAG coordinate 9, and where applicable, Myc coordinates 3 (low 
expression) or 5 (high expression). Data points are MFI ± SEM. Representative of 2 
experiments.  
(C) Alignment of the N-terminal portion of the STAT1, STAT4 and STAT5a NDs. 
The red rectangle marks conserved F81 and L82 residues, previously shown to be in the 
dimerization interface of the STAT1 and STAT4 NDs [106, 108]. 
(D) Fetal liver cells were electroporated with FLAG-Stat5 in the absence (blue 
histogram) or presence of either Myc-ND (red histogram) or its mutant, Myc-NDL82S 
(green histogram). p-Stat5 response histograms are shown for expression gates with 
(10,4) coordinates (upper panels). Myc expression for Myc-ND and Myc-NDL82S in 
gates (10,4) is very similar (lower panels).  
(E), (F) Fetal liver cells were electroporated with FLAG-Stat5 in the absence (blue 
histogram and curve) or presence of either Myc-ND (red histogram and curve) or its 
mutant, Myc-NDF81A/L82A (green histogram and curve). p-Stat5 response histograms 
are shown in ‘F’ for expression gates with (12,5) coordinates. The entire Epo dose/p-
Stat5 response curve for the same gates is shown in ‘E’. Hill coefficients are 1.44 for 
FLAG-Stat5, 2.2 for FLAG-Stat5 + Myc-ND, and 3.2 for FLAG-Stat5 + Myc-
NDF81A/L82A. Data points are MFI ± SEM. 
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Figure 2.16 
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Discussion 
Stat5 signaling in erythroblasts combines a low-intensity bistable signal with a 
high intensity graded response. Together, these allow fidelity in signal transduction in the 
low-basal Epo range, with the ability to generate a graded response over the wide range 
of stress Epo concentrations. High intensity, graded Stat5 signaling in early erythroblasts 
gradually transitions to a low intensity binary response in mature erythroblasts. This shift 
in signaling mode is caused by the gradual loss in Stat5 expression with erythroblast 
maturation. By restoring high Stat5 expression to mature S3 erythroblasts, we were able 
to reverse this shift and endow them with a high intensity graded p-Stat5 response.  
Using Stat5-/- and EpoR-HM mice, we show that the binary and graded p-Stat5 
signaling modes are required in basal and stress erythropoiesis, respectively.   
Further, we investigate the mechanism of bistability in Stat5 activation and show 
that it is caused by an autocatalytic positive feedback exerted by active p-Stat5 on 
inactive Stat5, that promotes Stat5 phosphorylation. Strikingly, the isolated Stat5 ND 
dramatically enhances the bistability, converting a graded, high intensity signal into a 
high-intensity bistable response. These data, together with biochemical and kinetic data, 
lead us to propose a model in which the ND of active p-Stat5 molecules promotes the 
Stat5 phosphorylation reaction.  
Co-existing graded and binary Stat5 signaling allows for fidelity in signaling over a 
wide Epo range 
Theoretical analysis and synthetic models have shown that a given signaling 
network may generate either binary (digital) or graded (analog) responses, depending on 
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the value of key parameters [149, 221, 222]. Recent reports suggest that both modes may 
coexist in cells [205, 223]. Thus, Ras signaling in lymphocytes is of a low-intensity, 
analog form, but can assume a high intensity, digital form when a SOS positive feedback 
loop is activated. Hence, distinct ways of juxtaposing binary and graded signaling modes 
have evolved that increase the information content of transduced signals. 
 A key feature of the erythropoietic system is its wide dynamic range. The precise 
erythropoietic rate generated by erythroid progenitors is dependent on Epo concentration, 
which varies from basal to stress erythropoiesis through three orders of magnitude. Our 
aim at the outset was to understand how Stat5 signaling reflects this vast Epo range. A 
graded signal transduction system would have made it possible for downstream responses 
to be augmented incrementally throughout the Epo range. However, a drawback of the 
graded mode of signaling is that, at low Epo concentrations, such as those that sustain 
basal erythropoiesis (<0.05 U/ml), the ratio of signal to noise would be low, reducing 
signaling fidelity. By contrast, a binary signaling mode, while generating a decisive 
signal, would not be able to respond to incremental changes in Epo concentration during 
increasing levels of stress.  
 Here we found that Stat5 signaling bridges this conundrum by combining bistable 
activation in response to low Epo in the basal range, with the capacity for a further, 
graded increase in Stat5 signal intensity in response to stress levels of Epo. The bistable 
activation of Stat5 results in a decisive signaling threshold, transducing with fidelity the 
low Epo concentrations that support basal erythropoiesis. In response to high Epo, the p-
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Stat5 signal can be increased further, in a graded incremental manner that reflects the 
level of stress.  
By comparing mouse genetic models that either completely lack Stat5 function 
(the Stat5-/- mouse), or that specifically lack the graded, high intensity signal (the EpoR-
HM mouse), we found that the binary, low-intensity signal is both necessary and 
sufficient for erythroblast survival and for maintenance of basal erythropoiesis (Figure 
2.11A). By contrast, the high intensity graded p-Stat5 signal is required for the response 
to erythropoietic stress, as seen from the inability of EpoR-HM mice to respond to stress. 
Further, exogenous Stat5 expression in EpoR-HM erythroblasts, which rescued their 
ability to signal via the graded high-intensity mode, also rescued high CD71 expression, a 
Stat5-dependent response specific to stress (Figure 2.11C).  
The binary form of the p-Stat5 signal in S3 erythroblasts is a result of bistable 
Stat5 activation in cells where Stat5 expression is low. In earlier S1 erythroblasts, 
however, the presence of higher levels of Stat5 permits high Epo concentrations to 
generate a higher-intensity graded signal beyond that generated through bistable 
activation. Several lines of evidence suggest that the high intensity response in S1 may 
mask an initial, low-intensity bistable activation of Stat5: 1) In EpoR-HM S1 cells, 
lacking high intensity Stat5 signaling, the residual signaling mode is binary. 2) There is a 
persistent, or hysteretic, low-intensity p-Stat5 signal in S1 cells following Epo wash or 
dilution, similar in intensity to that found in S3 cells (Figure 2.13B). 3) We found similar 
autocatalytic reaction kinetics in both S1 and S3 cells in response to Epo stimulation 
(Figure 2.13F).  
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It is unclear what confines bistable activation to a low-intensity response. Why is 
it that, in cells such as S1, which are capable of a high intensity response, autocatalysis 
does not continue until the maximal p-Stat5 response is obtained? We were able to 
artificially provoke such a binary, high intensity response in cells expressing high FLAG-
Stat5 by also co-expressing low-levels of the isolated Stat5 ND (Figure 2.14D).  
Whatever the mechanism that prevents such a high-intensity binary response under 
physiological conditions, it is clearly essential for the unique way in which bistable 
activation co-exists with graded p-Stat5 signaling in erythroblasts.  
Mechanism of bistability: p-Stat5-mediated positive feedback exerted at the Stat5 
phosphorylation step 
 We found a steep p-Stat5 response to Epo stimulation, with Hill coefficients in the 
range of 2 to 4, in fresh EpoR-HM erythroblasts (Figure 2.3D, E), and in electroporated 
wild-type S3 expressing low-levels of FLAG-Stat5 (Figures 2.14D, 2.10A). The potential 
mechanisms of such a binary response fall into two broad categories, monostable, or 
bistable. We found that the p-Stat5 response in S3 cells showed hysteresis, persisting well 
beyond either removal or dilution of the Epo stimulus (Figures 2.12A, 2.13A, B). This 
therefore indicated that the binary response resulted from bistable Stat5 activation.  
A key requirement for bistability is the presence of a positive loop, containing a 
positive feedback interaction and/or an even number of negative feedback links [149, 
224]. Such a loop ensures that the system ‘flips’ between two states without resting in 
intermediate states. In principle, any step in the Epo-mediated signaling pathway 
upstream of Stat5 phosphorylation, including Epo binding to its receptor and Jak2 
???
activation, may be the site of such a positive loop. Below we list evidence suggesting that 
inactive Stat5 is the target of positive feedback exerted by p-Stat5, and that this positive 
feedback is primarily responsible for bistable Stat5 activation:  
(a) A steep dependence of constitutive p-Stat5 on FLAG-Stat5 expression 
(nH=2.4). In the absence of Epo stimulation, S3 erythroblasts expressing high levels of 
FLAG-Stat5 contain Epo-independent (constitutive) p-Stat5 (Figure 2.12B). There is a 
steep dependence of constitutive p-Stat5 on FLAG-Stat5 expression, with a Hill 
coefficient of 2.4. Therefore, inactive Stat5 is a reactant in a phosphorylation reaction that 
involves either cooperativity or a positive loop. Since this reaction takes place in the 
absence of Epo stimulation, cooperativity or positive feedback must involve Stat5 
directly, and cannot be accounted for by upstream components of EpoR signaling.  
(b)  p-Stat5 promotes phosphorylation of inactive Stat5 in trans. We expressed 
two distinct populations of Stat5, distinguished by the presence or absence of a FLAG-
tag, in the same cells. We found that the presence of a population of untagged p-Stat5 
molecules in the cell caused an increase in the level of phosphorylation of the second, 
tagged population (Figure 2.12D, E). Therefore, p-Stat5 promotes in trans the 
phosphorylation of as yet inactive Stat5 molecules. In principle, p-Stat5 may promote 
Stat5 phosphorylation by either accelerating the forward, phosphorylation reaction, or 
alternatively, by retarding the reverse, dephosphorylation reaction.  
(c) The time course of p-Stat5 accumulation obeys autocatalytic reaction 
kinetics. Evidence in (a) above suggests that inactive Stat5 is the target of cooperativity 
or positive feedback, whereas evidence in (b) suggests that it is p-Stat5 that exerts 
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positive feedback on this phosphorylation reaction; taken together, these findings suggest 
that the Stat5 phosphorylation reaction is accelerated by its own product, p-Stat5. 
Therefore, Stat5 phosphorylation is an autocatalytic reaction. Autocatalysis is a type of 
positive feedback in which the product accelerates (or catalyzes) the reaction in which it 
is formed.   Second order autocatalytic reactions are defined as 
   A +B
? ??? 2B  (12) 
where substrate A is converted to the product B [218]. As a result of B’s interaction with 
A, the rate of reaction (12) is faster than the rate of the non-autocatalytic, first order 
reaction: 
  A
? ???? B  (13) 
The observations noted in (a) and (b) therefore suggest that the Stat5 phosphorylation 
reaction may be represented as an autocatalytic reaction similar to reaction (12): 
  (Stat5)+ (pStat5)
? ??? 2(pStat5)  (14) 
Support for this comes from the reaction kinetics of Stat5 activation. The time course of 
an autocatalytic reaction is characterized by an initial latent period or slow phase, 
accelerating into a rapid phase when the accumulating product feeds back to accelerate 
the reaction. We observed this pattern for the time course of p-Stat5 accumulation in 
response to phosphatase inhibition, as well as in response to Epo stimulation (Fig 2.13E, 
F).  
As noted above, the finding that p-Stat5 promotes phosphorylation of Stat5 in 
trans does not, by itself, allow us to determine whether it does so by accelerating the 
forward, phosphorylation reaction, or by inhibiting the reverse, dephosphorylation 
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reaction. However, the finding that p-Stat5 accumulation accelerates with time in a 
manner consistent with autocatalysis, even in the presence of phosphatase inhibition by 
pervanandate (Figure 2.13E), makes it less likely that p-Stat5 accelerates its own 
accumulation through phosphatase inhibition. We noted that the length of the slow phase 
for p-Stat5 accumulation in response to pervanadate is dependent on the concentration of 
inactive Stat5, being shorter in cells expressing higher FLAG-Stat5 (Figure 2.13E). This 
further supports our earlier conclusion (see (a) above) that inactive Stat5 participates 
directly in the positive feedback interaction.   
(d) The isolated Stat5 ND enhances bistability. In the physiological setting, the 
low-intensity p-Stat5 signal was bistable, whereas the high intensity signal was graded. 
The graded property of the high intensity signal was radically modified by the expression 
of the isolated Stat5 ND, which converted it into a high-intensity binary response (Figure 
2.14D). The isolated ND therefore uncouples the otherwise clear link between high 
intensity p-Stat5 signaling, and reduced steepness of the Epo dose/p-Stat5 response curve 
(Figures 2.3, 2.7, 2.9, 2.10). The ability of the isolated ND to break this link and generate 
a high intensity binary signal suggests that it is the ND that mediates the interaction 
responsible for the binary nature of the p-Stat5 response. In addition to increasing the Hill 
coefficient of the p-Stat5 response to Epo, the isolated ND increased constitutive p-Stat5 
for a given FLAG-Stat5 expression level (Figure 2.15C) and enhanced the hysteretic p-
Stat5 signal following Epo wash or dilution (Figure 2.15D). These findings support the 
hypothesis that the Stat5 ND is responsible for mediating the positive loop that gives rise 
to bistable Stat5 activation. They add to the kinetic and biochemical evidence in (a)-(c) 
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above, suggesting that autocatalytic p-Stat5 phosphorylation is a principal mediator of 
bistable Stat5 activation. 
Hypothesis: an autocatalytic conformational switch  
 We hypothesize that the ND may, in some way, either increase the likelihood of 
phosphorylation by the kinase, or alternatively, decrease the likelihood of the 
phosphatase reaction. The ND is connected to the core STAT molecule via a long flexible 
tether that is thought to provide it with mobility and therefore with the ability to interact 
with various domains within the STAT dimer [110]. In the inactive dimer conformation, 
reciprocal NDs are dimerized in an interaction that is thought to stabilize the inactive 
anti-parallel dimer [106]. Our finding that the FLAG-Stat5ΔND has an amplified 
response to Epo stimulation is consistent with decreased stability of the inactive, anti-
parallel dimer, as a result of the absence of the ND domains. Structural data and FRET 
experiments show that STAT activation results in separation of the two NDs [109]. 
Therefore, the Stat5 ND, which mediates an intra-dimer interaction within inactive 
dimers, becomes available for other interactions once Stat5 is phosphorylated. Consistent 
with this, the ND is required for the formation of tetramers of active STATs, through 
inter-dimer interactions [125, 220, 225]. The ND-mediated positive feedback may 
therefore be mediated by the newly–available NDs of p-Stat5, through inter-dimer 
interactions. Consistent with this, we coimmunoprecipitated inactive Stat5 with the 
isolated ND domain  (Figure 2.14G). 
In recent years, a new role had emerged for the ND, as an essential component in 
the radical reorientation between the parallel and anti-parallel conformations that STAT 
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molecules undergo during the phosphorylation/dephosphorylation cycle. Thus, ND-
truncated STAT1, STAT4, or STAT5 are deficient in this cycle, with STAT dimers either 
persisting in the phosphorylated, parallel conformation, in the case of STAT1 and STAT5 
[109, 110], or unable to form the parallel dimer conformation, in the case of STAT4 
[106]. Of interest here, the isolated STAT1 ND could complement the persistently 
phosphorylated, ND-truncated Stat1, allowing its dephosphorylation. This and other data 
suggested that the ND is required for facilitating the reorientation of parallel Stat1 dimers 
into the anti-parallel conformation [110]. The assumption had been that the STAT1 ND 
exerts this function ‘in cis’, from within the dimer undergoing reorientation.  
The role of the ND in dimer reorientation, together with the availability of the p-
Stat5 ND for inter-dimer interactions, suggests a mechanism for the positive feedback 
mediated by p-Stat5 in Stat5 phosphorylation. We propose that the reorientation of 
inactive Stat5 from the anti-parallel to the parallel conformation is relatively inefficient or 
energetically unfavorable, and may require a chaperone. The NDs of parallel, active 
dimers may chaperone this conformational switch, promoting the formation of parallel 
dimers (Figure 2.14H). The resulting parallel dimers have a higher likelihood of 
becoming phosphorylated, either because they may be better kinase substrates, or else 
they may be poorer phosphatase substrates; the latter is likely due to the masking of the 
phosphotyrosine within the SH2 domain.  
The resulting reaction, in which parallel dimers catalyze the conversion of anti-
parallel dimers to the parallel conformation, would result in self-replication of the parallel 
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structure, giving rise to a prion-like, autocatalytic process [226] that would form the basis 
for bistability and binary signaling.   
Site of interaction of the ND with Stat5 
 Co-expression of FLAG-Stat5ΔND with low-levels of the isolated Myc-ND 
resulted in a high-intensity binary p-Stat5 response, similar to that obtained when Myc-
ND was co-expressed with wild-type Stat5 (Figure 2.14D, F). Similarly, expression of the 
FLAG-Stat5ΔND with high levels of the Myc-ND promoted dephosphorylation (Figure 
2.16B) in the way it promoted the dephosphorylation of wild-type Stat5 (Figure 2.15B). 
The latter findings are similar to those reported for Stat1, where the isolated ND 
promoted the dephosphorylation of the ND-truncated Stat1 [110]. Together, these 
findings suggest that the inter-dimer ND-mediated interaction does not occur via an inter-
dimer ND dimerization. The ND therefore interacts in trans with a non-ND, core domain 
of the STAT molecule.  
We found that NDs bearing mutations at F81 or L82, two residues in the ND 
dimerization interface, were deficient in amplification of the p-Stat5 response (Figure 
2.16D-F). Given that ND dimerization does not play a part in the inter-dimer interaction, 
these findings raise the possibility that that the dimerization interface may, in addition to 
ND dimerization, also interact with the Stat5 core domain. An alternative possibility is 
that the ND domains of active Stat5 dimers may need to be in a homodimeric form in 
order to mediate inter-dimer interactions.  
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Implications for STAT’s role in disease 
Our work raises the possibility that activation of other STATs may also be 
bistable, since all STAT family members share highly conserved structural motifs. 
Further, many STATs are believed to undergo a similar conformational reorientation 
during their activation/deactivation cycle.  
STAT proteins are implicated in a variety of disease processes, and in particular, 
Stat3 and Stat5 have causal roles in cell transformation. The finding that Stat5 activation 
is bistable is relevant to leukemogenesis, where constitutively active Stat5 is an essential 
component of cell transformation downstream of many oncoproteins. Therefore, an 
understanding of the mechanisms that contribute to bistable activation would aid in 
designing novel therapeutic approaches.  
Materials and Methods 
Mouse models  
BALB/c ByJ and C57BL/6J and C57BL/6J-Ptpn6me-v/J strains were purchased from the 
Jackson Laboratory (Maine). Stat5-null were supplied by Dr. Lothar Hennighausen, 
NIDDK, Bethesda, MD, and EpoR-H and EpoR-HM by Dr Jim Ihle, St. Jude Children’s 
Research hospital, Memphis, TN. Mice were matched for the same background strain and 
embryonic age in all experiments.  
Erythropoietin injections in adult mice 
Adult mice were injected with a single dose of Epo (3-10 IU/gram sub-cutaneously). 
Mice were sacrificed at different time points, as described in the animal protocol, and the 
erythropoietic tissues, spleen and bone marrow, were collected in phosphowash, as 
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described previously [168]. The tissues were processed in phosphowash, fixed with 
paraformaldeyde, permeabilized with acetone and stored at -80C until the staining was 
performed. 
Fetal liver cell preparation 
Fetal livers were isolated at E12.5-E14.5, dissociated mechanically, and deprived of Epo 
for 90 minutes in the presence of 20% serum prior to Epo stimulation. Cells were then 
stimulated with different doses of Epo for a fixed time (dose response curve) or with a 
single dose of Epo at multiple time points (time course). 
Amaxa Biosystem Nucleofection 
Fresh fetal liver cells were prepared for electroporation using the Mouse ES Cell 
Nucleofector Kit (VPH-1001, Amaxa Biosystem) according to the manufacturer's 
instructions. Electroporations were performed using the Amaxa Biosystem Nucleofector 
(program X-001). Following electroporation, cells were incubated for 18 hours in Epo 
(0.2 U/mL), Stem Cell Factor (100 ng/mL) and Interleukin-3 (10 ng/mL), washed 3 times 
and incubated in 20% serum for 3 hours prior to Epo stimulation.  
Pervanadate treatment 
Cells were electroporated with a pcDNA3 vector expressing pcDNA3-FLAG-Stat5, 
pcDNA3-FLAG-Stat5Y694F or pcDNA3 vector alone and cultured overnight in the 
presence of SCF (100 ng/ml), IL3 (10 ng/ml) and Epo (0.5 U/ml). 18 hours after 
electroporation cells were washed 3 times, starved of growth factors for 3 hours and 
treated with pervanadate for different times as described [227]. Cells were collected, 
washed with phospho-wash buffer, fixed, permeabilized and frozen at -80C. Cells were 
subsequently analyzed for p-Stat5 by flow cytometry. 
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SOCS3 siRNA 
Fetal liver cells were electroporated with 2μg of SOCS3 (L-040626-01, Dharmacon) or 
control (D-001810-10, Dharmacon) siRNA. Cell were recovered in 20% serum for 4 
hours and subsequently stimulated with Epo (0.2 U/ml) in a time course experiment 
Mouse Embryonic Fibroblasts (MEFs) Infection 
Stat5-/- MEFs were seeded at 30% confluency. Cells were incubated with retroviral 
supernatant dilutions, in the presence of polybrene (4μg/mL), for 6 hours. The retroviral 
supernatant was removed and cells were collected at 48 hours post infection for western 
blotting. 
Flow cytometry 
Epo-stimulated cells were harvested in phosphowash (PBS, 1mM sodium orthovanadate, 
1mM β-glycerol phosphate, 1μg/mL microcystin), fixed in 1.6% paraformaldehyde, 
permeabilized in 80% acetone and stored at -80°C. Thawed cells were stained in PBS/3% 
milk with AF647-conjugated anti-phospho Stat5 (612599, BD Biosciences), for Ter119 
and CD71 as described [14], and where indicated, for Stat5 (ab 7969, Abcam followed by 
anti-rabbit-APC, Jackson ImmunoResearch Laboratories), FLAG (F4049, Sigma Aldrich) 
and Myc (2272, Cell Signaling Technology). In all electroporation experiments, cells 
were stained with LIVE/DEAD Fixable Blue Dead Cell Stain Kit for UV excitation (L-
23105, Invitrogen), prior to fixation and permeabilization in order to exclude dead cells 
from analysis. λ-phopsphatase treatment was for 15 minutes at 37C on fixed and 
permeabilized cells (1,000 units, New England Biolabs).  
???
Apoptosis assays were done on fresh fetal livers that were deprived of Epo for 90 minutes 
and then stained for CD71, Ter119 and Annexin V according to the manufacturer’s 
instructions (BD Biosciences). Spleen and bone marrow cells isolated from adult mice 
were immediately stained with CD71 and Ter119 as described [14]. Cells were analyzed 
on an LSRII cytometer (BD Biosciences). Data were analyzed with FlowJo software 
(Tree Star, Stanford University, Stanford, CA). 
DNA constructs: cloning and mutagenesis 
pcDNA3-Flag Stat5a, pcDNA3-Flag Stat5 1*6 were generated by cloning the FLAG-
Stat5 (wild type or mutant), provided by Dr. T. Kitamura, in the pcDNA3 construct 
(Invitrogen). Retroviral constructs were previously described (Socolovsky et al, 1999, 
Cell, 98: 181-91). pcDNA3-Flag Stat5a-Y694F was generated by mutagenesis using the 
QuickChange Site-Directed Mutagenesis Kit (Stratagene) according to the manufacturer's 
instructions. pcDNA3-Myc Stat5 N-terminal domain construct was generated by cloning 
the sequence corresponding to Stat5a amino acid 1-130 into a pcDNA3 vector, 
subsequent mutagenesis to remove the stop codon and cloning into a pcDNA3 vector 
containing a triple Myc tag (gift of Dr. Ralph Scully, Harvard Medical School). 
Stat5ΔND was generated by removal of the first 129 amino acids of wild-type Stat5. The 
NDL82S and NDF81A/L82A mutants were generated by site-directed mutagenesis.  
Quantitative RT-PCR 
RNA was extracted, using the AllPrep DNA/RNA Micro Kit (80284, Qiagen), from 
FACS-sorted fetal liver cells. Taqman real time PCR (Applied Biosystems) was 
performed on cDNA prepared using the SuperScript First-Strand kit (Invitrogen). The 
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following probes were used for SHP-1, SOCS3 and EpoR respectively (Mm 
00469148_g1, Mm 01249143_g1, Mm 01175895_g1, Applied Biosystems). 
Denaturing Immunoprecipitation and Quantitative Western Blotting 
Denaturing immunoprecipitation was performed on 10^7 cell equivalents of each protein 
lysate. Cells were boiled for 5 minutes in 200 µL of a buffer containing 50 mM Tris-HCl 
(pH 8.0), 0.5% SDS, 1mM DTT, 10 mM NaF, 1 mM Na3VO4, and 1 mM PMSF. Then, 
800 µL of a buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% sodium 
deoxycholate, 1% NP-40, 2mM EDTA, 10 mM NaF, 1 mM Na3VO4 and 1 mM PMSF, 
were added. The samples were rotated for 5 minutes in the cold room and then 
centrifuged at maximum speed for 15 minutes. The lysate was incubated with 10ul of 
Dynabeads Protein G (100.04D, Invitrogen) for 1h in the cold room. The beads were 
removed and the remaining lysate was incubated overnight with 100ul of Dynabeads 
Protein G that were precoated with the FLAG antibody (F1804, Sigma-Aldrich) in the 
cold room. The Dynabeads-Ip-Antigen complexes were washed 4 times with lysis buffer, 
resuspended in 2X sample buffer and bolied for 10 minutes. The eluate was loaded on a 
4-12% gradient poliacrylamide gels (Invitrogen). The gel was transferred onto a 
nitrocellulose membrane by semidry transfer method (Biorad), for 45 minutes at room 
temperature, according to the manufacturer instructions. After transfer the blot was 
analyzed using the Odyssey infrared imaging system (LI-COR, Biosciences, NE, USA). 
In summary, for FLAG staining, the membrane was incubated in Odyssey blocking 
buffer for 1 hour at room temperature. The membrane was then stained for 30 min in 
Odyssey blocking buffer in the presence of 1:1000 dilution of anti-FLAG antibody 
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(F1804, Sigma-Aldrich). The membrane was washed 4 times for 5 minutes in Tris-
Buffered Saline with Tween 20 (TBST) buffer (50 mM Tris.HCl, pH 7.4, 150 mM NaCl, 
0.2% Tween 20). Subsequently the membrane was incubated with 1:10000 dilution of 
anti-Mouse-IRDye 800CW secondary antibody (926-32210, LI-COR) for 1 hour at room 
temperature, in the dark. The membrane was finally washed 4 times for 5 minutes in 
TBST. For phospho-Stat5 staining the membrane was incubated in blocking buffer (5% 
milk in TBS) for 1 hour at room temperature. The membrane was then stained overnight 
in blocking buffer in the presence of 1:1000 dilution of anti phospho-Stat5 antibody 
(611964, BD Biosciences). The membrane was washed 4 times for 5 minutes in TBST. 
Subsequently the membrane was incubated with 1:10000 dilution of anti-Mouse-IRDye 
800CW secondary antibody (926-32210, LI-COR) for 1h at room temperature, in the 
dark. The membrane was finally washed 4 times for 5 minutes in TBST. The membranes 
were scanned using the Odyssey infrared imaging system (LI-COR, Biosciences, NE, 
USA) and the images were analyzed using the Odyssey software. 
Western Blot Analysis 
Cell lysates were loaded on a 4-12% gradient poliacrylamide gels (Invitrogen). The gel 
was transferred onto Polyvinylidene fluoride (PVDF) membrane by semidry transfer 
method (Biorad), for 45 minutes at room temperature, according to the manufacturer 
instructions. After transfer the membrane was incubated in blocking buffer (5% milk in 
TBST) for 1 hour at room temperature. The membrane was stained overnight in blocking 
buffer with anti-FLAG (F1804, Sigma-Aldrich), anti-Myc (2272, Cell Signaling), anti-p-
Stat5 (611964, BD Biosciences) or anti-Stat5 (610191, BD Biosciences) antibodies. The 
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membrane was washed 5 times for 7 minutes in TBST. The membrane was incubated 
with secondary antibody (anti-Rabbit HRP 1:5000 or anti-Mouse HRP 1:5000, Jackson 
ImmunoResearch laboratories, Inc.) in 5% milk TBST for 1 hour at room temperature. 
Immunodetection was performed by enhanced chemiluminescence (12015196001, 
Roche) for phospho-Stat5 and regular chemiluminescence (NEL104, Perkin Elmer) for 
Stat5, Myc and FLAG. 
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CHAPTER III: Identification and analysis of mouse erythroid 
progenitors using the CD71/Ter119 flow-cytometric assay 
Introduction  
The study of erythropoiesis aims to understand how red cells are formed from 
earlier hematopoietic and erythroid progenitors. Specifically, the rate of red cell 
formation is regulated by the hormone erythropoietin (Epo), whose synthesis is triggered 
by tissue hypoxia. A threat to adequate tissue oxygenation results in a rapid increase in 
Epo, driving an increase in erythropoietic rate, a process known as the erythropoietic 
stress response. The resulting increase in the number of circulating red cells improves 
tissue oxygen delivery. An efficient erythropoietic stress response is therefore critical to 
the survival and recovery from physiological and pathological conditions such as high 
altitude, anemia, hemorrhage, chemotherapy or stem cell transplantation.  
 The mouse is a key model for the study of erythropoiesis and its stress response. 
Mouse definitive (adult-type) erythropoiesis takes place in the fetal liver between 
embryonic days E11.5 and E15.5, in the neonatal spleen, and in adult spleen and bone 
marrow. Classical methods of identifying erythroid progenitors in tissue rely on the 
ability of these cells to give rise to red cell colonies when plated in Epo-containing semi-
solid media. Their erythroid precursor progeny are identified based on morphological 
criteria. Neither of these classical methods allow access to large numbers of 
differentiation-stage-specific erythroid cells for molecular study. Here we present a flow-
cytometric method of identifying and studying differentiation-stage-specific erythroid 
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progenitors and precursors, directly in the context of freshly isolated mouse tissue (Figure 
3.1). The assay relies on the cell-surface markers Ter119, CD71, and on the flow-
cytometric ‘forward-scatter’ parameter, which is a function of cell size. The 
CD71/Ter119 assay can be used to study erythroid progenitors during their response to 
erythropoietic stress in vivo, for example, in anemic mice or mice housed in low oxygen 
conditions. It may also be used to study erythroid progenitors directly in the tissues of 
genetically modified adult mice or embryos, in order to assess the specific role of the 
modified molecular pathway in erythropoiesis.  
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Figure 3.1 Experimental strategy to study erythropoiesis using flow cytometry. 
(A) The mouse is a key model for the study of erythropoiesis and its stress response. 
Mouse erythropoiesis occurs in the spleen, bone marrow, and in the fetal liver (middle). 
In these tissues, hematopoietic stem cells (HSC) are restricted to the erythroid lineage 
(blue and red stages), which in turn gives rise to red blood cells. Proper number of red 
cells maintains tissue oxygen (green) normal and negatively regulates Epo. Not enough 
red cells leads to tissue hypoxia. In turn, high Epo (green) increases erythropoiesis to 
correct the deficit. 
(B) To study erythroid cells, we first isolate total cells from hematopoietic tissues 
(e.g. fetal liver). 
(C) Freshly-isolated cells are labeled with fluorescent markers directed against 
erythroid, or any additional membrane or intracellular, antigens. Fluorescence data of the 
labeled sample is collected using flow-cytometer. Cells can be physically sorted using a 
cell sorter into separate tubes. 
(D) Sample data is then analyzed using Flowjo analysis for erythroid markers, 
apoptosis and cell cycle. Representative analysis of fetal liver is shown in the middle 
panel. Sorted populations can be cytospun onto microscope slides (cytospins shown), 
analyzed for their protein and mRNA content, or cultured for further analysis. 
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Figure 3.1 
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Protocol 
1. Harvesting of tissues: 
1.1  Prepare tubes containing 2 to 5 ml cold staining buffer (phosphate-buffered 
saline (PBS) with added 0.2% BSA and 5mM glucose). Keep tubes on ice 
prior to tissue harvest. 
1.2 Cull mice according to appropriate approved protocol (e.g. CO2 inhalation 
followed by cervical dislocation). 
1.3    Draw blood by cardiac puncture into EDTA or heparin blood-collection tubes 
for later analysis (e.g. hematocrit, reticulocyte count or CBC analysis). 
1.4 Harvest the spleen and bones, placing tissues from each mouse in a   separate 
tube, prepared in step 1. Easy access to spleen is from the left side. For the 
bone marrow, harvest one or both femurs. Keep tubes with harvested tissue on 
ice. 
1.5 If desired, weigh the spleen. Mice undergoing an erythropoietic stress 
response are likely to show a significant increase in spleen weight. 
2. Preparation of spleen cells: 
2.1 Using a pre-moistened 3 ml syringe plunger, gently push the spleen, or part of 
the spleen (ideally, 0.1 gram or less, equivalent to approximately 108 cells) 
through a 40 mm sterile cell strainer (Fisherbrand catalog number 22363547 
or other) placed on top of a 50 ml conical tube. Keep the tube on ice during 
this procedure. Wash the cells through the strainer with a total of 2 ml staining 
buffer.  
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2.2     Gently pipette the strained cell suspension to break up any small clumps.  If 
necessary, re-strain the cells. 
2.3 Wash the cells twice by centrifugation and resuspend in cold buffer. For   
centrifugation, spin for 3’ to 5’ at approximately 1400 RPM at 4°C. 
2.4 Count the cells using a hemocytometer. Typical yields are 1-2 x 108 
cells/spleen. For flow cytometry analysis, aliquote 1 to 2 x 106 cells per 
sample, either into FACS staining tubes (BD Falcon polystyrene round-
bottom tubes, 352008) or U-bottom 96 well plate (BD Falcon 353910). 
Sample staining volume is 200 µl, to a final cell concentration 0.5 to 1 x 107 
cells/ml or 1-2 x 106 cells/ 200 µl sample. 
3. Preparation of bone marrow cells: 
3.1 Prepare 1 or 3 ml syringes with an attached 26G needle, pre-filled with cold 
staining buffer.   
3.2       Remove muscles attached to the femur so as to visualize the bone clearly.  
3.3 Using sharp surgical scissors, snip off both ends of the femur, as close as 
possible to the ends of the bone. This should reveal a small hole at each cut 
end, leading into the bone-marrow cavity, which runs through the length of 
the femur. 
3.4     Using the pre-filled syringe in step 1, insert the needle through one of these 
holes, and gently flush the marrow out through the hole at the other end into a 
tube. 
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3.5 Dissociate the flushed cells by gentle pipetting, and strain through a 40 mm 
strainer as for the spleen above (see section 2.1). 
3.6 Wash cells twice by centrifugation in cold staining buffer. 
3.7 Count the cells and resuspend as in section 2.4. Typical yields are 
approximately 107 cells per femur.  
4. Preparation of fetal liver cells: 
4.1 To prepare timed-pregnant female mice, set up mice for mating in the 
evening; examine for vaginal plugs before 10 am the following day; the day 
on which the vaginal plug is detected is considered day 0.5. Veterinary staff 
may be able to assist investigators who are unfamiliar with this technique to 
identify pregnant females. 
4.2 Timed-pregnant female mice are culled on days E11.5 to 14.5 of pregnancy. 
The uterine horns are removed into a Petri-dish containing ice-cold culture 
medium or staining buffer. 
4.3 Embryos are removed from each uterus and the fetal liver is dissected. A 
dissecting microscope is required for E12.5 embryos or younger.  
4.4 Livers may be dissociated mechanically by pipetting in buffer, and are 
processed either individually in 96-well plates, or pooled together, depending 
on experimental requirements.  
4.5 A fetal liver at E13.5 has ∼107 cells. Cells are washed twice in staining buffer 
and resuspended at 1-2 x 106 cells/ 200 µl sample for flow-cytometric 
analysis.  
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5. Antibody staining for flow cytometry: 
5.1 Prepare a primary antibody staining pre-mix to be used for all samples, except 
for control samples, containing the following:  
• ChromePure Rabbit IgG (Jackson, 015-000-003), to a final concentration of 
200 µg/ml. Check the stock concentration on the bottle (it can vary). This is 
used to block Fc receptors in mouse cells; alternative species that may be used 
for this are mouse IgG or rat IgG. Species choice is determined by the 
potential presence in the staining protocol of secondary antibodies directed 
against primary rat/mouse/rabbit antibodies, in which case those species 
cannot be used as blocking antibodies. Alternatively, 5% rabbit serum may 
also be used in place of purified IgG. A further alternative is the use of 
monoclonal antibodies or Fab fragments directed at the mouse Fc receptors. 
The basic protocol below does not include any secondary antibodies and so 
IgG of any of the three species may be used. 
• CD71-FITC, diluted 1:200 (stock 0.5mg/ml, BD-Biosciences, 553266) 
• Ter119-PE, diluted 1:200 (stock 0.2mg/ml, BD-Biosciences, 553673) 
• Any additional antibodies directed at surface epitopes of interest, e.g. 
antibodies directed at Fas or FasL (final concentration 5μg/mL) (see [14, 
206]). Mix the antibody solution gently by inverting the tube 2-3 times. 
5.2 Add 200 µl of the pre-mix to each cell sample and gently resuspend the cells. 
5.3 Prepare control cell samples as follows: 
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• ‘Unstained’: these cells are left in staining buffer and provide the background 
autofluorescence of the cells. 
• ‘Single color’ controls: one such control is required for each antibody/color 
used in the protocol. The cells in these controls are stained either with a 
directly conjugated primary antibody, or with both a primary antibody and a 
conjugated secondary antibody. These controls are used to correct for spectral 
overlap between channels. 
• ‘Fluorescence minus one’ (FMO) controls: one such control is required for 
each antibody/color in the protocol: cells are stained with all the 
colors/antibodies in the protocol except for the color/antibody for which this is 
the FMO control. The FMO control for a particular channel provides the true 
background for that channel. It may include non-specific antibody of the same 
isotype, and conjugated with the same fluorescence mark as the test antibody 
(isotype control). 
5.4 Incubate samples and relevant controls in the primary antibody stain on ice for 
45’ to 1 hour in the dark (put aluminum foil cover on ice-bucket).  
5.5 At the end of incubation, wash the cells by adding 3 ml of staining buffer to 
each sample tube and spin for 3’ to 5’ at approximately 1400 RPM at 4°C. If 
using 96 well plates, wash the cells three times in a volume of 200 µl. 
5.6 If relevant, apply secondary antibody stain. Apply and wash as for the first 
antibody stain. 
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5.7 If relevant, a stain with Annexin V (apoptosis marker) is applied at the end of 
incubation, using a Hepes buffer as in the manufacturer’s instructions. This 
stain is applied for 15 minutes at room-temperature, or for 1 hour on ice. 
5.8 Cells are resuspended for flow cytometry analysis in staining solution 
containing a cell-impermeable DNA dye, to exclude dead cells. Several DNA 
dyes are available, including Propidium Iodide, 7-amino-actinomycin D 
(7AAD), or DAPI. The choice from amongst these depends on the available 
flow-cytometer channels, given the channels taken up for specific antibody 
staining, and channels available on the flow-cytometer. 7AAD is obtained 
from BD-Biosciences (559925) and used according to the manufacturer’s 
instructions. For DAPI staining, make a stock of 1mg/ml in 
dimethylformamide (DMF) from powder (Roche, 236276), keep at -20°C, and 
dilute 1:10,000 to 1:15,000 in staining buffer.   
6. Flow-cytometric sorting: 
6.1 Cells are labeled with CD71, Ter119, and a viability dye as described for 
flow-cytometric analysis (section 5). Cell concentration during labeling may 
be increased to 5 x 107/ml.  
6.2     Antibody labeling for lineage-positive non-erythroid cells may be added with 
the primary antibody stain, if required, as follows:  
Mix an equal volume of each of the following antibodies to make the lineage 
master mix:   
FITC Rat Anti-Mouse CD41 MWReg30, BD Pharmingen  553848 
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FITC Rat Anti-Mouse CD45R/B220 RA3-6B2, BD Pharmingen  553087 
FITC Hamster Anti-Mouse CD3e 145-2C11, BD Pharmingen  553061 
FITC Rat Anti-Mouse CD11b/Mac-1 M1/70, BD Pharmingen  557396 
FITC Rat Anti-Mouse Ly-6G and Ly-6C (Gr-1) RB6-8C5, BD Pharmingen  
553126  
Use the master mix at 1:80 (This is equivalent to 1:400 dilution of each 
individual antibody stocks, which are all 0.5 mg/ml). 
6.3 Use low-pressure sorting conditions and wide nozzles. For the Aria (BD 
Biosciences) we use 100 µm nozzle, 20 psi pressure. 
6.4 Collection buffer: PBS with added 20% Fetal Bovine Serum.  
6.5 To check the purities of the sorted populations, re-run a small aliquot from 
each sample in a buffer that contains a viability dye (7AAD or similar). 
Representative Results 
 CD71/Ter119 staining of adult bone marrow or spleen identifies a developmental 
sequence of four subsets, labeled ProE, EryA, EryB and EryC (Figure 3.2)[14]. 
Morphologically, these correspond to increasingly mature erythroblasts. Figure 3.2 
illustrates the gating sequence at the data analysis stage, which discards very small event 
(including nuclei, red cells), aggregated cells and dead cells.   
 Expression of cell-surface proteins may be measured simultaneously for each of 
these subsets, by adding the relevant antibodies at the same time as Ter119 and CD71 
staining. Figure 3.2 shows an example of cell-surface expression of the death receptor 
Fas [14]. This measurement was carried out in mice injected with Epo, or in control mice 
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injected with saline. It is apparent that Epo suppresses Fas expression in the EryA 
population in vivo [14]. Expression of intracellular proteins or cell cycle status may also 
be measured for cells in each subset. Figure 3.3 illustrates representative cell cycle 
analysis of freshly harvested bone-marrow cells. These measurements require, in addition 
to cell-surface staining with CD71 and Ter119, the fixation and permeabilization of cells 
for intracellular labeling (see Discussion section). 
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Figure 3.2 The CD71/Ter119 erythroid subsets in mouse spleen. 
(A) Gating strategy: Spleen cells were processed and labeled with antibodies directed 
at CD71 and Ter119. This figure shows the analysis strategy following the data 
acquisition step. Dot-plot I shows all acquired events. The diagonal gate represents events 
that are likely to be single cells/events, excluding doublets or larger aggregates. Cells in 
this gate are further analyzed in dot-plot II. Here, very small events, likely nuclei or 
debris, are excluded. The gated cells are shown in dot-plot III, where DAPI-positive cells, 
that are likely membrane-permeable apoptotic cells, are excluded from further analysis. 
Dot-plot IV shows the resulting population of viable spleen cells. The ProE gate contains 
CD71highTer119intermediate cells. Ter119high cells are further analyzed in dot-plot V. Here 
CD71high cells are subdivided into less mature, large ‘EryA’ erythroblasts 
(CD71highTer119highFSChigh) and smaller, more mature ‘EryB’ erythroblasts 
(CD71highTer119highFSClow). The most mature erythroblast subset is EryC 
(CD71lowTer119highFSClow). Dot-plot VI shows cell-surface Fas expression, specifically 
in the EryA subset, in mice in the basal state (injected with saline), and mice injected 
with a single dose of Epo. Staining with Fas was carried out simultaneously with the 
CD71/Ter119 staining. 
(B) Cytospin preparations of cells sorted from each of the indicated subsets. Cells 
were stained with Giemsa and with Diaminobenzidine, the latter generates a brown stain 
with hemoglobin. (Cytospin data was originally published in [14]). 
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Figure 3.2 
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 Figure 3.3 Cell cycle analysis of CD71highTer119high erythroblasts in mouse bone 
marrow. Mice were injected intraperitoneally with BrdU, and spleen and bone marrow 
were harvested 30 to 60 minutes later. Bone marrow cells were fixed and permeabilized, 
and in addition to being stained for CD71 and Ter119, were stained for BrdU 
incorporation into their replicating DNA with a monoclonal antibody directed at BrdU 
(fixation, permeabilization and BrdU-staining protocol was according to manufacturer’s 
instruction). BrdU-positive cells are in S-phase of the cycle. Interphase cells are BrdU-
negative and may be resolved into G1 or G2/M phases using the DNA dye 7AAD.  
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Figure 3.3 
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In fetal liver, non-erythroid cells are first excluded by gating on ‘Lin-’cells that are 
negative for CD41, Mac-1, Gr-1, B220 and CD3 (Figure 3.4). The remaining cells are 
sub-divided into 6 subsets, S0 to S5. The precise pattern of cells in fetal liver is 
dependent on embryonic age (see Discussion section). A representative cell cycle 
analysis of the S3 subset in E13.5 fetal liver is shown (Figure 3.5).  
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Figure 3.4 CD71/Ter119 erythroid subsets in mouse fetal liver. 
(A) Gating strategy: Fetal liver cells were labeled for CD71, Ter119, and a cocktail of 
FITC-labeled antibodies directed at non-erythroid lineage markers (‘Lin’). Viable cells 
(7AAD-negative) were analyzed for Lin expression, and the Lin- cells were further sub-
divided into the S0 to S5 erythroid subsets. Compared to E14, E13 fetal liver is composed 
of less mature erythroblasts, shown by the near absence of cells in the mature S4/S5 
subsets. 
(B) Cytospin preparations of cells sorted from each of the indicated subsets. Cells 
were stained with Giemsa and with Diaminobenzidine, the latter generates a brown stain 
with hemoglobin. (Cytospin data was originally published in [208]). 
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Figure 3.4 
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Figure 3.5 Cell cycle analysis of fetal liver erythroid subsets. 
Pregnant mice were injected with BrdU, and fetal livers were harvested 30 to 60 minutes 
later, fixed, permeabilized and stained with antibodies against CD71, Ter119 and BrdU. 
Cell cycle status of S3 cells is shown. 
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Figure 3.5 
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Discussion 
 The flow-cytometric methodology allows simultaneous investigation of any 
cellular function that may be detected with a fluorescence-conjugated specific antibody 
or ligand, including cell-surface markers, protein expression, cell survival, cell signaling 
using phospho-specific antibodies [169], and cell cycle status. These measurements may 
be made in each of a number of differentiation-stage specific subsets, in the context of 
freshly isolated erythropoietic tissue. This method therefore allows assessment of 
functional and molecular changes at different levels of the erythropoietic system, in 
response to a wide range of erythropoietic stimuli or as a result of genetic mutations.  
 No antibody is without cross-reactivity, and cross-reactivity may be tissue- 
specific. It is therefore important to verify, even for previously tested antibodies, their 
specificity in the context of erythropoietic tissue, using either a null or a knock-down cell 
model.  
 Cells from specific erythroid subsets may be sorted for RNA or transcriptome 
analysis. Sort experiments should use low sorting pressures and wide nozzles, in order to 
minimize the shear stress on the cells. We recommend checking cell purity and viability 
following each sorting experiment. Of note, in the case of multiparameter flow 
cytometry, the true background for each color is its ‘FMO’ control (see 5.3), which 
includes, in addition to autofluorescence, the background due to spectral overlap from all 
other colors. At the analysis stage, a subset-specific ‘FMO’ control needs to be used. 
 
???
Differentiation stage of erythroblasts within the flow-cytometrically defined subsets  
 The flow-cytometric ProE/EryA/EryB/EryC subsets are defined in terms of cell-
surface marker expression and forward scatter. While it is likely that each of these 
subsets corresponds to approximately the same morphological erythroblast differentiation 
stage in a wide variety of mouse models, we recommend verifying this when examining a 
new mouse model. Cells from each of the flow-cytometrically-defined subsets should be 
sorted and cytospin preparations examined for morphological staging of erythroblasts.  
 Although the CD71/Ter119 subsets each contain erythroblasts of similar 
differentiation stage, there remains a degree of heterogeneity within each subset. In the 
first application of the CD71/Ter119 method, we divided Ter119+ cells into regions I to 
IV based on their CD71 expression. The precise borders between these regions were 
determined arbitrarily [127]. We subsequently added cell size information to the analysis, 
in the form of the forward scatter parameter. This allowed us to divide Ter119high cells 
into subsets by following natural population contours [14] (Figure 3.2). This approach 
resulted in populations of more uniform maturation and in more reproducible results, and 
has been recently adapted by other investigators [228-230]. The EryA subset may be sub-
divided further where desired [230]. One group suggested the use of CD44 in place of 
CD71 [231]. Although CD44 is less useful in resolving early erythroblast stages, it may 
resolve later erythroblast subsets with more precision. Both markers may therefore be 
used, or alternatively, their choice may depend on the specific subsets of interest.  
 An alternative strategy employs multispectral imaging using the ImageStream 
technology (Amnis Corporation, Seattle, WA) [232]. It allows the simultaneous and rapid 
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acquisition of both morphological and flow-cytometric data on many thousands of cells. 
It is likely to become the ‘gold standard’ with respect to molecular analysis of stage-
specific erythroblasts, since the morphological criteria by which differentiation stage is 
defined may be measured directly. However, at the present time this technology is less 
widely available than conventional flow cytometry, and suffers from two drawbacks: it 
does not allow cell sorting; and it is limited to a smaller number of flow-cytometric 
parameters.  
Intracellular antigens 
 Detection of intracellular proteins or BrdU requires cell fixation and 
permeabilization. The precise fixation and permeabilization procedure depends on the 
intracellular antigen in question. We use the LIVE/DEAD Fixable Dead Cell Stain 
(Molecular Probes) during the fixation procedure, to distinguish viable from dead cells. 
Of note, permeabilization with detergents usually impacts the Ter119 signal, which is 
partially detergent soluble. We overcome this difficulty by using gentle detergents (such 
as the saponin-based ‘perm/wash’ buffer from BD Biosciences). We also stain for Ter119 
both prior to, and following, the fixation & permeabilization procedure, in order to 
optimize the Ter119 signal. Alternatively, it is possible to sort viable cells from each of 
the CD71/ Ter119 subsets first, and carry out fixation and permeabilization separately on 
purified cells from each subset e.g. see the cell cycle analysis in fetal liver [208]. 
Fetal liver CD71/Ter119 subsets 
 The CD71/Ter119 staining pattern in fetal liver is dependent on embryonic age 
[206] (Figure 3.4). We subdivide fetal liver cells into 6 subsets, S0 to S5 [208]. At the 
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onset of definitive erythropoiesis in fetal liver on embryonic day 11 (E11), cells are 
concentrated in subsets S0 and S1 and are largely erythroid colony-forming cells (CFU-
e). With embryonic development, CFU-e cells differentiate into proerythroblasts and 
maturing erythroblasts, and gradually populate subsets S2 to S5 (Figure 3.4).  
 Subsets S1 to S5 are composed almost entirely of erythroid cells of the definitive 
lineage. These subsets are absent in the EpoR-/- fetal liver. A small number of Ter119+ 
cells in fetal liver correspond to the primitive (yolk sac) erythroid lineage. These cells are 
apparent in EpoR-/- fetal liver, where no definitive lineage erythroblasts arise, but by 
E13.5 form less than 1% of Ter119+ cells in wild-type fetal liver [208].  
 The S0 subset is heterogeneous. At E13.5, 70% of S0 cells are erythroid cells at 
the CFU-e stage, just prior to the onset of EpoR dependence [208]. The remainder are 
earlier progenitors as well as cells of other hematopoietic lineages, principally 
megakaryocytes and macrophages; these cells may be sorted or gated out [208] (Figure 
3.4).   
Interpretation of changes in the frequency of erythroid subsets 
 Changes in the frequency of erythroid subsets should be interpreted with care. A 
change in frequency of cells in any given subset may be due to their altered apoptotic 
rate, altered transit time through that subset, or alternatively may be due to changes in the 
number of cells in other subsets. A common cause for increased frequency of early 
erythroblast subsets ProE and EryA is erythropoietic stress of multiple etiologies [14]. 
Similar findings have been noted in the 1960’s by inspecting erythroblast morphologies 
during the stress response [233]. The precise reason for the increase in the relative 
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frequency of earlier precursors during stress is not clear, but in part may be due to the 
improved survival of these precursors during stress [14].  
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CHAPTER IV: Conclusions and future directions 
1. Conclusions 
We explored the dynamics of Stat5 activation in basal and stress erythropoiesis by 
using a novel flow-cytometric method that allowed us to measure Stat5 phosphorylation 
at the single cell level, in freshly isolated mouse erythropoietic tissue. We discovered two 
distinct modes of Stat5 signaling in erythroblasts of different developmental stages. 
Digital (or binary), low intensity Stat5 signaling was characteristic of mature 
erythroblasts, and early erythroblasts in response to physiological Epo doses, and was 
sufficient for basal erythropoiesis. An analog (or graded), high intensity Stat5 signaling 
was observed in early erythroblasts in response to stress levels of Epo, and was required 
for stress erythropoiesis. A gradual decrease in Stat5 expression with maturation, 
characterized the shift from high-intensity to low-intensity Stat5 signaling in developing 
erythroblasts.  
We showed that digital Stat5 signaling is bistable and that bistability is the result 
of an autocatalytic loop. The isolated Stat5 N-terminal domain, which has been 
implicated in a radical conformational reorientation of Stat5 dimers required for Stat5 
activation, enhanced autocatalysis. We propose that the N-terminal domain of p-Stat5 
facilitates the reorientation of inactive dimers during the phosphorylation step, driving 
autocatalysis and binary signaling.  
Interestingly, digital (binary) and analog Stat5 signaling combine in early 
erythroid progenitors in a manner reminiscent of a dimmer light switch: a bistable switch 
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generates a low intensity but decisive p-Stat5 signal; in response to stress levels of Epo, 
the amplitude of the signal increases further in a graded manner. Our findings indicate 
that this bimodal Stat5 activation system ensures a faithful regulation of the 
erythropoietic rate over a wide range of Epo concentrations. We predict that the dynamic 
characteristics of Stat5 signaling are likely to impact its function in hematopoiesis and 
leukemogenesis. 
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Figure 4.1 Dimmer switch model of Stat5 signaling. 
The illustrated dimmer circuit contains a toggle switch that turns the light to a dim, ‘on’ 
level and is analogous to the bistable system that generates the digital low intensity p-
Stat5 signal. The switch is connected in series to a variable resistor that generates a 
graded increase in light output, analogous to the high intensity analog p-Stat5 signal. The 
scheme at the bottom of the figure summarizes the modes of Stat5 activation in early (S1 
cells) and late (S3 cells) erythroblasts. Stat5 activation is through a bistable switch that 
generates a low-intensity binary signal. Further increase in stimulus results in an analog, 
or graded, increase in the signal amplitude, but only in early, S1 cells expressing high 
Stat5 levels.  
???
Figure 4.1 
???
2. Significance of our findings 
The identification of digital and analog Stat5 signaling modes in erythroblasts has 
implications for hematopoietic stem cells as well as for hematopoietic lineages in which 
Stat5 is activated during development, or in adult life, such as myeloid and lymphoid 
lineage [68, 118-121]. Studies in hematopoietic stem cells showed that different levels of 
Stat5 activity play an important role in stem cell maintenance versus lineage commitment 
[121, 234-236], supporting the hypothesis that different Stat5 signaling modes might be 
modulating these processes. In addition, it has been shown that Stat5 is essential for 
lymphoid development and differentiation [118, 237]. Therefore, it would be interesting 
to examine whether digital and analog modes of Stat5 signaling are implicated in 
developmental decisions or functional specification in other hematopoietic lineages.  
Most important, our findings likely apply to other STAT molecules and therefore 
unravel a new level of regulation of STAT mediated biological processes. The ability to 
study cell signaling at the single cell levels opens the door to a new signaling universe. It 
is likely that future studies will uncover the dynamic features of many signaling 
molecules and their role in the regulation of biological systems. It is an exciting research 
area that holds potential for understanding the mechanisms of human diseases.  
3. Biological function of digital and analog signaling in erythropoiesis 
Stat5 activation culminates in the induction of gene expression. We hypothesize 
that digital and analog Stat5 signaling lead to differential gene expression in fetal liver 
early erythroblasts (S1 cells). To identify genes that are target of the two modes of 
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signaling we could perform gene expression profiling on S1 cells from wild type (exhibit 
digital ad analog signaling) and EpoR-HM mice (only exhibit digital signaling), upon 
stimulation with Epo doses that are within the physiological or hypoxic stress range. The 
results of these experiments will help us gain insights in the mechanisms responsible for 
the biological functions of digital and analog signaling.  
We have presented some evidence on the biological function of analog Stat5 
signaling. EpoR-HM mice, which lack analog signaling, are unable to mount an 
erythropoietic stress response: upon Epo injection they fail to increase their hematocrit 
and upregulate CD71 expression (Figure 2.11). However, exogenous expression of Stat5 
in fetal liver cells from these mice is able to rescue analog signaling (Figure 2.9B) and 
CD71 expression (Figure 2.11C). Analog signaling requires EpoR tyrosines. We think 
that in EpoR-HM mice high Stat5 expression levels are able to compensate for the lack of 
Stat5 docking sites and therefore rescue analog signaling, by increasing the local 
concentration of Stat5 molecules in proximity of the activated receptor. To prove in vivo 
the hypothesis that Stat5 analog signaling is required for stress erythropoiesis we will 
have to perform a bone marrow transplantation experiment in which bone marrow from 
EpoR-HM mice will be infected with a Stat5-expressing retrovirus and transplanted in 
irradiated EpoR-HM mice. Mice expressing high levels of Stat5 will be subjected to 
erythropoietic stress and hematocrit and CD71 expression will be measured. If our 
hypothesis is correct we will be able to rescue the erythropoietic stress response in EpoR-
HM mice upon transplantation. 
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4. Studying the regulation of Stat5 expression  
The finding that Stat5 levels modulate digital and analog signaling and, 
especially, are limiting for the production of p-Stat5 (Figures 2.7, 2.10), highlights the 
importance of understanding the regulation of Stat5 expression during erythroid 
maturation. In erythroblasts, Stat5 expression decreases with differentiation, both at the 
protein (Figure 2.7) and mRNA level (preliminary data), and cells that express low Stat5 
levels (S3 cells) lack analog signaling (Figures 2.7, 2.10). Moreover, our findings that 
exogenous high-level Stat5 expression leads to constitutive Stat5 activation (Figure 
2.12B), suggest that understanding the regulation of Stat5 expression, could help us gain 
insights into some of the mechanisms of leukemogenesis.  
It has been shown that the C-terminal region of Stat5 mediates proteasome-
dependent degradation of active Stat5 in cell lines [86, 238, 239]. However, it is not 
known whether post-translational regulation of Stat5 expression occurs during 
development. It would be interesting to explore this research direction and to understand 
the interplay between different mechanisms that control Stat5 expression. 
Several mechanisms could regulate Stat5 post-transcriptionally. Importantly, 
Stat5 expression could be modulated by microRNAs, which are able to fine-tune gene 
expression to a level that is essential for developmental processes to occur. One 
microRNA, microRNA-222, has been reported as regulator of Stat5A expression in 
human endothelial cells [240]. This microRNA has also been shown to be downregulated 
during in vitro expansion of erythroid progenitors [241] and its overexpression is able to 
inhibit erythropoiesis [242]. However, further studies are required to prove its regulation 
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of Stat5A expression outside of the vascular system. Identifying microRNAs that are 
responsible for Stat5 regulation could uncover signaling pathways that are essential for 
the modulation Stat5 expression in our system as well as in related biological and 
developmental processes.  
5. Investigating the mechanisms responsible for the coexistence of digital and analog 
signaling 
It is noteworthy that a single molecule can exhibit different modes of signaling in 
the same cell (Figure 4.1). However, it is still unclear what are the factors that allow the 
co-existence of digital and analog signaling in early erythroblasts. The generation of 
distinct modes of signaling within the same cell has been reported for Ras in T cells, 
where initial receptor activation leads to a low intensity, analog Ras signaling, whereas 
full receptor activation gives rise to high intensity digital Ras signaling upon induction of 
a positive feedback loop [205, 243, 244].  
Our findings raise an important question: what are the molecular mechanisms that 
limit the digital Stat5 signaling to a low intensity signal? Modulation of the positive 
feedback loop could be a mechanism. We were able to convert a high intensity graded 
into a high intensity digital response by expressing exogenous Myc-ND in the presence 
of FLAG-Stat5 in fetal liver cells (Figure 2.14D). These findings suggest that the 
availability of free Stat5 ND might be the limiting factor in the generation of a high 
intensity digital signal. The ND of multiple STAT proteins has been implicated in the 
formation of tetrameric or higher order molecular complexes [225, 245-249]. Therefore, 
sequestration of the ND of active Stat5 into multimeric Stat5 complexes could be a 
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mechanism to interrupt the Stat5-mediated positive feedback loop and therefore limit 
digital signaling to low intensity. It would be interesting to test this hypothesis in the 
future by studying the formation of Stat5 complexes under native conditions, in response 
to changes in the levels of Epo. Moreover, these studies could also be performed in the 
presence of exogenous wild-type or mutant ND.  
A possible mechanism for the coexistence of digital and analog signaling is the 
generation of semi-phosphorylated Stat5 dimers (in which only one monomer is 
phosphorylated) at low Epo doses. They might be able to mediate the positive feedback 
but once fully phosphorylated they could loose that property. Semi-phosphorylated Stat5 
dimers could be responsible for digital signaling at low Epo doses, whereas at Epo doses 
that are above physiological levels, an increase in fully-phosphorylated dimers or higher 
order molecular complexes, could lead to a graded increase of p-Stat5. Alternatively, an 
increase in the stability of phosphorylated Stat5 complexes could explain the emergence 
of analog Stat5 signaling with increasing Epo doses. For example it has been reported 
that STATs can form tetramers, which result in more stable DNA binding complexes 
compared to dimers and seem to regulate gene expression selectively [225, 245-248]. 
Moreover, the formation of high order molecular structures, which are more resistant to 
phosphatases compared to dimers, has been recently proposed for STAT1 [249]. 
Stat5 can form homodimers (Stat5A/Stat5A, Stat5B/Stat5B) as well as 
heterodimers (Stat5A/B), raising the possibility that different type of complexes could 
participate in digital versus analog Stat5 signaling. It is possible that Stat5A and Stat5B 
regulate each ther, bind to the EpoR with different affinities, form complexes that are 
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semi- or fully-phosphorylated or that have different half-lives. To determine whether the 
ratio of Stat5 hetero- to homo-dimers is different in digital and analog Stat5 signaling, 
studies of Stat5 complexes under native conditions could be performed. Moreover, to 
determine the contribution of individual Stat5 proteins to the two modes of signaling, the 
p-Stat5 response to Epo in Stat5a-/- or Stat5b-/- mice could be investigated. 
In addition to tyrosine phosphorylation, STATs undergo several post-translational 
modifications, such as serine phosphorylation [250-252], dephosphorylation by 
phosphatases [87, 90, 253, 254], arginine methylation [255, 256], 
acetylation/deacetylation [257], SUMOylation [258-260] and ubiquitination [86, 261]. It 
is not well understood how these distinct modifications are integrated and contribute to 
STAT function. Some of them might have a role in the regulation of the Stat5-mediated 
positive feedback and it would be interesting to investigate this possibility in future 
studies. 
6. Structural studies to confirm our hypothesis on the mechanisms of positive 
feedback 
We showed that low doses of Stat5 ND amplifies constitutive Stat5 activation 
(Figure 2.15C), enhances the p-Stat5 response to Epo (Figure 2.14C) and converts a high 
intensity analog response into a high intensity digital response (Figure 2.14D). Based on 
these findings we proposed that the ND of active Stat5 drives the Stat5 mediated 
autocatalytic loop by facilitating the conformational reorientation of antiparallel dimers to 
parallel dimers, during the phosphorylation step (Figure 2.14H). 
Several future directions stem from our hypothesis: 
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1) Mathematical modeling of the “antiparallel to parallel conformational 
reorientation reaction”, which will take into account the presence of a Stat5 
mediated positive feedback loop. Integration of our data with the mathematical 
model will allow us to test whether our positive feedback model (Figure 2.14H) is 
consistent with the data. 
2) Domain mapping studies. Based on our findings that the isolated ND is able to 
enhance the phosphorylation of an N-terminally truncated Stat5 (Stat5ΔND), we 
hypothesize that Stat5 ND is able to interact with other domains within the Stat5 
molecule, than just the ND. If our hypothesis is correct we should be abe to co-
immunoprecipitate a Stat5ΔND with a Stat5 ND, using purified proteins. If an 
interaction occurs, mutagenesis studies could be performed to identify the sites of 
interaction between the ND and the rest of the Stat5 molecule (Stat5 core). We 
predict that mutants NDs that do not interact with the Stat5 core will not be able 
to promote autocatalysis. 
3) Live cell Fluorescence Resonance Energy Transfer (FRET) measurements in 
the presence of isolated Stat5 ND. Previous studies have shown that Stat5 
molecules fused to YFP or GFP at their N-terminus were able to generate a FRET 
signal prior to cytokine stimulation, supporting the structural data according to 
which unphosphorylated STAT dimers are stabilized by ND-ND interaction. 
Upon prolactin stimulation the FRET signal was not detectable confirming the 
separation of NDs following activation [109]. It would be interesting to perform 
similar studies in our system in the presence of different concentration of isolated 
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ND and under different stimulation conditions, to define the role of the Stat5 ND 
in the conformational reorientation of Stat5 dimers. 
4) Crystallographic studies of the Stat5 core in the presence of the isolated ND. 
Structural studies are required to prove our hypothesis. First of all it is not clear 
how unphosphorylated Stat5 dimers approach the receptor, whether they are in the 
antiparallel or parallel form. Studying the details of this interaction is really 
important for understanding the molecular mechanisms of the positive feedback. 
Determining the crystal structure of the full length dimers in different 
conformations and understanding the interaction between the ND and the rest of 
the molecule will help us understand the dynamics of the interaction and will 
allow the design of small molecules that can inhibit the positive feedback. These 
drugs could be used for the treatment of leukemia that exhibit constitutively active 
Stat5 (Chapter IV-7). On the other hand being able to modulate the stability of the 
phosphorylated dimers and therefore the duration of the signal could be useful for 
the treatment of genetic conditions responsible for anemia.  
7. Stat5 and leukemia 
Stat5 is constitutively activated downstream of over-active kinases involved in the 
development of a variety of cancers [122, 123, 192, 194, 262-265]. Moreover, expression 
of a constitutively active Stat5 mutant is sufficient to cause multilineage leukemia in 
mice [125], indicating a central role for active Stat5 in leukemogenesis (Chapter I-13). 
We observed constitutive Stat5 activation in mouse fetal liver cells that expressed high-
levels of exogenous Stat5. Constitutive Stat5 activation occurred abruptly once a 
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threshold of Stat5 expression was reached. This was observed in a sigmoidal relationship 
between FLAG-Stat5 expression and constitutive p-Stat5, suggesting that constitutive 
Stat5 activation occurred as the result of a cooperative interaction (Figure 2.12B).  
We showed that digital Stat5 signaling is bistable and that bistability is the result 
of an autocatalytic loop in which active Stat5 promotes further Stat5 activation (Figure 
2.12). The intrinsic ultrasensitivity observed in bistable systems helps setting the 
threshold for the activation of the positive feedback, so that it doesn’t get set off by 
“noise”, or in our case by background kinase levels (Chapter I-12). We think that high 
Stat5 levels are able to lower this threshold and therefore allow activation of the Stat5-
mediated positive feedback loop in the presence of background kinase levels, leading to 
constitutive Stat5 phosphorylation. Therefore, we hypothesize that in tumor cells that 
lack a constitutively active kinase but still exhibit constitutively active Stat5, selection for 
Stat5 overexpression could be the mechanism leading to constitutively active Stat5. In 
support of our hypothesis, an unexplained increase in Stat5 expression has been reported 
in patients with myeloproliferative diseases [266, 267]. In order to test the hypothesis that 
Stat5 overexpression can be oncogenic we plan to perform a bone marrow transplantation 
experiment using cells infected with a Stat5-expressing retrovirus. We predict that 
infected stem cells expressing high levels of Stat5 will be transformed and will give rise 
to leukemia.  
Understanding the regulation of Stat5 expression together with the mechanisms of 
its bistable activation could help us gain insights into the mechanisms of Stat5 mediated 
???
oncogenesis. In the long run, our findings will lead to the development of targeted 
therapies not only for the treatment of red blood cell diseases but also for cancer.  
???
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APPENDIX I: Contrasting Dynamic Responses in vivo of the 
Bcl-xL and Bim Erythropoietic survival pathways 
Abstract 
 Survival signaling by the erythropoietin (Epo) receptor (EpoR) is essential for 
erythropoiesis and for its acceleration in hypoxic stress. A number of apparently 
redundant EpoR survival pathways were identified in vitro, raising the possibility of their 
functional specialization in vivo. Here we used mouse models of acute and chronic stress, 
including a hypoxic environment and β-thalassemia, to identify two markedly different 
response dynamics for two early erythroblast survival pathways in vivo. Induction of the 
anti-apoptotic protein Bcl-xL is rapid but transient, whilst suppression of the pro-
apoptotic protein Bim is slower but persistent. Similar to sensory adaptation, however, 
the Bcl-xL pathway ‘resets’, allowing it to respond afresh to acute stress superimposed on 
a chronic stress stimulus. Using ‘knock-in’ mouse models expressing mutant EpoRs, we 
found that adaptation in the Bcl-xL response is due to adaptation of its upstream regulator 
Stat5, both requiring the EpoR distal cytoplasmic domain. We conclude that survival 
pathways show previously unsuspected functional specialization for the acute and chronic 
phases of the stress response. Bcl-xL induction provides a ’stop-gap’ in acute stress, until 
slower but permanent pathways are activated. Further, pathological elevation of Bcl-xL 
may be the result of impaired adaptation, with implications for myeloproliferative disease 
mechanisms.  
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Introduction 
 Hypoxic stress accelerates the production of red cells by up to ten fold [268]. 
Erythropoietin (Epo) is essential for both basal and stress erythropoiesis. Epo exerts its 
effect by activating its receptor, EpoR, on the surface of erythroid progenitors [210]. 
Colony-forming unit-erythroid (CFU-e) progenitors and their immediate proerythroblast 
and basophilic erythroblast progeny are Epo-dependent [269]. Until recently, the rarity of 
these cells within hematopoietic tissue confined their biochemical study to in vitro culture 
systems, where they were found to undergo apoptosis when deprived of Epo [270]. It was 
therefore suggested that Epo regulates erythropoietic rate through the number of 
erythroid progenitors it rescues from apoptosis [270].  
 Recently, we [14] and others [231, 271] made use of cell-surface markers to 
identify maturation-specific erythroblast subsets directly within freshly isolated mouse 
hematopoietic tissue [14], including the Epo-responsive ProE (proerythroblasts, 
CD71highTer119medium) and EryA (early basophilic erythroblasts, CD71highTer119high 
FSChigh). This approach confirmed the central role of apoptosis in the erythropoietic 
stress response, showing that a substantial fraction of the early erythroblast compartment, 
particularly splenic ProE and EryA, undergo apoptosis in vivo in the normal basal state. 
Stress-induced high Epo levels suppress apoptosis and consequently promote early 
erythroblast expansion and an increase in erythropoietic rate [14]. 
Although a number of EpoR-activated survival pathways have been identified 
[47, 130, 272-274], relevance to erythropoiesis in vivo was documented for only a few, 
largely through gene ‘knockout’ studies revealing abnormal basal or stress erythropoiesis 
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[130, 228, 275-277]. Importantly, it is unknown how multiple survival pathways integrate 
in vivo to provide a coherent erythropoietic stress response, and whether the large number 
of survival pathways represents redundancy or functional specialization. The study of 
these pathways in vivo, now made possible with the advent of flow-cytometric techniques 
(Chapter III)[14, 231, 271], may assist in answering this question.  
 We recently investigated the role of the death receptor Fas, and its ligand, FasL, 
which are co-expressed by early erythroblasts and suppressed by EpoR signaling in vivo 
[14, 206, 278]. We found that, in addition to regulating cell survival, this pathway 
stabilizes basal erythropoiesis and accelerates its response to stress [279]. Therefore, anti-
apoptotic pathways may have system-level functions that are not immediately apparent 
from their anti-apoptotic effects in culture. Here we set out to investigate two apoptotic 
regulators of the bcl-2 protein family that are targeted by EpoR signaling, the anti-
apoptotic protein Bcl-xL, and the pro-apoptotic Bim protein. Bcl-xL induction is a major 
survival pathway in erythroblasts [280, 281], where it is regulated by EpoR-activated 
Stat5 [130, 213] synergistically with GATA1 [133]. Bcl-xL-/- mice die in utero of anemia, 
and Bcl-xL-/- ES cells do not contribute to erythropoiesis in chimeric mice [282]. In a 
Stat5-deficient mouse [129], reduced Bcl-xL in early erythroblasts results in ineffective 
erythropoiesis and anemia [275]. Severe ineffective erythropoiesis in adult erythroblasts 
conditionally-deleted for Bcl-xL [277] is corrected if mice are also deleted for the pro-
apoptotic proteins Bax and Bak [283], suggesting that the requirement for Bcl-xL in 
erythropoiesis is due to its anti-apoptotic effect.  
 In spite of the clear role for Bcl-xL in basal erythropoiesis, it is not known 
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whether erythroblast Bcl-xL levels increase further during stress, contributing to enhanced 
erythroblast survival. Elevated levels of erythroblast Bcl-xL have been implicated in 
polycythemia vera [284, 285], suggesting that Bcl-xL-mediated enhanced erythroblast 
survival has the potential to increase erythropoiesis above the basal rate [285]. It is not, 
however, known if this happens physiologically. 
We contrasted Bcl-xL with Bim, a BH3-only pro-apoptotic Bcl-2 family protein 
[286]. Bim downregulation is a key component of survival signaling by cytokines and 
oncoproteins such as Bcr-Abl or Jak2V617F in hematopoietic progenitors [287, 288]. 
EpoR survival signaling in vitro was recently shown to be in part due to decreased Bim 
mRNA [273, 289] and to ERK-mediated phosphorylation and degradation of the Bim 
protein [289]. Further, Bim-/- mice have normal red cell numbers but these arise from a 
smaller pool of progenitors with enhanced survival [289]. Like Bcl-xL, in addition to 
EpoR signaling, Bim suppression is also mediated by GATA-1, via its transcriptional 
target LRF [290]. LRF-/- mice, which die in utero secondary to severe erythroblast 
apoptosis and anemia, were partly rescued by Bim deletion [290]. In spite of the clear 
role of Bim suppression in erythroblast survival, it is not known whether this pathway 
participates in the stress response.  
Here we used intracellular multiparameter flow cytometry to measure Bcl-xL and 
Bim in stage-specific erythroblasts directly in erythropoietic tissue of fetal and adult mice 
as they are undergoing differentiation and responding to stress in vivo. We found a 
similar, highly dynamic activation of the Bim and Bcl-xL survival pathways in the fetus 
that was dependent on both developmental day and erythroblast differentiation stage. 
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These pathways diverge, however, in the adult, where their contrasting dynamic 
responses suggest a clear segregation of function during the acute and chronic phases of 
the stress response.  
Results 
Erythroid developmental delay in Stat5-/- embryos 
The definitive erythropoietic lineage generates enucleated red cells and first begins in the 
murine fetal liver on embryonic day 11.5 (E11.5). Using cell surface markers CD71 and 
Ter119, we divided fresh fetal liver into a developmental sequence of increasingly mature 
subsets S0 to S5 [208] (Figure A1.1A). Most S0 cells (≥70%) are erythroid progenitors at 
the colony-forming unit stage (CFU-e), just preceding the onset of Epo/EpoR dependence 
that takes place at the transition from S0 to S1 [208]. Subsets S1 to S5 contain 
increasingly mature Epo-dependent CFU-e, proerythroblasts and erythroblasts [208]. 
Between E11.5 and E14.5, fetal liver cell number increases 1000 fold, and the majority 
shift in maturational stage from earlier erythroid progenitors and precursors (S0/S1/S2) at 
E11-E12, to late erythroblasts at E13-E14 [206] (Figure A1.1A). We previously showed 
that these dynamic changes are associated with an apoptosis rate that is dependent on 
both differentiation stage and developmental day [206]. Apoptosis is seen principally in 
CFU-e and early erythroblasts (S1-S2), where it is highest on E11.5, decreasing to a low 
value on E12-E12.5 and rising again on E13-E14 [206].  
 Given this dynamic picture, we set out to characterize the developmental and 
maturation-stage-specific expression of Bcl-xL and Bim in wild-type and in Stat5-/- mice 
(Figure A1.1). The Stat5-/- mice [68] are anemic in utero leading to perinatal death, a 
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similar but more severe phenotype to that of the hypomorphic Stat5 mouse in which only 
the first Stat5 exon is deleted [129, 130]. We first analyzed the CD71/Ter119 profiles on 
sequential developmental days and found that erythroblast maturation in the Stat5-/- 
embryos was delayed, as seen by their delayed progression from the S1 to S3 (Figure 
A1.1A, B). Specifically, on E12.5, the S1 subset contained only 10% of wild-type fetal 
liver cells, but 35% of the Stat5-/- fetal liver cells (p<0.005); by contrast, the more mature 
S3 subset contained ≥60% of wild-type, but only 20% Stat5-/- fetal liver (p=0.005). This 
pattern was not simply due to delayed expression of the cell surface markers Ter119 or 
CD71, as evident from cell size analysis of the S1 and S3 subsets using the flow-
cytometric forward scatter parameter, which was unaltered for cells in each respective 
subset (not shown).   
Bcl-xL and Bim expression in fetal liver is differentiation-stage and embryonic-day 
dependent  
 We assessed Bcl-xL and Bim protein expression using intracellular flow 
cytometry (Figure A1.1C, D), employing an anti-Bcl-xL antibody that we previously 
verified for its specificity [275], and an anti-Bim antibody whose specificity we verified 
using Bim-/- splenocytes (Figure A1.2A). We found that, consistent with previous 
findings in vitro [213, 281], Bcl-xL is expressed at very low levels in the early S0-S2 
compartment and increases with erythroblast differentiation (Figure A1.1C, D, upper 
panels). However, in addition, Bcl-xL expression was highly dependent on developmental 
day, with high levels in the early S0-S2 subsets of E11.5 embryos, decreasing rapidly in 
the same subsets with embryonic age (Figure A1.1D upper panel).  
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Expression of the anti-apoptotic Bim protein is also dependent on both 
differentiation stage and embryonic day. We found a highly significant increase in both 
the long (BimL) and extra-long (BimEL) transcripts (Figure 3.S1B, p<0.0001) and in the 
Bim protein (Figure A1.1D lower panel, p< 0.0001) with the transition from S0 to S1, a 
transition that marks the onset of erythroid progenitor dependence on EpoR [208]. This 
raised the possibility that induction of the pro-apoptotic Bim protein at the S0/S1 
transition may be the cause of EpoR dependence. However, we found no significant 
differences in Epo dependence or n the sensitivity of Bim-/- fetal liver erythroid 
progenitors to Epo using a CFU-e assay in vitro (Figure A1.2C). 
Bim protein expression peaks in S1 and is gradually suppressed with erythroid 
differentiation, reaching its lowest values in mature erythroblasts (Figure A1.1D lower 
panel). Similar to Bcl-xL, Bim expression was also a function of developmental day. For 
a given maturation subset, Bim expression is lowest on E11.5, peaking on E12.5, and 
decreasing in older embryos (Figure A1.1D). The changing fetal liver Bcl-xL and Bim 
during embryonic days E11.5-E12.5 match our previous findings of large changes in 
apoptosis, cell number and Fas expression at this time [206].  
Bim and Bcl-xL expression in fetal liver are regulated by Stat5 
The rapidly changing expression of Bim and Bcl-xL during E11.5-E12.5 (Figure 
A1.1D), and the developmental delay in the Stat5-/- fetal liver (Figure A1.1A, B), together 
impede our ability to assess the role of Stat5 in regulating Bim and Bcl-xL expression at 
this time. However, the CD71/Ter119 profiles and Bim and Bcl-xL expression begin to 
stabilize at E13.5, and the Stat5-/- fetal liver profile approaches that of wild-type embryos 
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(Figure A1.1A, B, D). We therefore compared Bim and Bcl-xL expression in Stat5-/- fetal 
liver and wild-type littermates on E13.5-E14.5 (Figure A1.1E, Figure A1.2D, E).  
Bcl-xL expression in the Stat5-/- fetal liver was 1.5 to 2 fold lower in the early 
erythroblast subsets S1 (p=0.01), S2 (p=0.03) and S3 (p=0.002). Bim levels in Stat5-/- 
fetal liver were 30% and 40% higher, respectively, in the S3 and S4/5 subsets (p<0.01), 
suggesting Stat5 regulates its expression. For comparison, we also assessed expression of 
the erythroblast apoptotic regulators Fas and FasL in the Stat5-/- fetal liver. We found no 
significant difference in Fas expression between Stat5-/- embryos and wild-type 
littermates (Figure A1.3). 
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Figure A1.1 Delayed maturation and altered Bcl-xL and Bim expression in Stat5-/- 
fetal liver. 
(A) Representative CD71/Ter119 profiles of Stat5-/- fetal livers and wild-type 
littermates freshly isolated on consecutive embryonic developmental days (E11.5 to 
E14.5). S0 to S4/5 are increasingly differentiated erythroid progenitors and precursors 
subsets [208]. Dead cells were excluded using LIVE/DEAD viability dye. 
(B) Summary statistics for analysis performed as in ‘A’, on 5 to 21 embryos per data 
point (mean ±SEM). Pooled from 3 independent experiments with multiple litters. Stars 
indicate statistically significant difference between wild-type and Stat5-/- subsets with the 
following p values: For S1, E12.5 *p=0.002, E13.5 *p=0.00001. E14.5 *p=0.014. For S3, 
E12.5 *p=0.005, E13.5 *p=0.00004. E14.5 *p=0.010 (two-tailed t-test, unequal 
variance). 
(C) Intracellular flow cytometry for Bcl-xL and Bim proteins, in the indicated fetal 
liver subsets. Representative histograms are shown. Freshly isolated wild-type E14.5 fetal 
liver cells were stained with CD71, Ter119 and the LIVE/DEAD viability dye as in ‘A’. 
Cells were then fixed, permeabilized and stained intracellularly: with an anti-Bcl-xL 
antibody, an anti-Bim antibody or with an IgG isotype control.  
(D) Bcl-xL and Bim protein expression profiles, measured as in panel ‘C’, in fresh 
wild-type fetal liver cells at the indicated embryonic days, in each of the indicated 
differentiation subsets S0 to S4/5. Expression is measured as median fluorescence 
intensity (MFI), from which non-specific background fluorescence, defined as the MFI of 
the corresponding subset when binding an isotype control antibody, was subtracted. Data 
points are mean ± SEM.  
For Bcl-xL: n=5 to 14 wild-type embryos per datapoint, pooled from 3 independent 
experiments with multiple litters. Statistical significance values: S1, E11.5 vs. E14.5, 
*p<0.05 (two-tailed t-test, unequal variance). E14.5 S2 vs. S3, and E14.5 S3 vs. S4-5, 
*p<0.0002 (paired t-test).  
For Bim: n=6 wild-type Balb/C embryos per datapoint. Statistically significance values: 
E13.5 S0 vs. E13.5 S1, *p<0.0001; E12.5 S1 vs. E12.5 S3, *p<0.0001; E11.5 S1 vs. 
???
E12.5 S1, *p<0.0001 (two-tailed t-test, unequal variance). Similar developmental pattern 
were observed in C57BL/6 and Balb/C backgrounds.  
(E) Lower Bcl-xL and higher Bim protein expression in E14.5 Stat5-/- embryos 
compared with wild-type littermate controls, at the indicated differentiation subset. 
For Bcl-xL: n=11 to 21 embryos per genotype, with each symbol type representing 
median expression for one litter. Means ± SEM for the population are indicated. 
Statistical significance values: S2, *p=0.03. S3, *p=0.002 (paired t test).  
For Bim: data points are individual embryos. Mean ±SEM for the population is shown. 
Statistical significance values: S3 and S4-5, *p<0.01, two-tailed t-test, unequal variance. 
See also Figure A1.2D, E. 
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Figure A1.2  Bim and Bcl-xL in fetal liver erythropoiesis. 
(A) Bim protein measurement by intracellular flow cytometry. Freshly explanted 
spleen cells from wild-type (blue) and Bim-/- (red) mice were stained with the LIVE/Dead 
viability dye, fixed, permeabilized, and stained with an anti-Bim antibody (Cell 
Signaling, #2819) or isotype control IgG, as described in materials and methods. Dead 
cells were excluded from analysis. 
(B) Quantitative real-time PCR for the Bim isoforms BimEL and BimL in sorted S0 
and S1 subsets from freshly harvested wild-type fetal liver. Data was expressed as a ratio 
to β-actin mRNA in each sample and normalized to the levels measured in S0 cells. 
Differences between S0 and S1 are statistically significant, BimEL+L, *p=0.0003; BimL, 
*p=0.0000004 (two-tailed t-test, unequal variance). 
(C) CFU-e assay performed on wild-type and Bim-/- fetal livers. CFU-e colonies per 
whole fetal liver are shown for each genotype. Data are mean ± SEM of 6 individual fetal 
livers per genotype from the same E13.5 litter. Grey bars are a pool containing one Bim 
wild-type embryo and five Bim+/- embryos. No significant (NS) difference in CFU-e 
numbers between the genotypes was observed (p>0.05, two-tailed t-test, unequal 
variance). Similar results were obtained when data were expressed as CFU-e colonies per 
1x106 plated cells. Representative of two similar experiments. 
(D) Lower Bcl-xL expression in Stat5-/- embryos compared with wild-type littermate 
controls, at the indicated embryonic day and differentiation subset. n=11 to 21 embryos 
per genotype, with each symbol type representing median expression for one litter. 
Means ± SEM for the population are indicated. Statistical significance values: E13.5 S1, 
*p=0.012 (paired t-test).  
(E) Higher Bim protein expression in Stat5-/- embryos compared with wild-type 
littermate controls: data points are individual embryos. Mean ±SEM for the population is 
shown. Statistical significance values: E13.5 S3 and S4-5, *p<0.01, two-tailed t-test, 
unequal variance. 
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Figure A1.3 Fas expression in E14.5 fetal liver erythroblasts. 
Cell-surface Fas was measured on freshly explanted fetal livers from wild-type or Stat5 
heterozygous embryos (n=6) and from Stat5-/- embryos (n=3). No significant differences 
were detected between the genotypes. (two-tailed t-test, unequal variance). 
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Bcl-xL is rapidly induced in adult early erythroblasts in response to a single Epo 
injection  
We examined Bcl-xL expression in response to a single dose of Epo, the principal 
mediator of the stress response. A single subcutaneous injection (300 U/25 g) results in a 
rapid increase in serum Epo, peaking by 6 hours, persisting for 24 hours and declining to 
baseline by 36 hours (Figure A1.4A). We measured Bcl-xL expression by intracellular 
flow cytometry, in each of the adult flow-cytometric erythroblast subsets ProE, EryA, 
EryB and EryC [14] (Chapter III and Figure A1.4B), in freshly explanted bone-marrow 
and spleen at the indicated time points (Figure A1.4C-E). In control, saline-injected mice, 
Bcl-xL expression increases 6 fold with differentiation from ProE to EryC in both bone-
marrow and spleen, a pattern similar to that of fresh fetal liver (representative histograms 
in Figure A1.4C, summary of several experiments in Figure A1.4E). Injected Epo caused 
a further induction of Bcl-xL expression in all erythroblast subsets (Figure A1.4C, E). 
Proportionally, this increase was largest and most rapid in the earliest subsets, where 
basal Bcl-xL levels are lowest, and where it peaked 5 fold its basal level within 16 hours 
of Epo injection in splenic ProE (p=0.0006) and 3 fold by 18 hours in splenic EryA 
(p=0.0009) (Figure A1.4C, E).  
To assess the sensitivity of the Bcl-xL pathway to injected Epo, we carried out a 
dose/response curve in vivo, injecting mice with the indicated Epo dose and examining 
peak Bcl-xL expression at 18 hours in splenic EryA (Figure A1.4D). This analysis shows 
that half the maximal response is obtained with the injection of 3 U/25 g, estimated to 
result in a serum concentration of 0.3 U/ml, approximately a ~10 fold increase above 
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basal serum Epo. This response is more sensitive than that of the Fas-suppression 
pathway, where we found a half-maximal response with an injection of 10 U/25 g [279].  
Induction of the Bcl-xL protein is associated with an increase in the Bcl-xL mRNA 
that follows a similar time course (Figure A1.5A). 
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Figure A1.4 Bcl-xL induction in adult early erythroblasts in response to Epo 
injection. 
(A) Time course of plasma Epo, assayed by ELISA, following a subcutaneous 
injection of 300 U/ 25 g. Two mice (identified as either circles or triangles) were assayed 
per time point.  
(B) Gating strategy for freshly explanted ProE, EryA, EryB and EryC spleen 
erythroid subsets [14]. Live cells were selected, and subsets gated based on Ter119, 
CD71 expression and forward scatter (FSC). 
(C) Representative flow-cytometric histograms of intracellular Bcl-xL protein in the 
indicated spleen erythroblast subsets. Anti-Bcl-xL antiserum was used to stain 
erythroblasts from a saline-injected mouse (blue histograms), or an Epo-injected mouse 
(300 U/ 25 g, red histograms) in freshly explanted spleen at 18 hours post injection. An 
isotype control antibody was used to measure the non-specific binding in each subset 
(grey histograms). 
(D) Epo dose/ Bcl-xL response in vivo in spleen EryA. Wild-type Balb/C mice were 
injected subcutaneously with either saline (=basal, blue circle) or a single, increasing 
dose of Epo (1, 3, 10, 20, 30, or 300 U/ 25 g, red circles). Bcl-xL was measured by flow 
cytometry as in panel ‘C’ at 18 hours post-injection, with the non-specific fluorescence 
reading subtracted for each subset. Data from two independent experiments was pooled 
and normalized. Datapoints were fitted with a Hill curve. Each datapoint represents mean 
±SEM of n=3 to 4 mice. 
(E) Bcl-xL expression measured as in panel ‘C’ in freshly explanted spleen, in each 
erythroblast subset at each of the indicated time-points following a single Epo injection 
(300 U/ 25 g). Each data point for Epo-injected mice is mean ±SEM of n=4 mice for 
t=16, 18, 24, 48 hours; and mean of 2 mice for t=12 hours. Blue curves are mean ±SEM 
of n=14 saline-injected mice pooled from all time-points. The same blue curves are 
reproduced for comparison with Epo-injected mice at each time-point). Statistical 
significance values: ProE at t=16h, in bone-marrow *p=0.005, in spleen *p=0.0006. 
EryA in spleen, *p=0.0009 at 16h, *p=0.0009 at 18h. EryA in bone-marrow, *p=0.013 at 
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16h, *p=0.015 at 18h. The induction of Bcl-xL in splenic EryA was significantly higher 
than in bone-marrow EryA (*p=0.021). Two-tailed t-test with unequal variance used for 
all comparisons. 
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Expression pattern of Bim in basal and stress adult erythropoiesis 
 We used intracellular flow cytometry in adult spleen and bone-marrow, freshly 
explanted at the indicated time points following either saline or Epo injection (300 U/ 
25g), to examine Bim expression. Bim is expressed at its highest levels in the early, ProE 
subset, declining gradually in subsequent differentiation subsets and reaching a quarter of 
its ProE level in EryC (Figure A1.5B). In response to an Epo injection Bim levels 
decreased further in all subsets (Figure A1.5B, C), with the largest decline in the early 
bone-marrow and spleen ProE progenitors, where they fell ~2 fold (p<0.0001).  
Importantly, the time course of Bim suppression in response to Epo injection was 
much slower, and more prolonged, than the Bcl-xL response. Maximal Bim suppression 
was reached at 72 hours post injection in most subsets, a time when the Bcl-xL induction 
had already peaked and returned to baseline (Figure A1.5C).  
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Figure A1.5 Transient Bcl-xL induction contrasts with slower Bim suppression in 
response to Epo injection. 
(A) Time course of Bcl-xL mRNA expression following a single Epo injection (300 
U/ 25g), in freshly isolated and sorted spleen and bone-marrow EryA. Quantitative real-
time PCR, data points are mean ±SEM of 3 independent experiments. Data is expressed 
relative to the β-actin mRNA and normalized to the value in bone-marrow EryA in 
saline-injected mice.  
(B) Bim protein expression in adult erythroid differentiation subsets 3 days following 
a single injection of either Epo (red, 300 U/ 25 g) or saline (black). Bim was measured by 
flow cytometry in freshly explanted tissue, as illustrated in Figure A1.2A. Data are mean 
±SEM of n=21 mice for saline injection, and n=10 mice for Epo injection. *p<0.000005 
(two-tailed t-test, unequal variance) for differences between Epo-injected and saline-
injected mice. 
(C) Time course of Bcl-xL upregulation (red symbols, plotted on the left, red-
numbered y-axis) and Bim suppression (black symbols, plotted on the right-numbered y-
axis) in spleen (circles) and bone-marrow (BM, triangles) in response to a single Epo 
injection (300 U/ 25 g) on day 0. Includes a subset of the data plotted in panel ‘B’ (for 
Bim) and Figure A1.4E (for Bcl-xL). For Bim, 5 experiments were normalized together. 
Bim data are mean ±SEM of n=21 mice for day 0, and n=3 to 10 mice for days 1 to 5. 
Bim ProE curves (black lines) for spleen and bone-marrow were hand-drawn. Statistical 
analysis was performed by comparing Bim readings on day 0 with readings on the 
following days. Where indicated, spleen ProE: *p<0.005. Spleen EryA: *p<0.025. BM 
ProE: *p<0.02; BM EryA: *p<0.01. For all statistical tests, two-tailed t-test with unequal 
variance was used. 
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The erythroblast response to reduced atmospheric oxygen 
The modulation of erythroblast Bim and Bcl-xL levels by an Epo injection in vivo 
suggested that these pathways are likely to play a role in the physiological stress 
response. To test this, we placed mice in a reduced oxygen environment in which 
atmospheric partial oxygen pressure was reduced to 11% for up to 5 days (Figure A1.6). 
Epo levels in blood plasma rose rapidly in the first 24 hours, from a basal level of 12 
mU/ml, to a peak of 29 mU/ml (p=0.001). This high Epo level was sustained until day 3. 
On days 4 and 5 Epo began to decline to a new lower plateau of 18 mU/ml (Figure 
A1.6A).  
 The hematocrit response was rapid, rising from 51.5% to 56% in the first 24 
hours, and reaching a sustained plateau of 57% (Figure A1.6B). The rapid initial increase 
in hematocrit is likely in part to be the result of plasma volume adjustment in response to 
hypoxia [291, 292].  
 We examined the response of individual flow-cytometric erythroblast subsets in 
freshly explanted tissue at the indicated time points (Figure A1.6C-I). The results shown 
are from 23 pooled experiments, with at least 6 mice per time point. To evaluate the 
various responses in relation to the plasma Epo levels, the Epo response in Figure A1.6A 
is replicated as a gray line in subsequent panels (Figure A1.6E-I). 
 The absolute numbers of spleen ProE and EryA erythroblasts increased over the 
initial 3 days, reaching new plateaus that were 4 and 3 fold higher than basal values, 
respectively (Figure A1.6C, D). This increase in cell number was associated with a 
marked and significant reduction in apoptosis, with the number of Annexin V+ cells 
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declining from 55% to 32% (p=0.002) and 42% to 30% (p=0.001) in the ProE and EryA 
subsets, respectively (Figure A1.6E). 
The response of erythroblast Bim, Fas and Bcl-xL to reduced atmospheric oxygen 
 Given the clear changes in ProE and EryA apoptosis, we investigated their 
expression of the apoptotic regulators Fas, Bim and Bcl-xL. We previously showed that 
cell surface Fas on spleen ProE and EryA decreases in response to a number of acute and 
chronic erythropoietic stress conditions. Maximal Fas suppression is reached within 24 to 
48 hours and is maintained for the duration of the stress stimulus (Figure A1.6F) [14, 
279].  
 The Bcl-xL response was rapid and transient, its expression peaking by 18 hours 
in both ProE and EryA, and then rapidly dipping below baseline by 24 hours, in spite of 
the persisting high Epo levels (Figure A1.6G). The response of Bim, by contrast, was 
slower, reaching maximal suppression at 48 hours, with low levels maintained for the 
duration of high Epo levels (Figure A1.6H, I).  
 We examined the possibility that the transient increase in Bcl-xL may be due to 
the relatively modest increase in plasma Epo generated by the hypoxic environment. We 
injected mice with Epo (300 U/ 25 g) daily for 3 consecutive days, which generates 
increasingly high plasma Epo equivalent to that of maximal stress conditions [268] 
(Figure A1.1A). We measured the Bcl-xL response 18 hours following each injection 
(Figure A1.7). The amplitude of the Bcl-xL response was larger in response to this higher 
Epo dose than in the response to the hypoxic environment, as expected from the Epo 
dose/Bcl-xL response curve (Figure A1.4). However, the response to the second and third 
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Epo injections was smaller or absent (Figure A1.7), suggesting that the transience of the 
Bcl-xL response is unrelated to Epo dose. 
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Figure A1.6 A reduced oxygen environment elicits a rapid, transient Bcl-xL 
induction and a slow, persistent Bim suppression. 
(A – I) Mice were placed in a low oxygen chamber (11%) on day 0, for the numbers of 
days indicated. 
(A) Endogenous plasma Epo, assayed by ELISA. Data are mean ±SEM. Difference 
relative to day 0 (n=27 mice) were significant at the following levels: day 1 (n=6) 
*p=0.001; day 3 (n=6), *p=0.006; day 4 (n=12), *p<0.0001; day 5 (n=3), *p=0.0000005. 
This Epo time course is drawn as a grey line in panels E to I. 
(B) Daily hematocrit (HCT) measurement on blood collected immediately post 
euthanasia. Data are mean ±SEM of n≥6 mice per time-point. Differences from day 0 are 
significant at the following levels: 12h, *p=0.019; 18h to day 5, *p<0.0002. 
(C-D) Absolute number of spleen ProE and EryA per gram body weight. Data pooled 
from 23 independent experiments. Each datapoint is mean ±SEM of n≥6 mice. 
Differences from day 0 (n=82 mice) are significant at the following levels: Spleen ProE 
day 1, *p=0.005; day 2, *p=0.047; days 3 to 5, *p≤0.005. Spleen EryA day 2, *p=0.034; 
days 3 to 5, *p≤0.001. 
(E) Annexin V binding in spleen ProE (blue) and EryA (black). Data points are mean 
±SEM of 33 mice for day 0 and 3 to 7 mice for subsequent days, pooled from 2 to 5 
independent experiments per day. Differences from day 0 are significant at the following 
values: Spleen ProE days 3 to 5, *p≤0.002. Spleen EryA day 1, *p=0.001; day 3, 
*p=0.03; day 4, *p=0.02; day 5, *p=0.001.  
(F) Fas-positive cell frequency in spleen ProE (blue) and EryA (black), measured by 
flow cytometry in freshly explanted tissue. Data are mean ±SEM of n=26 mice, pooled 
from 4 experiments (day 0) or n=3 mice for subsequent days. Differences from day 0 are 
significant at the following values: Spleen ProE day 1, *p=0.024; day 3, *p<0.00001; day 
5, *p=0.001. Spleen EryA day 5, *p=0.04.  
(G) Bcl-xL protein expression in spleen ProE and EryA measured by flow cytometry 
in freshly explanted tissue. Data pooled from three independent experiments. Each data 
point is mean ±SEM of n≥3 mice. Differences from day 0 (n=17) are significant at the 
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following levels: Spleen ProE 18h (n=3), *p<0.001; 24h (n=7), *p=0.019; day 2 (n=5), 
*p<0.0005. Spleen EryA 12h, *p=0.046; 18h, *p<0.0001; day 2, *p=0.02 
(H-I) Bim protein expression in spleen (H) and bone-marrow (I) ProE and EryA, 
measured by flow cytometry in freshly explanted tissue. Data are mean ±SEM of n≥3 
mice. Differences from day 0 are significant at the following levels: Spleen ProE day 4, 
p=0.04. Spleen EryA day 3, p=0.04; day 4, p=0.02. Bone-marrow ProE day 2, p=0.007; 
day 3, p<0.00001; day 4, p<0.001; day 5, p=0.04. Bone-marrow EryA day 1, p=0.002; 
day 2, p=0.0001; day 3, p=0.05. 
For all statistical tests, two-tailed t-test with unequal variance was used. 
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Figure A1.7 The Bcl-xL response to repeated Epo injections. 
Bcl-xL expression following consecutive Epo injections. Wild-type mice were injected at 
time-points 0, 24 and 48 hours with either Epo (300 U/25g, indicated with arrowheads) or 
with saline. Bcl-xL expression was assayed by flow cytometry in 2 mice for each 
treatment, 18 hours following each injection. 
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Response of the Bim and Bcl-xL pathways to chronic erythropoietic stress  
We went on to assess the Bim and Bcl-xL response to chronic erythropoietic stress. The 
Bcl-xL expression profiles in the ProE/ EryA-C subsets in either spleen or bone-marrow 
was unaltered by 3 distinct erythropoietic stress conditions: pregnancy at mid-gestation, 
chronic anemia due to β-thalassemia [293], and chronic erythrocytosis due to tissue-
specific deletion of the von Hippel-Lindau gene that results in elevated Epo (ts-VHL-/-) 
[294] (Figure A1.8A). Plasma Epo is elevated to 30 mU/ml and 220 mU/ml in the ts-
VHL-/- and β-thalassemia mice, respectively (Figure A1.9), a concentration range in 
which Bcl-xL induction was seen in acute stress (Figure A1.6). Further, we have 
previously shown that cell surface Fas and FasL are downregulated in the same chronic 
stress models [14]. 
Unlike Bcl-xL, Bim expression in the β-thalassemia mice was suppressed in all 
erythroblast subsets (Figure A1.8B), to levels similar to those seen in response to an acute 
Epo injection (Figure A1.5B). 
The Bcl-xL response to an ‘acute on chronic’ stress stimulus 
  The transience of the Bcl-xL response to stress is reminiscent of sensory systems 
that undergo adaptation, such as neutrophil chemotaxis or sensory neural adapting 
systems. These systems respond to a change in the stimulus, rather than to absolute 
stimulus levels [215]. We therefore asked whether the desensitization of the Bcl-xL 
pathway to chronic stress was permanent, or whether an acute change in the level of 
stress, superimposed on a chronic stress stimulus, would re-stimulate Bcl-xL induction.  
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 We injected β-thalassemia mice with a single Epo dose of 300 U/25 g, and 
examined their Bcl-xL response at 18 hours post injection. We found a clear induction in 
Bcl-xL in all erythroblast subsets in the β-thalassemia mice, closely resembling that of 
control mice in the bone-marrow, and only a little short of the wild-type response in the 
spleen (Figure A1.8C). This experiment suggests that while the Bcl-xL response 
desensitizes to chronic stress, it rapidly responds to new changes in stress superimposed 
on the chronic stress levels. 
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Figure A1.8 The Bcl-xL response to chronic stress and to ‘acute on chronic’ stress.  
(A) Bcl-xL expression in each of the three indicated mouse models of erythropoietic 
stress (red symbols) and matched controls (blue symbols), measured in freshly explanted 
tissue. Each data point is mean ± SEM of 2 to 4 mice. There were no statistically 
significant differences between chronic stress and control mice. 
(B) Representative experiment showing Bim expression in β-thalassemia mice in 
spleen (top) and bone-marrow (bottom). Two wild-type (black symbols) and one β-
thalassemia mouse (red symbols) are shown.  
(C) The Bcl-xL response to an ‘acute on chronic’ stimulus. Bcl-xL expression in 
spleen and bone-marrow erythroblasts in β-thalassemia mice and matched controls, 18 
hours following a single injection of either Epo (300 U/ 25g, red symbols) or saline (blue 
symbols). Datapoints are mean ±SEM of n=3 to 4 mice. Representative of 4 independent 
experiments. Statistically significant differences in Bcl-xL between Epo and saline 
injections in each mouse model were seen in wild-type spleen ProE, *p=0.025; EryA, 
*p=0.0009; EryB, *p=0.01; EryC, *p=0.006; β-thalassemia spleen EryA, *p=0.0004; 
EryB, *p=0.004; EryC, *p=0.03; Wild-type BM EryA, EryB and EryC, *p≤0.0005; β-
thalassemia BM EryA and EryB, *p<0.0005; EryC, *p=0.025. The increase in spleen 
EryA Bcl-xL was significantly higher (p=0.023) in wild-type spleen than in wild-type β-
thalassemia mice. For all statistical tests, two-tailed t-test with unequal variance was 
used. 
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Figure A1.9 Plasma Epo measurements in mice with β-thalassemia and  
in ts-VHL-/- mice.  
For each mouse model, two independent ELISAs, each with similar results, were pooled 
together. Individual mouse data as well as mean ± SEM are shown. Epo increase in β-
thalassemia was significant at p=0.002 (two-tailed t-test, unequal variance). 
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Stat5 activation in vivo undergoes adaptation 
 We asked whether adaptation in the Bcl-xL stress response is due to adaptation in 
Stat5, its upstream regulator. We first examined the time course of Stat5 activation in 
vivo following Epo injection (300 U/ 25g), using intracellular flow cytometry in freshly 
explanted spleen and bone-marrow at the indicated time points post-injection (Figure 
A1.10A). The number of ProE and EryA containing active, phosphorylated Stat5 (p-
Stat5) increased rapidly following injection, peaking by 30 minutes, but declining rapidly 
to a lower level by 6 hours (Figure A1.10A). Of note, plasma Epo peaked at 6 hours 
(Figure A1.1A), suggesting the decline in p-Stat5 is intrinsic to the p-Stat5 response and 
is not due to declining Epo.  
 Signal adaptation may be due to negative feedback [295, 296]. p-Stat5-mediated 
transcriptional activation of SOCS family proteins results in their feedback inhibition of 
the Jak2 and Stat5 response [297]. This negative regulation in part depends on SOCS 
protein binding to phosphotyrosines on the activated EpoR cytoplasmic domain [210]. To 
investigate the possibility that Stat5-mediated negative feedback is responsible for 
adaptation in the p-Stat5 response, we investigated two ‘knock-in’ mouse models, 
expressing the EpoR mutants EpoR-H and EpoR-HM [46], both lacking the negative 
regulatory distal portion of the EpoR cytoplasmic domain containing 7 of its 8 
phosphotyrosines, including SOCS family docking sites [210]. In EpoR-HM, the 
remaining Y343, a Stat5 docking site, is mutated to phenylalanine [46]. The EpoR-H 
mouse has a mildly elevated basal hematocrit. By contrast, the EpoR-HM mouse has only 
a mild anemia in the basal state but a deficient stress response [46].  
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 We tested the response of freshly harvested fetal liver early erythroblasts derived 
from EpoR-H, EpoR-HM and wild-type embryos to continuous stimulation with Epo for 
up to 6 hours in vitro. The time course of response of wild-type erythroblasts was similar 
to that of adult erythroblasts in vivo (Figure A1.10A,B). The peak p-Stat5 response to 
Epo stimulation in EpoR-HM erythroblasts was 15% of the response in wild-type or 
EpoR-H mice, in agreement with previous results [25]. In EpoR-H erythroblasts, peak p-
Stat5 was similar to that of the wild-type response, though baseline p-Stat5 was higher. In 
both EpoR-HM and EpoR-H, duration of the initial p-Stat5 peak was prolonged 
substantially (Figure A1.10B). These findings suggested that the distal EpoR cytoplasmic 
domain, likely through binding to Stat5-induced SOCS family proteins, is responsible for 
curtailing the p-Stat5 response. 
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Figure A1.10 Adaptation in the Bcl-xL and p-Stat5 responses is dependent on the 
EpoR C-terminal cytoplasmic domain.  
(A) The p-Stat5 response in spleen ProE and EryA in vivo, measured in freshly 
explanted spleen at the indicated time points following a single Epo injection (300 U/ 
25g). Data is pooled from four independent experiments. Each time point is the mean ± 
SEM of data from 2 to 4 mice. 
(B) The p-Stat5 time course in response to Epo stimulation for the indicated periods. 
Freshly harvested fetal liver cells from EpoR-HM, EpoR-H and matched wild-type 
embryos at E13.5 were stimulated in vitro with 2 U/ml Epo. p-Stat5 in S1 cells is shown, 
expressed as median fluorescence intensity above background (isotype-control antibody). 
Representative of 3 similar experiments. 
(C) The Bcl-xL response in EpoR-H and EpoR-HM mice. Bcl-xL was measured 18 
hours following a single injection of either Epo or Saline, in freshly explanted spleen 
ProE and EryA of EpoR-H, EpoR-HM or wild-type controls. Data are mean ±SEM of 
n=3 to 5 mice per bar. Significant Bcl-xL increase from basal levels in spleen ProE and 
EryA was seen in Epo vs. Saline injected wild-type (black) and EpoR-H (red) mice (stars 
without brackets: WT ProE *p=0.003; EpoR-H ProE *p=0.012; WT EryA *p=0.00004; 
EpoR-H EryA *p=0.0001), but not in EpoR-HM mice. Bcl-xL was reduced in basal state 
EpoR-HM spleen EryA (red star with red bracket, *p=0.027) compared with wild-type 
basal control. Bcl-xL induction in wild-type spleen EryA was significantly above that of 
EpoR-HM EryA (black stars with brackets, *p=0.007, two-tailed t-test with unequal 
variance). 
(D) Time course of the Bcl-xL response in EpoR-H mice and in matched wild-type 
controls, following a single Epo injection (300 U/ 25g). Measurements were made in 
freshly explanted spleen at the indicated time points. Bcl-xL is significantly higher in 
EpoR-H at 36 and 48 hours (p<0.005, paired t test on all subsets).  
(E) Bim protein in spleen ProE and EryA of wild-type and EpoR-HM mice on day 3 
following a single Epo injection (300 U/ 25 g). Data are mean ± SEM of n=4 to 5 mice 
per bar. There was no significant difference in basal Bim between EpoR-HM and wild-
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type control mice. Bim was significantly suppressed following Epo injection (*p<0.001). 
Bim was suppressed by a significantly smaller extent in EpoR-HM ProE and EryA 
subsets (stars with brackets, *p=0.03 and *p=0.001, respectively, two-tailed t-test with 
unequal variance).  
(F) The p-Stat5 histograms in vivo at peak response (30 minutes) following a single 
injection of either Epo (300U / 25g) or saline, in either β-thalassemia mice or in matched 
wild-type controls, measured in freshly explanted spleen ProE. The p-Stat5+ gate was 
drawn based on the non-erythroid population in spleen (grey histograms). 
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Figure A1.10 
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The Bcl-xL and Bim stress responses in EpoR-H and EpoR-HM mice 
 The finding that the p-Stat5 signal undergoes adaptation (Figure A1.10A, B) 
suggests it may be responsible for the adaptation in the Bcl-xL response. To test this, we 
asked whether failure of p-Stat5 adaptation in the EpoR-H mice (Figure A1.10B) would 
prevent adaptation of the Bcl-xL response.   
 We therefore injected EpoR-H mice with Epo (300 U/ 25g) and examined the 
resulting induction in Bcl-xL. The peak Bcl-xL response was closely similar to that of 
matched wild-type control mice (Figures A1.10C, A1.11A). There was little increase in 
Bcl-xL in EpoR-HM mice, consistent with p-Stat5 as the principal regulator of the Bcl-xL 
stress response (Figures A1.10C, A1.11A). Importantly, there was a failure of adaptation 
of the Bcl-xL response in EpoR-H mice. Bcl-xL levels remained elevated well above their 
initial baseline at 36 and 48 hours post-injection in spleen ProE, and at 36 hours in EryA 
and EryB (p<0.005, Figure A1.10D), even though Bcl-xL levels in wild-type mice (Figure 
A1.10D) and serum Epo (Figure A1.4A) had returned to baseline. This strongly suggests 
that adaptation in the Bcl-xL response requires the EpoR distal cytoplasmic domain and is 
most likely a result of adaptation in the p-Stat5 response, also dependent on this domain 
(Figure A1.10B).  
 Bim expression was suppressed in EpoR-HM mice in response to a single Epo 
injection (300 U/ 25 g). However, suppression was less efficient than in wild-type mice, 
by a small but statistically significant amount (Figures A1.10E, A1.11B, p=0.03 and 
p=0.001 in ProE and EryA, respectively). These results suggest that, in addition to Stat5, 
other pathways, likely ERK, regulate the EpoR-mediated Bim suppression [289].  
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Figure A1.11 The Bcl-xL and Bim Epo responses in the EpoR-H and EpoR-HM 
mice. 
Experiment and same mouse dataset as in Figure A1.10C, A1.10 E.  
(A) Bcl-xL expression in spleen (left) and bone-marrow (right) in erythroid subsets, 18 
hours post- Epo or saline injection in wild-type, EpoR-H, and EpoR-HM mice. 
Experiment and same mouse dataset as in Figure A1.10C.  
 Left panel: Black stars without brackets indicate significant Bcl-xL induction in 
spleen EryB and EryC subsets in Epo treated mice (*p<0.005). No significant Bcl-xL 
induction was observed in EpoR-HM spleens (light blue vs. dark blue bars). EpoR-HM 
mice failed to increase Bcl-xL to the level of EpoR-H or wild-type mice (black stars with 
brackets, *p<0.02). Basal Bcl-xL levels in EpoR-HM EryB and EryC were also lower 
than in basal wild-type mice (red stars with red brackets, *p<0.05). 
 Right panel: Bcl-xL induction in the bone-marrow erythroid subsets was observed 
for all three genotypes. Stars indicate significant differences. Wild-type Epo response vs. 
control: ProE, EryA and EryB, *p<0.0002. EpoR-H Epo response vs. control: ProE, EryA 
and EryB, *p<0.0001; EryC, *p=0.025. EpoR-HM Epo response vs. control: ProE, 
*p=0.003; EryA, EryB and EryC, *p<0.05. Magnitude of Bcl-xL induction in EpoR-HM 
subsets was lower compared with wild-type induction (black stars with brackets, 
*p<0.006). Basal Bcl-xL levels in EpoR-HM bone-marrow subsets were lower than in 
basal wild-type mice (red stars with red brackets, *p<0.02).  
(B)  Bim expression in spleen (left) and bone-marrow (right) in erythroid subsets, 3 
days following Epo or saline injection in wild-type, EpoR-H, and EpoR-HM mice. 
Experiment and same mouse dataset as in Figure 3.6E. Data are mean ±SEM of n=4 to 5 
mice per bar.  
 In both wild-type and EpoR-HM spleen EryB and EryC subsets, Bim was 
significantly suppressed below their respective basal levels with Epo (black stars, no 
brackets, *p<0.001). Similar findings were observed in the bone-marrow subsets (wild-
type subsets: *p<0.0005; EpoR-HM subsets: *p<0.03). Magnitude of Bim suppression in 
EpoR-HM mice was lower than in the wild-type mice (black stars with brackets, 
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*p<0.005). Some differences in basal Bim levels were observed between wild-type and 
EpoR-HM mice (gray bars vs. light blue bars, not indicated in plots: spleen EryB, p=NS; 
spleen EryC, *p=0.02; BM ProE, *p=0.004; BM EryA, *p=0.01; BM EryB, p=NS; BM 
EryC, *p=0.03). 
???
Figure A1.11 
 
 
???
The p-Stat5 response to an ‘acute on chronic’ stress stimulus 
 Although Bcl-xL expression is not elevated in chronic stress, it is induced in 
response to an acute stimulus superimposed on the chronic stress stimulus (Figure 
A1.8C). Given the proposed role of Stat5 activation in Bcl-xL induction, we similarly 
examined the p-Stat5 response to chronic and ‘acute on chronic’ stress stimuli. We found 
no increase in the level of p-Stat5 activation in ProE freshly isolated from β-thalassemic 
mice (Figure A1.10F, upper panel), in spite of the chronically elevated plasma Epo in 
these mice (Figure A1.9). A single injection of Epo (300 U/25 g) however, resulted in a 
rapid increase in p-Stat5 activation in both β-thalassemic mice and in matched control 
mice (Figure A1.10F, lower panels). Therefore, both the p-Stat5 and Bcl-xL responses 
‘reset’ during chronic stress, allowing them to respond afresh to an acute change in stress. 
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Discussion 
We examined Bim suppression and Bcl-xL induction, two EpoR-activated 
erythroblast survival pathways in fetal and adult basal and stress erythropoiesis. Their 
analysis in vivo revealed previously unsuspected functional specialization of EpoR- 
pathways to either the chronic or acute phases of the stress response. Bcl-xL induction 
behaves like a classical sensory adapting pathway, being insensitive to the prevailing 
level of stress, and instead responding only to changes in stress level. Adaptation allows 
Bcl-xL to provide a stop-gap at the onset of stress that rapidly rescues early erythroblasts 
from apoptosis, until slower but persistent stress pathways, such as Bim or Fas 
suppression, are activated. Mechanistically, we suggest that adaptation in the Bcl-xL 
response is the result of adaptation in the response of p-Stat5, its upstream regulator.  
Regulation of Bim and Bcl-xL expression in early vs. late erythroblasts  
We delineated the expression pattern of both Bim and Bcl-xL proteins throughout 
erythroid maturation in adult and fetal hematopoietic tissue in vivo. The basal pattern 
observed in the absence of stress is one of low Bcl-xL and high Bim in early erythroblasts, 
gradually inverting with differentiation so that in mature erythroblasts Bim levels are 
low, and Bcl-xL levels are high (Figure A1.12A). These results are consistent with the 
previously reported increase in Bcl-xL transcript and protein with erythroid differentiation 
in vitro [213, 281], and with the increase in Bcl-xL and decrease in the pro-apoptotic Bid 
and Bax transcript with the transition from early to late erythroblasts in murine bone-
marrow [271]. Together with our previous findings of high Fas and FasL co-expression in 
early, but not late, erythroblasts [14, 19, 206], a strong pattern emerges of apoptosis-
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prone early erythroblasts, containing high levels of pro-apoptotic regulators and only low 
levels of anti-apoptotic proteins, gradually transitioning into apoptosis-resistant late 
erythroblasts in which anti-apoptotic proteins predominate. This underlying pattern 
explains why high levels of apoptosis are seen in early erythroblasts but not in late 
erythroblasts during normal fetal and basal adult erythropoiesis in vivo [14, 19, 206, 279] 
(Figure A1.1D, Figure A1.4E and A1.5B), and was recently suggested as being 
responsible for the sensitivity of early erythroblasts to irradiation [271].  
Bcl-xL expression is regulated by both GATA-1 and by EpoR-activated Stat5 
[133]. Similarly, Bim suppression is regulated by both EpoR-activated ERK [289] and by 
GATA-1-induced LRF [290]. Here we find that in addition, Bim is regulated by EpoR-
activated Stat5, as suggested by higher Bim levels in the Stat5-/- fetal liver and to a lesser 
extent in the adult EpoR-HM mouse (Figure A1.1E, Figures A1.10E, A1.11B). Lower 
Bcl-xL in the S1-S3 subsets of the Stat5-/- fetal liver, and in EpoR-HM mice in the basal 
state, support older reports of the role of Stat5 in the induction of erythroid Bcl-xL [130, 
213, 275]. The role of Stat5 is especially notable, however, in the Bcl-xL stress response, 
which is absent in the EpoR-HM mice (Figure A1.10C).  
Based on their expression patterns, we propose that EpoR and GATA-1 -mediated 
regulation of Bim and Bcl-xL are largely segregated into the early and late erythroblast 
compartments, respectively (Figure A1.12A). Specifically, the underlying, largely stress-
insensitive gradual increase in Bcl-xL and gradual suppression of Bim with 
differentiation, is likely to be mediated by GATA-1. Superimposed on this pattern are 
Epo-mediated, stress-dependent adjustments that accelerate Bcl-xL induction and Bim 
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suppression in early erythroblasts (Figures A1.4 and A1.5 , Figure A1.12 A). Thus, only 
the apoptosis-prone CFU-e, proerythroblasts and early basophilic erythroblasts (=’early 
erythroblast compartment’) are dependent on EpoR signaling for survival in the basal 
state. Further, during hypoxic stress, it is principally the early erythroblast compartment 
that is Epo-responsive, undergoing expansion as a result of a rapid drop in apoptosis [14, 
19, 206, 279] (Figure A1.6E). The susceptibility of the early erythroblast compartment to 
apoptosis is precisely the characteristic that gives plasticity to the erythropoietic system, 
allowing the level of EpoR signaling to determine erythropoietic rate. 
We previously showed that Epo-mediated suppression of early erythroblast 
apoptosis during stress is strongly correlated with suppression of early erythroblast Fas. 
Using Fas and FasL-mutant mice, we recently found that the Fas suppression pathway 
accounts for ~30% of the early erythroblast expansion in stress [279]. Bim suppression 
and Bcl-xL induction are therefore likely to cooperate with Fas suppression, and 
potentially with as yet uncharacterized other anti-apoptotic pathways, in achieving the 
full expansion of the early erythroblast compartment during stress.  
In late erythroblasts, Bim, Bcl-xL and Fas expression are relatively unaffected by 
EpoR-stress signaling. Consistent with this, in Stat5-/- embryos and in EpoR-HM mice, 
where EpoR-Stat5 signaling is deficient, Bcl-xL levels are only modestly lower in late 
erythroblasts; the underlying pattern, likely GATA-1-mediated, of a gradual increase in 
Bcl-xL and decline in Bim, is preserved.  
Importantly, our results show that Stat5-regulated Bcl-xL expression in vivo varies 
with differentiation stage, with embryonic day, and with the phase of the stress response. 
???
These factors should therefore be considered in the interpretation of Bcl-xL measurements 
in vivo and in models of this system in vitro.  
Adaptation allows functional specialization of the Bcl-xL response to the acute phase 
of stress 
 The acute and chronic phases of the stress response differ in their requirements. 
At the onset of stress the speed of the response is paramount, a property that is 
unimportant during the chronic, maintenance phase. Here we find that the Bcl-xL 
response is significantly faster than Bim or Fas suppression. In addition, the Bcl-xL 
response undergoes rapid adaptation, which makes it insensitive to the prevailing 
absolute level of stress. Like other classical sensory adapting mechanisms, though, it is 
re-activated as soon as a new change in stress takes place. In this way, the dynamic range 
of the Bcl-xL response is extended, allowing a rapid response to changes in stress 
irrespective of the baseline stress levels. Our new data on the Bcl-xL pathway shows that 
distinct molecular mechanisms regulate the acute and chronic phases of stress. The EpoR 
is therefore capable of generating at least two broad types of signal: persistent, giving rise 
to persistent suppression of Bim and Fas, and a rapidly adapting signal, responsible for 
the adaptation of the Bcl-xL response (Figure A1.12B).  
Mechanism of adaptation in the Bcl-xL response 
We identified adaptation in the p-Stat5 response in erythroblasts in vivo and 
suggest this to be the mechanism of adaptation in the Bcl-xL response. Both p-Stat5 and 
Bcl-xL respond similarly to an ‘acute on chronic’ stress stimulus, a response typical of 
other biological adapting systems like sensory adaptation or neutrophil chemotaxis. 
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Adaptation of both p-Stat5 and Bcl-xL depends on the distal domain of the EpoR, a 
previously documented negative regulatory domain that contains docking sites for the 
Stat5-induced SOCS family of negative regulators [210] (Figure A1.12C). Negative 
feedback is a well-documented mechanism of adaptation in sensory systems [295, 296]. 
Stat5 transcriptionally activates SOCS inhibitors that feed back to limit Jak2 and Stat5 
activation [297]. Though well-documented, the precise effect of this pathway on the p-
Stat5 signal was not previously investigated. Here we found that in EpoR-H mice that 
lack this feedback inhibition, peak p-Stat5 signal intensity is not higher than in wild-type. 
However, the duration of the peak is prolonged (Figure A1.10D). Therefore, p-Stat5-
mediated negative feedback is likely responsible for the adaptation of both the p-Stat5 
and Bcl-xL responses. 
Implications for myeloproliferative disease mechanisms 
 The rapid adaptation of the Bcl-xL response to stress raises the possibility that 
prolonged periods in which Bcl-xL is elevated may be harmful. Indeed, persistently 
elevated levels of Bcl-xL are characteristic of Polycythemia Vera and other 
myeloproliferative syndromes [284, 285, 298]. High Bcl-xL was suggested as a cause of 
Epo-independent erythroid differentiation in Polycythemia Vera and of the apoptosis 
resistance of other myeloproliferative syndromes and neoplasms [284, 298, 299]. Our 
results, supported by recent reports of SOCS protein inactivation in myeloproliferative 
disease [300, 301], suggest that impairment of p-Stat5 and Bcl-xL adaptation may 
contribute to their prolonged activation. Together these point to the importance of 
adaptation in the Bcl-xL response as a homeostatic and tumor-suppressive mechanism. 
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Figure A1.12 Regulation of Bcl-xL and Bim expression in erythropoiesis. 
(A) Model depicting expression of Bcl-xL and Bim in the late and early erythroblast 
compartments, in basal erythropoiesis (solid lines) and during stress (fading shaded area). 
GATA-1 induces Bcl-xL and suppresses Bim with differentiation, with maximal 
responses achieved in late erythroblasts. During stress, EpoR signaling operates 
principally in the early erythroblast compartment, accelerating both Bim suppression and 
Bcl-xL induction. 
(B) Contrasting dynamic stress responses of the Bcl-xL, Bim and Fas pathways, both 
driven by the EpoR in the early erythroblast compartment. A sudden increase in stress 
drives a rapid, but transient adapting Bcl-xL response. This response is re-activated with a 
further change in the stress level, but is insensitive to the absolute level of stress. Bim and 
Fas suppression in response to stress is slower but persistent and reflects the level of 
stress.  
(C) Mechanism of adaptation in the Bcl-xL response. EpoR-HM activation of both p-
Stat5 and the Bcl-xL is drastically attenuated, due to the absence of Stat5 phosphotyrosine 
docking sites on the EpoR-HM mutant receptor, in support of the role of p-Stat5 in the 
EpoR and stress-induced Bcl-xL induction. In wild-type mice, the EpoR distal 
cytoplasmic domain binds p-Stat5-activated negative regulators of Jak2 and Stat5 such as 
SOCS3, SOCS2 and CIS, limiting the duration of both the p-Stat5 and the Bcl-xL 
responses. In EpoR-H mice, absence of the distal EpoR domain results in a prolonged 
response and loss of adaptation. 
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Material and Methods  
Mice 
 Stat5-/- mice were obtained from Dr. Lothar Hennighausen, (NIDDK, Bethesda, 
MD). β-thalassemia mice and the ts-VHL-/- mice were described previously [14]. Bim-/- 
mice: B6.129S1-Bcl2l11tm1.1Ast/J (stock #004525) were purchased from Jackson 
Laboratories (Bar Harbor, ME). EpoR-H and EpoR-HM mice were obtained from Dr. 
James Ihle, St. Jude Children’s Research hospital, Memphis, TN [46]. In all experiments, 
mice were matched for the same background strain and embryonic age. For low oxygen 
chamber experiments, Balb/C male littermates of 6 to 11 weeks of age were used. All 
experiments were conducted in accordance with an animal protocol approved by the 
University of Massachusetts Medical School IACUC committee. 
Erythropoietic stress  
 Recombinant human Epo (Epoetin alfa, Amgen, Thousand Oaks, CA) was 
injected subcutaneously in a total volume of 150 µl in sterile isotonic saline. Reduced 
atmospheric oxygen treatment was conducted using the BioSpherix A-chamber 
(BioSpherix, Lacona, NY). Hypoxia was achieved by displacing oxygen with nitrogen at 
normal atmospheric pressure. Temperature, humidity and carbon dioxide readings were 
monitored. 
Flow cytometry 
 Flow cytometry was performed on freshly explanted fetal liver, bone-marrow or 
spleen, as described [14, 19].  
Live cell surface-staining (as described in Chapter III). Cells from freshly isolated 
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tissues were gently strained through 40-μm strainer in the presence of cold phosphate-
buffered saline and 5% fetal calf serum (PBS/5% FCS) or 0.2% bovine-serum albumin 
(BSA). Cells were immunostained for 20-45 minutes on ice in the presence of blocking 
rabbit IgG (Jackson ImmunoResearch, West Grove, PA), 2.5 μg/mL fluorochrome-
conjugated anti-Ter119 (BD Biosciences, San Diego, CA), and 2.5 μg/mL fluorochrome-
conjugated anti-CD71 (BD Biosciences). 7-AAD (BD Biosciences) or DAPI (Roche, 
Indianapolis, IN) was used to exclude dead cells. Staining for Fas or FasL was for 1 hour 
on ice with 5 μg/mL biotin-conjugated anti-Fas (Jo2 clone, BD Biosciences) or 5 μg/mL 
biotin-conjugated anti-FasL (MFL3 clone, BD Biosciences) and APC-conjugated 
streptavidin (Invitrogen). Annexin V staining was carried out according to the 
manufacturer’s instructions (BD Biosciences).  
Intracellular protein staining. To detect intracellular Bcl-xL and Bim, cells were first 
stained with LIVE/DEAD fixable viability stain (Invitrogen), followed by surface-
labeling for Ter119 and CD71 in the presence of blocking IgG. Next, cells were fixed 
with PBS solution containing 3% paraformaldehyde and 2% sucrose, and permeabilized 
with BD Cytofix/CytopermTM Perm/Wash reagents, and stained in the Perm/Wash 
solution with anti-Ter119 (to maintain Ter119 signal in fixed cells) and with anti-Bcl-xL 
antiserum (BD Biosciences 556361) or anti-Bim antibody (Cell Signaling, #2819), or 
isotype control. Isotype control for Bcl-xL was Normal Rabbit Serum (Jackson 
Immunoresearch). Isotype control for Bim was Rabbit IgG (Jackson Immunoresearch). 
Primary Bcl-xL or Bim staining was detected using secondary antibody (anti-Rabbit-
APC, Invitrogen A-10931). Biological sample used for determining the isotype control’s 
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background fluorescence consisted of a cell mix pooled from all mouse samples in a 
given experiment (isotype signal was similar across individual biological samples 
regardless of genotype or treatment). 
Phospho-Stat5 staining. Cells were first stained with LIVE/DEAD viability dye, then 
resuspended in phosphowash (PBS, 1mM sodium orthovanadate, 1mM β-glycerol 
phosphate, 1μg/mL microcystin), fixed in 1.6% paraformaldehyde, permeabilized in 80% 
acetone and stored at -80°C. Thawed cells were stained in PBS/3% milk with AF647-
conjugated anti-phospho-Stat5 antibody (BD Biosciences, 612599) and for Ter119 and 
CD71 as described previously. For all flow cytometry experiments, cells were analyzed 
on LSR II flow cytometer (BD Biosciences). Cell sorting was done on a DakoCytomation 
MoFlo (Fort Collins, CO). 
Flow cytometry data analysis. Data were analyzed with FlowJo software (Tree Star, 
Ashland, OR) as described in Chapter IV [14, 208]. Singlets and live cells (based on 
DAPI, 7-AAD, or LIVE/DEAD stains) were selected, and subsets were gated based on 
Ter119, CD71 expression and forward scatter (FSC). Gating strategy for fetal liver and 
adult erythroblasts was performed as described in Chapter IV. For Fas surface stain, Fas-
positive gate was drawn based on secondary-only control, as described. For Annexin V, 
positive gate was drawn based on the sample where Annexin V stain was omitted, as 
described. For each subset in each biological sample, non-specific isotype control’s mean 
fluorescent intensity (MFI) signal was subtracted from the MFI of Bcl-xL or Bim prior to 
plotting the data. 
 
???
Quantitative real-time PCR 
 Total RNA was prepared from freshly sorted erythroblasts using the AllPrep 
DNA/RNA Micro Kit (Qiagen) with on column DNase treatment. Reverse-transcription 
was conducted using Superscript II (Invitrogen) with random hexamer primers. The ABI 
7300 sequence detection system, TaqMan reagents and TagMan MGB probes (Applied 
Biosystems) were used and several dilutions of each template were used to ensure 
detection in the linear range of the assay. A ‘no template’ and ‘no reverse-transcriptase’ 
controls were included. The threshold cycle (Ct) for housekeeping genes GAPDH or β-
actin were subtracted from the Ct for genes of interest to yield a relative expression value. 
The relative expression for each gene of interest in each sample was then normalized to 
expression in the S0 subset. QRT-PCR probes used: Gapdh (Mm99999915_g1), β-actin 
(Mm02619580_g1), β-globin (Mm01611268_g1). Bcl-xL primers were 
CTGGGACACTTTTGTGGATCTCT and GAAGCGCTCCTGGCCTTT. BimEL primers 
were TCTTTTGACACAGACAGGAGC and AATCATTTGCAAACACCCTCC. BimL 
primers detected both BimEL and BimL isoforms, and were 
CTCAGTGCAATGGCTTCCATA and AATCATTTGCAAACACCCTCC. 
CFU-e colony assay  
 Freshly isolated fetal liver cells were plated in M3231 Methocult® 
methylcellulose (StemCell Technologies, Vancouver, Canada) with the indicated dose of 
rh-Epo (Amgen). On day 3, plates were stained with 3,3'-Diaminobenzidine (Sigma-
Aldrich) and scored for erythroid colonies. 
 
???
Enzyme-linked Immunosorbent Assay (ELISA)  
 ELISA for endogenous mouse erythropoietin was performed according to the 
manufacturer’s instructions (Quantikine ELISA, R&D Systems, Minneapolis, MN). 
EnVision 2102 Multilabel Reader (Perkin Elmer, Waltham, MA) was used to quantify 
fluorescence. Data was converted into mU/ml by multiplying pg/ml value by 129,000 
IU/mg (International Standard for fully glycosylated Epo protein)[302]. 
Data analysis  
 Data analysis, including all statistical tests, was performed using Microsoft Excel 
Software (Redmond, WA), or GraphPad Prism Software (La Jolla, CA) where indicated. 
???
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